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ABSTRACT
This thesis focuses on classical and Bayesian mixed model analysis of microarray data for
detecting gene expression and DNA differences. It consists of three research papers. The first
study discusses the selection of gene specific linear mixed models in microarray data analysis.
In a microarray experiment, one experimental design is used to obtain expression measures
for all genes. One popular analysis method involves fitting the same linear mixed model for
each gene, obtaining gene-specific p-values for tests of interest involving fixed effects, and then
choosing a threshold for significance that is intended to control False Discovery Rate (FDR)
at a desired level. When one or more random factors have zero variance components for some
genes, the standard practice of fitting the same full linear mixed model for all genes can result
in failure to control FDR. We propose a new method which combines results from the fit of full
and selected linear mixed models to identify differentially expressed genes and provide FDR
control at target levels when the true underlying random effects structure varies across genes.
The second study discusses a hierarchical Bayesian modeling strategy for microarray data
analysis. Some microarray experiments have complex experimental designs that call for mod-
eling of multiple sources of variation through the inclusion of multiple random factors. While
large amounts of data on thousands of genes are collected in these experiments, the sample
size for each gene is usually small. Therefore, in a classical gene-by-gene mixed linear model
analysis, there will be very few degrees of freedom to estimate the variance components of all
random factors considered in the model and low statistical power for testing fixed effects of
interest. To address these challenges, we propose a hierarchical Bayesian modeling strategy
to account for important experimental factors and complex correlation structure among the
expression measurements for each gene. We use half-Cauchy priors for the standard deviation
xparameters of the random factors with few effects. We rank genes with respect to evidence
of differential expression across the levels of a factor of interest by calculating a single sum-
mary statistic per gene from the posterior distribution of the treatment effects considered in
the model. Simulation shows that our hierarchical Bayesian approach is much better than a
traditional gene-by-gene mixed linear model analysis at distinguishing differentially expressed
genes from non-differentially expressed genes.
The third study focuses on the identification of Single Feature Polymorphisms (SFPs)
using Affymetrix gene expression data. In microarray data analysis, the identification of SFPs
is important for producing more accurate expression measurements when comparing samples
of different genotypes. Also, portions of DNA that differ between parental lines can serve
as markers for tracking DNA inheritance in offspring. We summarize several SFPs discovery
methods in the literature. To identify single probes defining SFPs in the data, we developed
two new algorithms where a difference value is defined for each probe after accounting for
the overall gene expression level differences in the probe set. The first method contrast the
difference value of each probe with the average of the difference values for the rest of the probes
in that probe set. Second method is a robust version of the first method. The performance
of all methods are compared through two publicly available published data sets, where truth
about the sequence polymorphism is known for some “Gold Standard” probes. It was shown
that our algorithms provided performance superior to the other methods in ordering probes
for evidence of SFPs.
1CHAPTER 1. General Introduction
Introduction:
Microarray technology has become an important tool in conducting biological research. It
provides simultaneous measurements for the abundance of thousands of mRNA transcripts in
multiple biological samples. These measurements are used to detect differentially expressed
genes over different experimental conditions, time points, tissue samples, etc. Microarray ex-
periments allow scientists to understand gene functions and learn how genes work together
to carry out biological process. Based on the biological interest, microarray experiments are
designed in various ways and based on the design, different statistical methods have been
proposed for identifying differentially expressed genes. When the experiments have complex
experimental designs that call for modeling of multiple sources of variation through the inclu-
sion of multiple random factors, the use of linear mixed models is one of the common choice
to make inference for each of thousands of genes. The motivation of this thesis is to provide
improvement over analyses of microarray data that use linear mixed model for each gene.
In a microarray experiment, one experimental design is used to obtain expression measures
for all genes. Traditional analysis method involves fitting the same linear mixed model for each
gene, obtaining gene-specific p-values for the test of interest involving fixed effects and then
choosing a threshold for significance that is intended to control False Discovery Rate (FDR) at
a desired level. The primary focus in this analysis is the inference for fixed parameters. Such
inference depends on the correct choice of random factors in each linear mixed model. Even
though every gene shares the same experimental design, one or more random factors may affect
the expression of only a subset of all measured genes. Then the standard practice of fitting
the same full linear mixed model for all genes can result in failure to control FDR. Therefore
2we propose a new method which combines results from the fit of full and selected linear mixed
models to identify differentially expressed genes and provide FDR control at target levels when
the true underlying random effects structure varies across genes.
Some biological problems require microarray experiments to have complex experimental de-
signs. The linear mixed model need to include multiple random factor to account for multiple
sources of variation. While large amounts of data on thousands of genes are collected in these
experiments, the sample size for each gene is usually small. When a classical gene-by-gene
mixed linear model analysis is conducted, there will be very few degrees of freedom to estimate
the variance components of all random factors considered in the model and low statistical
power for testing fixed effect(s) of interest. To address these challenges, it is common to use
Bayesian models, which borrows strength across genes in estimating the gene specific parame-
ters. One important requirement for this method to work properly is to choose the right prior
distribution to account for the shared information between genes on the same array. We pro-
pose a hierarchical Bayesian modeling strategy to account for important experimental factors
and complex correlation structure among the expression measurements for each gene. Instead
of classical prior choices for variance parameters, this model make use of the half-Cauchy priors
for the standard deviation parameters of the random factors with few effects. We rank genes
with respect to evidence of differential expression across the levels of a factor of interest by
calculating a single summary statistic per gene from the posterior distribution of the fixed
treatment effects considered in the model. We showed that our hierarchical Bayesian approach
is much better than a traditional gene-by-gene mixed linear model analysis at distinguishing
differentially expressed genes from non-differentially expressed genes.
In many microarray experiments, high-density oligonucleotide arrays are often used for
measuring gene expression levels over different experimental conditions, time points, tissue
samples. These arrays are also used for identifying possible DNA differences between genotypes,
which include single nucleotide polymorphisms (SNPs) and insertion/deletions polymorphisms
(IDPs) (Cui et al., 2005). Polymorphisms detected by a single probe in an oligonucleotide array
are called a single-feature polymorphism (SFPs), where a feature refers to a probe in the array
3(Borevitz et al., 2003). The identification of SFPs is important for producing more accurate
expression measurements when comparing samples of different genotypes. Also, portions of
DNA that differ between parental lines can serve as markers for tracking DNA inheritance
in offspring. Therefore, there is need for new statistical methods to identify possible SFPs
between genotypes. We address this problem by introducing two new statistical algorithms
that make use of the linear mixed model analysis.
Finally, microarray experiments arise many challenging statistical problems, which moti-
vates statistician to search for more appropriate methods in microarray data analysis. By this
thesis, we provided an improvement over some current statistical analyses of microarray data
that use the linear mixed models.
Thesis Organization:
This thesis consists of an introduction, three research papers, and a conclusion.
The second chapter is a paper accepted by Biometrics for publication. It focuses on se-
lection of gene specific linear mixed models in microarray data analysis. The objective is to
provide an improvement over analyses of microarray data that use the same linear mixed model
for each gene. We proposed a two-step hybrid method for identifying differentially expressed
genes with linear mixed model analysis. We have shown that our method provides better rank-
ing with respect to evidence of differential expression across the levels of a factor of interest
and FDR control at target levels. We used a barley microarray experiment as a motivating
example.
The third chapter is an unpublished manuscript in which we present a hierarchical Bayesian
modeling strategy for microarray data analysis. When the classical gene-by-gene linear mixed
models cannot provide precise estimates of gene specific parameters due the small sample size
for each gene, our hierarchical Bayesian model borrows strength across genes in estimating
the gene specific parameters. We showed that with the right prior selection, the hierarchical
Bayesian approach is much better than a traditional gene-by-gene mixed linear model analysis
at distinguishing differentially expressed genes from non-differentially expressed genes.
The fourth chapter is also an unpublished manuscript which focuses on the identifica-
4tion of Single Feature Polymorphisms using Affymetrix gene expression data. In microarray
data analysis, the identification of SFPs is important for producing more accurate expression
measurements when comparing samples of different genotypes. We summarized several SFP
discovery methods in the literature, and additionally, we introduced two new algorithms. The
performances of all methods were compared through two publicly available published data sets,
where truth about the sequence polymorphism is known for some “Gold Standard” probes. It
was shown that our algorithms provided performance superior to the other methods in ordering
probes for evidence of SFPs.
Chapter 5 provides a brief summary and general discussion.
5CHAPTER 2. Linear Mixed Model Selection for False Discovery Rate
Control in Microarray Data Analysis
A paper accepted by Biometrics
Cumhur Yusuf Demirkale, Dan Nettleton, and Tapabrata Maiti
Abstract: In a microarray experiment, one experimental design is used to obtain expression
measures for all genes. One popular analysis method involves fitting the same linear mixed
model for each gene, obtaining gene-specific p-values for tests of interest involving fixed effects,
and then choosing a threshold for significance that is intended to control False Discovery Rate
(FDR) at a desired level. When one or more random factors have zero variance components
for some genes, the standard practice of fitting the same full linear mixed model for all genes
can result in failure to control FDR. We propose a new method which combines results from
the fit of full and selected linear mixed models to identify differentially expressed genes and
provide FDR control at target levels when the true underlying random effects structure varies
across genes.
KEY WORDS: Analysis of variance; Method of moments; Multiple testing; Restricted maxi-
mum likelihood; SAS; Variance component estimation.
2.1 Introduction
Microarray technology provides a means for simultaneously measuring the abundance of
thousands of mRNA transcripts in multiple biological samples. These measurements are used
to detect differentially expressed genes over different experimental conditions, time points,
6tissue samples, etc. Many statistical methods for identifying differentially expressed genes
have been proposed in the statistics literature in recent years.
One popular strategy involves conducting a linear mixed model analysis for each of thou-
sands of genes. The basic approach was first proposed by Wolfinger et al. (2001) and has been
applied in various forms by many researchers. The use of linear mixed modeling is convenient
because such models allow for a natural and principled accounting for multiple sources of vari-
ation. Because all the observations from a single microarray slide or chip share the same levels
of all factors in a microarray experiment, the same experimental design applies to every gene.
Thus, it is customary to fit the same linear mixed model for each gene. The common model
is fit separately to the data from each gene to allow model parameters to be gene-specific.
Tests for fixed effects of interest are carried out for each gene, and some correction for multiple
testing is employed to help focus attention on the most relevant results.
False Discovery Rate (FDR) has become the most common error measure to control or
estimate when declaring genes to be differentially expressed. FDR was first introduced by
Benjamini and Hochberg (1995) and is formally defined as E(Q) where Q is the proportion of
mistakenly rejected null hypotheses among all rejected null hypotheses or 0 if no hypotheses
are rejected. Among many other approaches, Storey and Tibshirani’s (2003) method for FDR
estimation has become a popular procedure that is less conservative than the original proposal
of Benjamini and Hochberg.
When applying linear mixed models in microarray analysis, inference for the fixed param-
eters is the primary focus. Such inference depends on the correct choice of random factors in
each linear mixed model. Even though every gene shares the same experimental design, one or
more random factors may affect the expression of only a subset of all measured genes. Thus,
an analysis that fits the same linear mixed model for each gene may not provide correct fixed
effect inferences, and it may be important to consider strategies for selecting the most appro-
priate random factors on a gene-by-gene basis. Ideally, random factors with positive variance
should be retained while those with zero variance components should be excluded. Tests for
nonzero variance components could be used to identify relevant random factors. However,
7available tests (e.g., Stram and Lee, 1994; Lin, 1997; Hall and Praestgaard, 2001) are only
valid asymptotically. As the sample size for each gene is usually small, application of these
tests to microarray data may be problematic.
A novel approach proposed by Chen and Dunson (2003) is to use a hierarchical Bayesian
model for random-effects model selection, based on a decomposition of the covariance matrix of
the random-effects distribution. The decomposition enables specification of a prior distribution
that allocates positive probability to reduced models that exclude one or more random effects
by setting their variances to zero. Although this method worked well for their simulated data,
the application of this method to a simulated data set mimicking microarray data described
in the next section was not successful, perhaps because of the limited per-gene sample sizes
typical in microarray experiments. Additionally, this method is computationally intensive so
that it is impractical to apply to each of thousands of genes in a microarray experiment.
Statistical analysts often use standard model selection measures such as Akaike’s informa-
tion criterion (AIC) or Bayesian information criterion (BIC) to compare models with different
random components. Although using AIC or BIC to choose random factors may be asymp-
totically effective, application of these methods to analysis of a small data set for each gene
from a microarray experiment may not be successful. In general for small data sets, these in-
formation criteria unfortunately often fail to identify the correct covariance structure (Gomez
et al. 2005). Furthermore, fixed effects testing following AIC or BIC model selection may not
lead to valid inferences. In particular, we demonstrate in Section 2.4 that FDR controlling
procedures can fail seriously when applied to p-values from tests of fixed effects from AIC- or
BIC-selected linear mixed models.
In this paper, we propose a two-step hybrid method for identifying differentially expressed
genes with linear mixed model analysis. Our method offers an improvement over analyses of
microarray data that use the same linear mixed model for each gene. In the first step, we fit
a full model for each gene based on the design of the experiment and produce a traditional
ANOVA table. We construct F -tests for each fixed factor of interest based on appropriate
ratios of mean squares to obtain a list of p-values (one for each gene) for any fixed factor of
8interest. Each list of p-values is used in conjunction with a standard FDR estimation procedure
to find the number of genes to be declared as differentially expressed while controlling FDR
at a specified level. In the second step, a gene-specific model is determined by using BIC
to select the random part of the model among all random factors considered based on the
design of the experiment. An hypothesis test of a fixed factor is performed by fitting the BIC
favored model for each gene. Genes are ordered with respect to the p-values from this analysis.
A target level false discovery rate is achieved for this list by declaring the same number of
genes to be differentially expressed as identified in the first step. Therefore, the new method
combines results from the fit of full and selected linear mixed models to identify differentially
expressed genes and provides FDR control at target levels when the true underlying random
effects structure varies across genes.
Our approach is motivated by several key observations that we note below and illustrate
in subsequent sections of this paper. First, the traditional ANOVA analysis described above
provides valid p-values as long as the true model is either the full linear mixed model or a
reduced linear mixed model that contains a subset of the factors in the full model. Second,
fixed effects inference following model selection is too liberal; i.e., estimated FDR levels tend
to be much lower than the actual FDR. Third, although model selection prior to fixed effects
inference leads to underestimation of FDR, the rank ordering of genes from most significant
to least significant that is produced by model selection prior to testing is superior to the rank
ordering produced by the traditional ANOVA analysis. Taken together, these observations
imply that our procedure will be superior to a traditional full-model ANOVA analysis with
regard to identification of differentially expressed genes but will also control FDR. Thus, our
procedure maintains the most desirable features of full-model ANOVA analysis and analysis
following model selection.
2.2 Example: Gene Expression in Barley
Caldo, Nettleton and Wise (2004) conducted a microarray experiment to identify barley
genes that play a role in resistance to a fungal pathogen. To illustrate our methods, we describe
9the analysis of a subset of the data they considered.
2.2.1 Data
Two genotypes of barley seedlings, one resistant and one susceptible to a fungal pathogen,
were grown in separate trays randomly positioned in a growth chamber. Each tray contained
six rows of 15 seedings each. The six rows in each tray were randomly assigned to six tissue
collection times: 0, 8, 16, 20, 24, and 32 hours after fungal inoculation. After simultaneously
inoculating plants with the pathogen, each row of plants was harvested at its randomly assigned
time. One Affymetrix GeneChip was used to measure gene expression in the plant material
from a pool of the 15 seedlings in each row. The entire process was independently repeated
a total of three times, yielding data on 22,840 probe sets (corresponding to barley genes) for
each of the 36 GeneChips (two genotypes × six time points × three replications). The actual
experiment involved a third barley genotype as well as a second infection type, but we focus
on the reduced data set here to simplify the presentation of our main ideas. The expression
levels in the reduced data were log-transformed and median centered before an analysis was
performed.
2.2.2 Linear Mixed Model
The design of the experiment can be viewed as a split-plot with replications as blocks, trays
as whole plots and rows of seedlings within trays as split plots. Note that although time is
a factor in this experiment, this is not a repeated-measures design because no one plant or
pool of plants is measured at multiple time points. Instead, because the measurement process
is destructive, different randomly selected plants are sampled at each time. Therefore the
following linear mixed model corresponding to the split-plot design was considered as a base
model for each gene. Let
Yijk = µ+ γj + τk + θjk + αi + βij + δik + ǫijk (2.1)
i = 1, 2, 3; j = 1, 2; k = 1, . . . , 6;
10
where Yijk is the observed intensity of a gene at the k
th harvesting time for the jth genotype
during the ith replication, γj is the fixed genotype effect, τk is the fixed tissue collection time
effect, θjk is the genotype-by-time interaction effect, αi ∼ NID(0, σ
2
α) is the random replica-
tion effect, βij ∼ NID(0, σ
2
β) is the replication-by-genotype interaction effect (corresponding to
trays) , δik ∼ NID(0, σ
2
δ ) is the replication-by-time interaction effect, and ǫijk ∼ NID(0, σ
2
ǫ )
is the error (NID=Normally and Independently Distributed). Though not standard for a
split-plot design, the replication-by-time interaction effects were included to account for the
possibility of variation across harvest events; one random effect was included for each combi-
nation of replication and time so that the two observations for the two samples (one of each
genotype) collected at any one time in any one replication were allowed to be correlated due to
the shared replication-by-time random effect. All the random effects are assumed to be jointly
independently distributed and to be independent of the residual errors.
For each gene, this linear mixed model was fit to the 36 log-scale measures of expression
using the SAS PROC MIXED procedure. Scientists were interested in identifying barley genes
that play a role in resistance to the fungal pathogen. Such genes were expected to show patterns
of expression over time that differed between the two genotypes. Therefore, the hypothesis
test for interaction between genotype and time was considered to be of primary importance
for each linear mixed model analysis, though tests for genotype main effects and time main
effects were conducted also. Restricted Maximum Likelihood (REML) was used to estimate
the variance components, and the Kenward-Roger (KR) method (Kenward and Roger, 1997)
was used to determine the denominator degrees of freedom and F -statistics for tests of fixed
effects. Applying the method of Storey and Tibshirani (2003) to obtain nominal control of
FDR at 1% yielded a total of 399, 13202, and 93 genes for the tests of genotype, time, and
interaction effects, respectively.
For each of the 22,840 genes, SAS PROC MIXED also produced REML estimates of the
three variance components corresponding to three random factors. The variance component
estimate for replication, replication-by-genotype, and replication-by-time was reported as zero
for a total of 8153, 7824, and 7235 genes, respectively. For these genes, SAS PROC MIXED
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with KR adjustment automatically fits a reduced model that excludes random factors whose
variance component estimates are zero. Thus, this common analysis strategy employs an
implicit gene-specific model selection step where random factors are selected for the model if
and only if their variance component estimates are positive. Considering the full model or
a reduced model may alter the result of any fixed-effect test substantially. In Section 4, we
investigate the impact of this and other model selection strategies on tests for fixed-effects
inference in linear mixed model analysis of microarray data when correct random structure
varies from gene to gene.
2.3 Candidate Analysis Methods
In this section, we describe five methods for conducting gene-by-gene linear mixed model
analysis of our microarray data set. Our list of methods is, of course, not exhaustive. However,
we have included what we believe are the five most obvious choices, and it is easy to generalize
our final recommendation to incorporate other strategies. We first list the five methods and
then provide some additional explanation of the methods before comparing them in a simulation
study in Section 4.
1. SKR: REML estimation of variance components with the KR method for conducting
fixed-effects inference.
2. SC: REML estimation of variance components with SAS’s containment method for con-
ducting fixed-effects inference.
3. SAIC: Selection of random factors according to Akaike’s Information Criterion (AIC)
followed by analysis of the selected model using REML estimation of variance components
with the KR method for conducting fixed-effects inference.
4. SBIC: Selection of random factors according to Schwarz’s Bayesian Information Criterion
(BIC) followed by analysis of the selected model using REML estimation of variance
components with the KR method for conducting fixed-effects inference.
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5. ANOVA : Full model fitting using the method of moments to estimate variance compo-
nents and F -test construction based on expected mean squares.
Note that, for our experimental design and tests, methods 1, 2, and 5 produce identical p-values
when all REML variance component estimates are positive. All five methods produce identical
p-values when all REML variance component estimates are positive and AIC and BIC each
select the full model.
2.3.1 Methods Involving Selection
The first four methods have abbreviations that begin with S to indicate that some form
of model selection is employed. If there are q random factors, 2q candidate models can be
considered. According to the experimental design of the barley data set described in Section
2.1, three random factors were considered in the full model for each gene. Therefore we can
choose the best model for each gene among 23 = 8 models. For the SKR and SC approaches, the
model selection is simply carried out by removing random factors whose variance components
are estimated to be zero. The SKR approach was described in Section 2.2.2. The SC approach
differs from SKR in that the denominator degrees of freedom used for testing genotype, time,
and genotype-by-time interaction are held constant at their full model values of 2, 10, and 10,
respectively, regardless of which variance components are estimated to be zero.
The SAIC and SBIC approaches use the standard model selection measures AIC and BIC
to choose random factors. For each of these models, AIC and BIC are calculated by SAS
PROC MIXED as
AIC = −2l + 2d and BIC = −2l + d log(n),
respectively, where l is the maximized log-likelihood (ML) or maximized restricted log-likelihood
(REML), d is the total number of parameters in the model (ML) or number of parameters in
the covariance structure (REML), and n equals the number of levels of the first random factor
specified in the model. A model with smaller AIC or BIC is considered to be better. We used
the total number of observations per gene (36 in our data set) as n when using BIC to compare
models with different random factors. We argue in Appendix A that this is preferable to the
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SAS default which depends on the order that factors are listed in the RANDOM statement and
can lead to obviously poor model choices when leading factors have zero variance component
estimates.
Eight models were fitted for each of 22,840 genes in the barley data set. AIC and BIC were
used to select random factors for each gene. The number of models favored by AIC and BIC
are reported in Table 2.1. For example, for 4277 genes, AIC chose a model whose random part
consisted of the replication random factor only, whereas BIC favored this same model for 3787
genes. Gomez et al. (2005) conducted a simulation study regarding the performance of AIC and
BIC in selecting the true covariance structure from a large set of repeated-measures covariance
structures. In Appendix A, we examine the effectiveness of AIC and BIC covariance selection
in the context of our linear mixed model and present findings similar to those of Gomez et al.
(2005).
2.3.2 The ANOVA Approach
The ANOVA approach involves no model selection. The full model is fit to every gene
regardless of variance component estimates or information criteria. The classical analysis of
variance (ANOVA) table is used to construct F -tests for the fixed effects of interest. The test
statistic for testing each fixed factor is defined by
F =
SSFF /df1
SSRF /df2
, (2.2)
where SSFF and df1 are the sum of square and degrees of freedom with respect to a fixed
factor of interest, respectively, and SSRF and df2 are the sum of squares for the random
factor corresponding to the experimental units of the fixed factor and its degrees of freedom,
respectively. The expected mean squares E(SSFF /df1) and E(SSRF /df2) are identical when
the null hypothesis is true. Under the standard linear mixed model assumptions outlined
previously, the test statistic follows an F -distribution under the null hypothesis, even if one
or more true variance components are zero. Details for our model and tests are provided in
Web Appendix B. These ANOVA-based F -tests are easily obtained with SAS PROC MIXED
by setting METHOD=TYPE3.
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2.4 Simulation Study
The power and type I error properties of tests of fixed-effects following random factor
selection are generally unknown and analytically intractable. Nonetheless, some type of data-
dependent model selection – either formal or informal – is commonly used by data analysts
when fitting linear mixed models to individual data sets. Because microarray data analysis
involves thousands of such analyses, the impact of model selection on inferential properties
can be dramatic. In this section, we describe a large data-driven simulation study designed to
examine the performance of the methods described in Section 2.3.
2.4.1 Simulation Design
Fifty data sets, each containing 22,840 genes, were generated from versions of the linear
mixed model (1) described in Section 2.2.2. When simulating the data sets, we mimicked the
original barley data by generating a random effects structure for each gene that matched the
random effects structure of the model selected by AIC for that gene (see Table 2.1). The
selected random effects were sampled independently from normal distributions with mean zero
and variance equal to the variance component estimate of the corresponding random factor.
Genotype, time, and genotype-by-time interaction effects were set to zero for 90% of the genes
in each data set. For the other 10% of the genes in each data set, the observed gene-specific
means for each combination of genotype and time in the original barley data were added to
the normally distributed mean-zero random effects to create non-null genotype, time, and
genotype-by-time interaction effects for these genes.
The five methods described in Section 2.3 were used to analyze each of the 50 data sets.
One set of 22,840 p-values was produced for each combination of data set, method, and test
(genotype, time, or interaction) for a total of over 17 million p-values. More than 9 million
linear mixed model analyses were conducted because the SAIC and SBIC methods required
that 8 models be fit to each data set and gene. Each set of 22,840 p-values was converted to
q-values using the method of Storey and Tibshirani (2003), and these q-values were used to
produce estimates of FDR for any significance threshold.
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2.4.2 Simulation Results
In this section, we describe the performance of our methods for the test of genotype-by-
time interaction which is of primary interest in our application. Analogous results, including
tables and figures, are presented for the test of genotype main effects and time main effects
in Appendix C. For the test of interaction, we begin with an examination of receiver oper-
ator characteristic (ROC) curves to compare the effectiveness of the methods for separating
differentially and non-differentially expressed genes. The p-values produced by each method
provide a rank order of genes from most evidence for differential expression to least evidence.
The quality of the ranking varies from method to method and can be judged by comparing
ROC curves. The greater the area under an ROC curve the better the corresponding method
is at distinguishing null genes from non-null genes. The left panel of Figure 2.12.3 shows ROC
curves for the five methods averaged over the 50 simulated data sets. The patterns of the
curves and differences among the curves were quite similar for each simulation run so little in-
formation is lost by averaging. Differences among the curves are statistically significant except
for the SAIC and SBIC comparison. For example, pointwise standard errors are approximately
0.001 or less at 1−specificity values of 0.005, 0.015, and 0.025; and simple sign tests for pair-
wise differences between the curves at these 1−specificity values yield significance at below the
0.000001 level for all comparisons except SAIC vs. SBIC. Note also that we have plotted the
curves over only the most informative ranges of sensitivity and 1− specificity. The left panel of
the figure shows that an analysis with AIC or BIC selected models is slightly more effective at
distinguishing non-null from null genes than the SKR approach. The SC approach lags behind
the SKR approach, and the ANOVA method is least effective.
The ability to correctly rank genes with regard to evidence for differential expression is
clearly important because the goal of our analysis is to identify differentially expressed genes.
However, the effectiveness of a method at ranking genes is not the only important measure
of performance. Good statistical procedures include an accurate assessment of the degree of
uncertainty associated with an analysis. In microarray analysis, it is common to produce a list
of differentially expressed genes and an estimated false discovery rate. The number of genes
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placed on the list is often determined by the FDR level that a researcher is willing to tolerate.
Thus, we now investigate the FDR control properties of our five methods.
Using notation from the seminal FDR paper by Benjamini and Hochberg (1995), we let
V = the number of type I errors when the R tests with the smallest p-values are declared to
be non-null. Separately for each set of p-values, we recorded the actual false positive fraction
(V/R) and the estimated FDR level (F̂DR given by the q-value for the Rth gene) for all values
of R from 1 to 22,840. We averaged the results for each method over the 50 data sets to
obtain the right panel of Figure 2.12.3. Again, the results for individual data sets were quite
consistent so that no important information was lost by averaging.
Ideally, the plotted curves would fall on or above the diagonal reference line to indicate
that the actual average false positive fraction (V/R) was no larger than the average estimated
FDR level. For all methods that involve some form of model selection, the estimated curves
fell substantially below the reference line. This indicates a clear problem with FDR control
for these methods. In contrast, the ANOVA approach produced FDR estimates that were on
average very close to the actual average false positive fraction. This is expected because the
ANOVA-based F -tests have the correct size as discussed in Appendix B.
The top portion of Table 2.2 further illustrates the error control properties of our proce-
dures. For each of the 50 data sets and each of the five methods discussed in Section 3, the
approach of Storey and Tibshirani (2003) was used to generate lists of significant genes for
nominal FDR control at the 0.01 and 0.05 levels. The number of genes on each list and the
number of false positives on each list was recorded. The average V/R fraction and the average
number of genes on the list across the 50 data sets were computed. Although the ANOVA ap-
proach identified the fewest genes on average, it was the only procedure that provided control
of FDR at or below nominal levels. Note that the SKR and SAIC approaches had estimated
FDR levels (V/R) more than twice the nominal rate. Although not presented in Table 2.2, for
each of the 50 data sets, the false positive fraction was always higher than the nominal FDR
levels (0.01 and 0.05) for the first four methods in the Table 2.2.
The results in this section present a challenging situation summarized as follows. Of the
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five analysis methods, the one that is least effective at distinguishing null from non-null tests
(ANOVA) is the only approach that appropriately controls type I error rate for each individual
test and the FDR for a family of tests. In the next section, we discuss a hybrid procedure that
combines the positive attributes of the testing procedures into a single approach that provides
good power for distinguishing null and non-null tests while controlling FDR.
2.5 Two-Stage Hybrid Method
2.5.1 Description
We propose a hybrid method which combines results from the fit of full and selected linear
mixed models to identify differentially expressed genes and provide FDR control at target levels
when the true underlying random effects structure varies across genes. The two-step procedure
can be described as follows:
1. For each gene, perform the ANOVA F -test of fixed effects. For any test of a fixed factor of
interest, estimate FDR by using the method of Storey and Tibshirani (2003) or any other
method with similar FDR controlling properties. For a desired level of FDR, determine
D = the number of genes to be declared as differentially expressed.
2. For q possible random factors in the design of the experiment, fit all 2q possible models
for each gene. Find the model with the lowest AIC or BIC value for each gene and obtain
the p-value for the test of interest from that model. Declare the D genes with the D
smallest p-values to be differentially expressed, where D is as determined in step 1.
Because both the AIC- and BIC-selected models better distinguish null and non-null genes
than the ANOVA approach, this hybrid method will have lower FDR and better power than
the ANOVA approach. Because the ANOVA approach appropriately controls FDR, the hybrid
will also control FDR – albeit at lower levels than nominal. We demonstrate these properties
via simulation in the next subsection.
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2.5.2 Application to Simulated data
To illustrate the performance of the hybrid method in identifying differentially expressed
genes and providing FDR control at or below target levels, 50 microarray data sets were
generated. As described in Section 2.4, in each data set, the true underlying random effects
structure varied across genes, and the data for 10% of the genes were simulated with non-zero
genotype, time, and interaction effects.
We applied the hybrid method using AIC model selection in step 2 and also using BIC model
selection in step 2. We also considered the hybrid approach where the full model fit with the
KR method and containment method were used in step 2 rather than either of the formal
model selection approaches. These methods are referred to as ANOVA-SAIC, ANOVA-SBIC,
ANOVA-SKR, and ANOVA-SC, respectively, in the results presented below. For brevity, we
report the results only for the test of interaction between genotype and time. Similar results
for the test of genotype and time are discussed in Appendix C.
As for the methods of Section 2.3, we calculated the length of the significant gene list
and the true false positive fraction (V/R) associated with each of the gene lists for each
data set and averaged over the 50 data sets. The results are presented in the lower portion
of Table 2.2. By comparison with the top portion of Table 2.2, we can see that each of
the two-step hybrid methods improved on the ANOVA approach by providing smaller false
positive fractions than the ANOVA approach. In practice, the hybrid approach will identify
the same number of genes as ANOVA but will tend to include more genes that are truly
differentially expressed than ANOVA alone. Though our simulation results show that all
the hybrid methods provided FDR control at better than nominal levels, ANOVA-SAIC and
ANOVA-SBIC outperformed ANOVA-SKR and, especially, ANOVA-SC. Thus, we recommend
either ANOVA-SAIC or ANOVA-SBIC in practice.
2.5.3 Application of the Hybrid Method to the Barley Data
Scientists were interested in identifying barley genes that play a role in resistance to a
fungal pathogen. Such genes are believed to have patterns of expression over time following
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infection that differ between susceptible and resistant genotypes. Therefore, we are particularly
interested in identifying genes that exhibit interaction between genotype and time.
Table 2.3 shows the number of genes identified as differentially expressed at nominal FDR
levels of 0.01 and 0.05 using each of the nine methods that we have studied in this paper. The
gene lists produced by the recommended methods ANOVA-SAIC and ANOVA-SBIC differed
from each other by 2 and 23 genes at nominal FDR of 0.01 and 0.05, respectively, and differed
from the pure ANOVA approach by 17 and 86 genes (ANOVA-SAIC) and 15 and 89 genes
(ANOVA-SBIC). Either the ANOVA-SAIC gene lists or the ANOVA-SBIC gene lists would be
appropriate to use in practice. Although the first four methods in Table 2.3 provided longer
gene lists, the simulations in Section 2.4 suggest that FDR levels will be higher than nominal
for these procedures.
2.6 Performance when ANOVA Tests are Not Exact
Although our proposed method is versatile and can be applied to data from many complex
experimental designs, the approach is not guaranteed to perform well when ANOVA-based
F -tests are not exact. An approximate F -test will not necessarily control type I error rates at
nominal levels, especially when sample sizes are small. If the type I error rate of an individual
test is not controlled, the usual FDR controlling procedures will fail in the multiple hypothesis
testing setting.
In practice, there are several situations in which ANOVA-based F -tests may fail to be ex-
act. Missing data or the presence of outlying observations are two related problems commonly
encountered in microarray analysis that can lead to non-exact tests. Due to the technological
challenges of measuring the expression of thousands of genes simultaneously in multiple sam-
ples, some outlying observations are inevitable. If such observations are included as part of the
data set, the error distribution tends to be heavy-tailed for at least some genes, and the usual
assumption of normally distributed errors becomes questionable. As an alternative, some data
analysts favor strategies that involve automated outlier detection and removal. The impact of
these often ad hoc strategies on the inferential properties of subsequent tests is unknown and
20
cannot be studied here. However, we have conducted additional simulation studies to assess
the effect of either heavy-tailed errors or missing data on our proposed analysis strategies.
2.6.1 Assessing the Impact of Heavy-Tailed Errors
The simulation study described in Subsection 2.4.1 was repeated using scaled t-distributed
errors rather than normal errors. For each gene, the ǫijk terms in model (1) were obtained
by drawing 36 independent observations from a t distribution with five degrees of freedom.
These observations were then multiplied by the gene-specific error standard deviation that was
estimated from the original barley data. Other than a decrease in power for all methods, the
results were essentially the same as those discussed in Sections 2.4 and 2.5. In particular, for
the interaction test, the ANOVA approach controlled FDR at the 0.01 and 0.05 levels, the
methods involving selection were too liberal, and the hybrid approaches ANOVA-SAIC and
ANOVA-SBIC performed best overall. The complete results – including figures and tables
for the tests of genotype main effects, time main effects, and interaction – are provided in
Appendix D.
2.6.2 Assessing the Impact of Missing Data
Imbalance in data due to missing observations can make some ANOVA F -tests non-exact.
In our case, the test for interaction between genotype and time remains exact when data are
missing completely at random. In contrast, the ANOVA F -tests for genotype and time main
effects become only approximate (unless data remain balanced following the loss of a complete
replication). To study the effect of imbalance caused by missing data on ANOVA-based mixed
linear model analyses, we conducted two new variations of the simulation study described
in Subsection 4.1. In the first version, three entire gene chips were randomly selected and
removed from the data set so that all genes were missing three of their 36 observations. In
the second version, four genotype-by-time combinations were randomly selected and two of the
three observations for each selected combination were randomly selected for removal from the
data set. This process was done separately for each gene. Thus, in the second version of the
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simulation study, a random eight of the 36 observations were missing for each gene.
Table 2.4 presents results for the test of interaction between genotype and time when data
are missing. By comparison with Table 2.2, it is clear that all methods suffered a decrease
in power as the proportion of missing data increased. Also, the failure of the SKR, SAIC,
and SBIC methods to control FDR worsened as the proportion of missing data increased. In
contrast, the liberal bias of the SC method – although still clearly evident at the nominal
5% level – was reduced by missing data. The ANOVA method and all hybrid approaches
continued to control FDR at or below nominal levels. As in the case of no missing data, the
ANOVA-SAIC and ANOVA-SBIC methods provided the best performance among methods
that controlled FDR. However, note that when eight of the 36 observations were missing for
each gene, the ANOVA and hybrid approaches had almost no power to identify differentially
expressed genes. This is not surprising given that nearly one fourth of each data set was missing
and only two error degrees of freedom were available for nearly half the genes. Although the
ANOVA tests for genotype and time main effects defined in (2.2) are no longer exact when
data are missing, control of FDR below nominal levels was obtained for both of our missing
data scenarios. Complete results for the tests of genotype and time main effects are provided
in Appendix D.
2.7 Concluding Remarks
We have focused on the specific problem of using linear mixed model analyses of microarray
data to control the false discovery rate when identifying differentially expressed genes. Our
main idea applies in greater generality. Consider any multiple hypothesis testing problem
involving N tests where FDR control is desired. Consider two procedures (denoted P1 and P2)
for ranking the tests from most evidence against the null hypothesis to least evidence. Suppose
that it is possible to determine R1 = the number of tests according to P1 to declare non-null
so that FDR will be controlled at level α. By definition of FDR, this means that
E[V1(R1)/(R1 ∨ 1)] ≤ α, (2.3)
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where Vk(r) denotes the number of true null hypotheses among the top r tests as ranked by
procedure Pk. Suppose that
E[V1(r)] ≥ E[V2(r)] for all r = 1, . . . , N. (2.4)
It is straightforward to show that (2.3) and (2.4) imply E[V2(R1)/(R1 ∨ 1)] ≤ α. Thus, using
procedure P1 to determine the number of null hypotheses to reject while using procedure P2
to determine which null hypotheses to reject will control FDR and provide fewer type 2 errors
on average than using procedure P1 alone. In our case, we can choose ANOVA and SAIC (or
SBIC) approaches as P1 and P2, respectively, to obtain the desired performance characteristics
as illustrated through simulation in Section 2.4.
Although we have focused on obtaining correct fixed-effects inference rather than necessarily
identifying the correct random-effects model, correct inference and correct model selection
are undeniably connected. Tables 2.5 and 2.6 are contingency tables that give counts for
each combination of true and selected model for AIC and BIC selection, respectively, for
one simulated example data set. Both AIC and BIC selected the correct model for slightly
more than 50% of the genes (52.5% for AIC and 52.8% for BIC). This performance is typical
and consistent with the findings of Gomez et al. (2005). It is likely that other model selection
strategies (e.g., corrected AIC, Hurvich and Tsai, 1989) could improve the probability of correct
selection, but such methods will undoubtedly suffer from the type I error control problems that
we have documented for AIC and BIC selection.
Based on our simulation results in Sections 2.4 through 2.6, it is clear that our hybrid
procedure can be quite conservative in that actual FDR levels may be far below nominal. This
situation results because the operator characteristics of testing following model selection are
far superior to those of the ANOVA method alone. We are of the traditional opinion that an
error rate below nominal is preferred to an error rate above nominal. The ability to produce
error rates no larger than nominal is one hallmark of a good statistical testing procedure and
a feature that distinguishes statistical approaches from other approaches that offer decisions
without assessments of the uncertainty associated with those decisions. Nonetheless, there is
room to improve the power of our proposed procedures, and we hope to address this issue in
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future research.
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2.9 Appendix A: Model Selection
2.9.1 BIC Formulation
Selection of the preferred model using BIC as computed by SAS can be problematic when
some variance components are estimated to be zero. For example, assume that a full mixed
linear model including d random factors is fit to a data set. Suppose the variance component
of the first random factor is estimated to be zero while all other variance components are
estimated to be positive. Then PROC MIXED will automatically fit a reduced model that
excludes the first random factor. SAS will correctly use d − 1 as the number of parameters
in the REML likelihood but will inappropriately use the number of levels of the first random
factor as n in BIC calculation even though this factor has been excluded from the model. If
we manually fit the reduced model by omitting the first random factor, all results are identical
to the results from the full model fit except that the number of levels of the second random
factor in the full model will be used as n in BIC calculation. If the number of levels of second
random factor is greater than the number of levels of the first random factor, the BIC that
SAS calculate for the full model will be lower than the BIC that SAS calculates for the reduced
model even though requesting the full model fit in SAS actually results in the reduced model
fit. An algorithm that would fit all 2d mixed models would favor the full model over the reduced
model which excludes the first random factor even though there is no evidence to support the
more complicated model. To avoid this problem, we calculated BIC using the total number of
observations per gene (36 in our data set) as n in the BIC formula.
2.9.2 AIC and BIC for Model Selection
We conducted a simulation study to explore AIC and BIC covariance selection in the setup
of the barley data design. A data set, containing 22,840 genes, was generated by following
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the method described in Section 2.4. Eight models were fit for each of 22,840 genes, and AIC
and BIC were each used to select a model for each gene. Both AIC and BIC selected the
correct model for slightly more than 50% of the genes (52.5% for AIC and 52.8% for BIC).
The following supplementary Tables 2.5 and 2.6 are contingency tables that give counts for
each combination of true and selected model for AIC and BIC selection, respectively.
2.10 Appendix B: Exact Inference Using ANOVA
2.10.1 Mixed Linear Model
Consider the mixed linear model described in Section 2.2.2
Yijk = µ+ γj + τk + θjk + αi + βij + δik + ǫijk (2.5)
i = 1, 2, 3; j = 1, 2; k = 1, . . . , 6.
where
• Yijk is the observed intensity of a gene at the k
th harvesting time for the jth genotype
during the ith replication,
• γj is the fixed genotype effect,
• τk is the fixed tissue collection time,
• θjk is the genotype-by-time interaction,
• αi is the random replication effect, assume αi ∼ NID(0, σ
2
α),
• βij is the replication-by-genotype interaction, assume βij ∼ NID(0, σ
2
β),
• δik is the replication-by-time interaction, assume δik ∼ NID(0, σ
2
δ ), and
• ǫijk ∼ NID(0, σ
2
ǫ ) is the error.
Hence Y ∼ N(0,Σ) with
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Σ =

V 0 0
0 V 0
0 0 V

V =
 (σ2δ + σ2ǫ )I + (σ2α + σ2β)J σ2δI + σ2αJ
σ2δI + σ
2
αJ (σ
2
δ + σ
2
ǫ )I + (σ
2
α + σ
2
β)J

• where I is the 6× 6 identity matrix and
• J equals the 6× 6 matrix containing only ones.
2.10.2 ANOVA Construction of F -tests Based on Expected Mean Squares
For testing fixed effects, we can construct F tests from the ANOVA table (Table 2.7) by
taking the ratio of mean squares. For example, the F -statistic for testing the fixed genotype
effect is the ratio of the mean square for genotype and the mean square for replication-by-
genotype. Under the standard mixed linear model assumptions outlined previously, this test
statistic follows an F distribution even if the underlying true model for this gene is different
from the full model. As an illustration, for three cases (underlying true models), we will show
that this is true. For other models, the same argument follows.
1. Assume that full model was the true model for the data, i.e., σ2α > 0, σ
2
β > 0, and
σ2δ > 0.
• Hypothesis Test for fixed genotype effect: The null hypothesis is
H0 : γ1 +
1
K
∑
k
θ1k = γ2 +
1
K
∑
k
θ2k (2.6)
and based on the ANOVA table above, the test statistic is the ratio of two mean squares
such that
F1 =
MSgeno
MSrep−geno
=
IK
∑
j(Y .j. − Y ...)
2/(J − 1)
K
∑
i
∑
j(Y ij. − Y i.. − Y .j. + Y ...)
2/(I − 1)(J − 1)
=
Y TA1Y/(J − 1)
Y TA2Y/(I − 1)(J − 1)
(2.7)
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where
A1 =
1
36

J −J J −J J −J
−J J −J J −J J
J −J J −J J −J
−J J −J J −J J
J −J J −J J −J
−J J −J J −J J

,
A2 =
1
36

2J −2J −J J −J J
−2J 2J J −J J −J
−J J 2J −2J −J J
J −J −2J 2J J −J
−J J −J J 2J −2J
J −J J −J −2J 2J

and A1A1 = A1, A2A2 = A2, A1A2 = 0.
A1Σ = (σ
2
ǫ + 6σ
2
β)A1 and A2Σ = (σ
2
ǫ + 6σ
2
β)A2
Then Y TA1Y/(σ
2
ǫ + 6σ
2
β) ∼ χ
2
(J−1) and Y
TA2Y/(σ
2
ǫ + 6σ
2
β) ∼ χ
2
(I−1)(J−1) and
A1ΣA2 = (σ
2
ǫ + 6σ
2
β)A1A2 = 0. Hence Y
TA1Y and Y
TA2Y are independent.
Hence, F1 ∼ F(J−1),(I−1)(J−1).
• Hypothesis Test for fixed time effect: The null hypothesis is,
H0 : τ1 +
1
J
∑
j
θj1 = τ2 +
1
J
∑
j
θj2 = . . . = τK +
1
J
∑
j
θK1 (2.8)
and based on the ANOVA table, the test statistic is expressed as,
F2 =
MStime
MSrep−time
=
IJ
∑
k(Y ..k − Y ..)
2/(K − 1)
I
∑
j
∑
k(Y .jk − Y .j. − Y ..k + Y ...)
2/(I − 1)(K − 1)
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=
Y TA3Y/(K − 1)
Y TA4Y/(I − 1)(K − 1)
(2.9)
where
A3 =
1
36

6I − J · · · 6I − J
...
. . .
...
6I − J · · · 6I − J

and
A4 =
1
36

2(6I − J) 2(6I − J) −(6I − J) −(6I − J) −(6I − J) −(6I − J)
2(6I − J) 2(6I − J) −(6I − J) −(6I − J) −(6I − J) −(6I − J)
−(6I − J) −(6I − J) 2(6I − J) 2(6I − J) −(6I − J) −(6I − J)
−(6I − J) −(6I − J) 2(6I − J) 2(6I − J) −(6I − J) −(6I − J)
−(6I − J) −(6I − J) −(6I − J) −(6I − J) 2(6I − J) 2(6I − J)
−(6I − J) −(6I − J) −(6I − J) −(6I − J) 2(6I − J) 2(6I − J)

and A3A3 = A3, A4A4 = A4, and A3A4 = 0.
A3Σ = (σ
2
ǫ + 2σ
2
δ )A3 and A4Σ = (σ
2
ǫ + 2σ
2
δ )A4
Then Y TA3Y/(σ
2
ǫ + 2σ
2
δ ) ∼ χ
2
(K−1) and Y
TA4Y/(σ
2
ǫ + 2σ
2
δ ) ∼ χ
2
(I−1)(K−1) and
A3ΣA4 = (σ
2
ǫ + 2σ
2
δ )A3A4 = 0. Hence Y
TA3Y and Y
TA4Y are independent.
Hence, F2 ∼ F(K−1),(I−1)(K−1).
• Hypothesis Test for the interaction between genotype and time:
The null hypothesis is,
H0 : θ1k − θ2k − θ1l + θ2l = 0, k 6= l = 1, . . . , 6. (2.10)
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and based on the ANOVA table, the test statistic follows as,
F3 =
MSgeno−time
MSE
=
I
∑
j
∑
k(Y .jk − Y .j. − Y ..k + Y ...)
2/(J − 1)(K − 1)
MSE
=
Y TA5Y/(J − 1)(K − 1)
Y TA6Y/(I − 1)(J − 1)(K − 1)
(2.11)
where
A5 =
1
36

(6I − J) −(6I − J) (6I − J) −(6I − J) (6I − J) −(6I − J)
−(6I − J) (6I − J) −(6I − J) (6I − J) −(6I − J) (6I − J)
(6I − J) −(6I − J) (6I − J) −(6I − J) (6I − J) −(6I − J)
−(6I − J) (6I − J) −(6I − J) (6I − J) −(6I − J) (6I − J)
(6I − J) −(6I − J) (6I − J) −(6I − J) (6I − J) −(6I − J)
−(6I − J) (6I − J) −(6I − J) (6I − J) −(6I − J) (6I − J)

and A6 =
1
36

2(6I − J) −2(6I − J) −(6I − J) (6I − J) −(6I − J) (6I − J)
−2(6I − J) 2(6I − J) (6I − J) −(6I − J) (6I − J) −(6I − J)
−(6I − J) (6I − J) 2(6I − J) −2(6I − J) −(6I − J) (6I − J)
(6I − J) −(6I − J) −2(6I − J) 2(6I − J) (6I − J) −(6I − J)
−(6I − J) (6I − J) −(6I − J) (6I − J) 2(6I − J) −2(6I − J)
(6I − J) −(6I − J) (6I − J) −(6I − J) −2(6I − J) 2(6I − J)

and A5A5 = A5, A6A6 = A6, A5A6 = 0.
A5Σ = σ
2
ǫA5 and A6Σ = σ
2
ǫA6
Then Y TA5Y/σ
2
ǫ ∼ χ
2
(J−1)(K−1) and Y
TA6Y/σ
2
ǫ ∼ χ
2
(I−1)(J−1)(K−1) and
A5ΣA6 = σ
2
ǫA5A6 = 0. Hence Y
TA5Y and Y
TA6Y are independent.
Hence, F3 ∼ F(J−1)(K−1),(I−1)(J−1)(K−1).
2. Assume that none of the random effects is present in the model, i.e., σ2α = 0, σ
2
β = 0, and
σ2δ = 0.
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The full model from (1) will reduce to
Yijk = µ+ γj + τk + θjk + ǫijk
and the variance-covariance matrix will be,
Σ1 = σ
2
ǫ I
where I is the 36× 36 identity matrix.
• Hypothesis Test for fixed genotype effect: The null hypothesis is the same as
(2) and the test statistic is the same as (3). It is sufficient to show
A1
(σ2ǫ + 6σ
2
β)
Σ1 =
A1
σ2ǫ
σ2ǫ I = A1,
A2
(σ2ǫ + 6σ
2
β)
Σ1 =
A2
σ2ǫ
σ2ǫ I = A2,
and A1 and A2 are idempotent. Then,
Y TA1Y/(σ
2
ǫ + 6σ
2
β) ∼ χ
2
(J−1) and Y
TA2Y/(σ
2
ǫ + 6σ
2
β) ∼ χ
2
(I−1)(J−1) and
A1Σ1A2 = σ
2
ǫA1A2 = 0. Hence Y
TA1Y and Y
TA2Y are independent.
Hence, F1 ∼ F(J−1),(I−1)(J−1).
• Hypothesis Test for fixed time effect: The null hypothesis is the same as (4)
and the test statistic is the same as (5). It is sufficient to show
A3
(σ2ǫ + 2σ
2
δ )
Σ1 =
A3
σ2ǫ
σ2ǫ I = A3,
A4
(σ2ǫ + 2σ
2
δ )
Σ1 =
A4
σ2ǫ
σ2ǫ I = A4,
and A3 and A4 are idempotent. Then,
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Y TA3Y/(σ
2
ǫ + 2σ
2
δ ) ∼ χ
2
(K−1) and Y
TA4Y/(σ
2
ǫ + 2σ
2
δ ) ∼ χ
2
(I−1)(K−1) and
A3Σ1A4 = σ
2
ǫA3A4 = 0. Hence Y
TA3Y and Y
TA4Y are independent.
Hence, F2 ∼ F(K−1),(I−1)(K−1).
• Hypothesis Test for the interaction between genotype and time: The null
hypothesis is the same as (6) and the test statistic is the same as (7). It is sufficient to
show
A5
σ2ǫ
Σ1 =
A5
σ2ǫ
σ2ǫ I = A5,
A6
σ2ǫ
Σ1 =
A6
σ2ǫ
σ2ǫ I = A6,
and A5 and A6 are idempotent. Then,
Y TA5Y/σ
2
ǫ ∼ χ
2
(J−1)(K−1) and Y
TA6Y/σ
2
ǫ ∼ χ
2
(I−1)(J−1)(K−1) and
A5Σ1A6 = σ
2
ǫA5A6 = 0. Hence Y
TA5Y and Y
TA6Y are independent.
Hence, F3 ∼ F(J−1)(K−1),(I−1)(J−1)(K−1).
3. Assume that replication and replication-by-genotype random effects are present in the
model but no replication-by-time, i.e., σ2α > 0, σ
2
β > 0, and σ
2
δ = 0.
The full model from (1) will reduce to
Yijk = µ+ γj + τk + θjk + αi + βij + ǫijk
and the variance-covariance matrix will be,
Σ5 =

V5 0 0
0 V5 0
0 0 V5

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V5 =
 σ2ǫ I + (σ2α + σ2β)J σ2αJ
σ2αJ σ
2
ǫ I + (σ
2
α + σ
2
β)J

• Hypothesis Test for fixed genotype effect: The null hypothesis is the same as
(2) and the test statistic is the same as (3). It can be shown that
A1
(σ2ǫ + 6σ
2
β)
Σ5 = A1,
A2
(σ2ǫ + 6σ
2
β)
Σ5 = A2.
and A1 and A2 are idempotent. Then,
Y TA1Y/(σ
2
ǫ + 6σ
2
β) ∼ χ
2
(J−1) and Y
TA2Y/(σ
2
ǫ + 6σ
2
β) ∼ χ
2
(I−1)(J−1) and
A1Σ5A2 = (σ
2
ǫ + 6σ
2
β)A1A2 = 0. Hence Y
TA1Y and Y
TA2Y are independent.
Hence, F1 ∼ F(J−1),(I−1)(J−1).
• Hypothesis Test for fixed time effect: The null hypothesis is the same as (4)
and the test statistic is the same as (5). It can be shown that
A3
(σ2ǫ + 2σ
2
δ )
Σ5 = A3,
A4
(σ2ǫ + 2σ
2
δ )
Σ5 = A4.
and A3 and A4 are idempotent. Then,
Y TA3Y/(σ
2
ǫ + 2σ
2
δ ) ∼ χ
2
(K−1) and Y
TA4Y/(σ
2
ǫ + 2σ
2
δ ) ∼ χ
2
(I−1)(K−1) and
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A3Σ5A4 = σ
2
ǫA3A4 = 0. Hence Y
TA3Y and Y
TA4Y are independent.
Hence, F2 ∼ F(K−1),(I−1)(K−1).
• Hypothesis Test for the interaction between genotype and time: The null
hypothesis is the same as (6) and the test statistic is the same as (7). It can be shown
that
A5
σ2ǫ
Σ5 = A5,
A6
σ2ǫ
Σ5 = A6.
and A5 and A6 are idempotent. Then,
Y TA5Y/σ
2
ǫ ∼ χ
2
(J−1)(K−1) and Y
TA6Y/σ
2
ǫ ∼ χ
2
(I−1)(J−1)(K−1) and
A5Σ5A6 = σ
2
ǫA5A6 = 0. Hence Y
TA5Y and Y
TA6Y are independent.
Hence, F3 ∼ F(J−1)(K−1),(I−1)(J−1)(K−1).
2.11 Appendix C: Tests for Main Effects
In this supplementary section, we describe the performance of our methods for the test of
genotype main effects and time main effects. As stated in the main paper, the scientists were
interested in identifying genes that exhibit interaction between genotype and time. Therefore
the test for interaction between genotype and time was considered to be of primary importance
for each mixed linear model analysis, though tests for genotype main effects and time main
effects were conducted also. Note, however, that the test for genotype main effects has only
2 denominator degrees of freedom in the full model and thus will have low power. The test
for time main effects, on the other hand, is based on 10 degrees of freedom in the full model.
Furthermore, many genes are expected to undergo substantial changes in expression over the
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time period spanning more than 24 hours because of circadian rhythms and extreme changes
associated with the transition from light to dark and back. Such changes were not the focus
of this experiment, but we present the results here for the sake of completeness and comment
on the similarities and differences between our conclusions for the interaction test and our
conclusions for the tests of main effects.
2.11.1 The Test of Genotype Main Effects
For the test of genotype main effects, we begin with examination of receiver operator char-
acteristic (ROC) curves to compare the effectiveness of the methods for separating differentially
and non-differentially expressed genes. The p-values produced by each method provide a rank
order of genes from most evidence for differential expression to least evidence. The quality of
the ranking varies from method to method and can be judged by comparing ROC curves. The
greater the area under an ROC curve the better the corresponding method is at distinguishing
null genes from non-null genes. The left panels of Figure 2.12.3 show ROC curves for the five
methods averaged over the 50 simulated data sets. The pattern of the curves was quite similar
for each simulation run so little information is lost in averaging. Note also that we have plotted
the curves over only the most informative ranges of sensitivity and 1− specificity. Unlike the
interaction test, the figure shows that the SC approach is as effective as an analysis with AIC
or BIC selected models at distinguishing non-null from null genes for the genotype effect. The
SKR approach lags behind the SAIC and SBIC, and the ANOVA method is least effective.
The ability to correctly rank genes with regard to evidence for differential expression is
clearly important because the goal of our analysis is to identify differentially expressed genes.
However, the effectiveness of a method at ranking the genes is not the only important measure
of performance. Good statistical procedures include an accurate assessment of the degree of
uncertainty associated with an analysis. In microarray data analysis, it is common to produce
a list of differentially expressed genes and an estimated false discovery rate. The number of
genes placed on the list is often determined by the FDR level that a researcher is willing to
tolerate. Thus, we now investigate the FDR control properties of our five methods.
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Using notation from the seminal FDR paper by Benjamini and Hochberg (1995), we let
V = the number of type I errors when the R tests with the smallest p-values are declared to
be non-null. Separately for each set of p-values, we recorded the actual false positive fraction
(V/R) and the estimated FDR level (F̂DR given by the q-value for the Rth gene) for all values
of R from 1 to 22,840. We averaged the results for each method over the 50 data sets to obtain
the panels on the right side of Figure 2.12.3. Again, the results for individual data sets were
quite consistent so that no important information is lost by averaging.
Ideally, the plotted curves would fall on or above the diagonal reference line to indicate that
the actual average false positive fraction (V/R) was no larger than the average estimated FDR
level. The analysis by fitting the same model under containment method (SC) produced FDR
estimates almost around 1 for any number of genes declared to be significant. This approach
is extremely conservative and would provide little if any power for identifying differentially
expressed genes under our simulation settings.
Table 2.8 further illustrates the error control properties of our procedures. For each of
the 50 data sets and each method, the approach of Storey and Tibshirani (2003) was used
to generate lists of significant genes for nominal FDR control at the 0.1 and 0.2 levels. The
number of genes on each list and the number of false positives on each list was recorded. The
average V/R ratio and the average count of the number of genes on the list across the 50
data sets was computed. Since the FDR control under SC approach is very conservative, we
could not declare any genotype main effects significant at these FDR levels. Although the
ANOVA approach identified very few genes on average, it was the only procedure (besides
the SC approach) that provided control of FDR at or below nominal levels. Note that other
methods, involving some form of model selection, had estimated FDR levels (V/R) far more
than the nominal rate. Although not presented in Table 2.8, for each of the 50 data sets, the
false positive fraction was always higher than the nominal FDR levels (0.1 and 0.2) for the
SKR, SAIC and SBIC approaches.
The 50 simulated microarray data sets were also used to illustrate the performance of two-
stage hybrid method in identifying differentially expressed genes and providing FDR control
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at or below target levels. As described in Section 2.4 of the main paper, in each data set, the
true underlying random effects structure varies across genes, and the data for ten percent of
the genes were simulated with non zero genotype, time, and interaction effects.
We applied the two-stage hybrid method using AIC model selection in step 2 and also using
BIC model selection in step 2. We also considered the hybrid approach where the full model fit
with KR method and containment method were used in step 2 rather than either of the formal
model selection approaches. These methods are referred to as ANOVA-SAIC, ANOVA-SBIC,
ANOVA-SKR, and ANOVA-SC, respectively. For these methods, we calculated the length of
the significant gene list and the actual false positive fraction (V/R) associated with each of the
gene lists for each data set and averaged over the 50 data sets. The results are also presented
in Table 2.8. The table shows that each of the two-step hybrid methods improved on the
ANOVA approach by providing smaller false positive ratios than the ANOVA approach. In
practice, the hybrid approach will identify the same number of genes as ANOVA. Therefore,
for genotype main effects, all the methods declared only very few genes to be differentially
expressed. This illustrates the importance of additional replication whenever genotype main
effects are of scientific interest.
2.11.2 The Test of Time Main Effects
For the test of time main effects, we also begin with examination of ROC curves to compare
the effectiveness of the methods for separating differentially and non-differentially expressed
genes. The panels on the left side of the Figure 2.12.3 show ROC curves for the five methods
averaged over the 50 simulated data sets. The pattern of the curves was quite similar for each
simulation run so little information is lost in averaging. Note also that we have plotted the
curves over only the most informative ranges of sensitivity and 1− specificity. Similar to ROC
panels in Figure 2.12.3, ROC panels in Figure 2.12.3 show that an analysis with AIC or BIC
selected models is as effective as the SC approach at distinguishing non-null from null genes.
The SKR approach lags behind the SC approach, and the ANOVA method is least effective.
We also investigated the FDR control properties of our five methods when testing for the
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time effects. We averaged the results for each method over the 50 data sets to obtain the
panels on the right side of the Figure 2.12.3. Again, the results for individual data sets were
quite consistent so that no important information is lost by averaging. The analysis where
the full model fit with KR method and containment method produced FDR estimates above
the reference line. For other methods that involve some form of formal model selection (AIC
or BIC), the estimated curves fell below the reference line. This indicates a clear problem
with FDR control for these methods. In contrast, the ANOVA approach still produces FDR
estimates that are on average close to the actual average false positive fraction.
Table 2.9 further illustrates the error control properties of our procedures. For each of
the 50 data sets and each method, the approach of Storey and Tibshirani (2003) was used to
generate lists of significant genes for nominal FDR control at the 0.01 and 0.05 levels. The
number of genes on each list and the number of false positives on each list was recorded. The
average V/R fraction and the average count of the number of genes on the list across the 50
data sets was computed. When 10% or 20% of genes are non-null, SKR and SC approaches
had estimated FDR levels (V/R) lower than the nominal rate, and of those two methods, SKR
was most powerful. Note that SAIC and SBIC approaches had estimated FDR levels far more
than the nominal rate. Again, the ANOVA approach provided control of FDR at the nominal
levels. However, the ANOVA approach was less powerful than SKR, which also appropriately
controlled FDR in this case. Thus, for the test of time main effects, the SKR procedure can
be recommended.
In Table 2.9, we also summarize the performance of two-stage hybrid method in identifying
differentially expressed genes and providing FDR control at or below target levels. All of the
two-step hybrid methods improved on the ANOVA approach by providing smaller false positive
ratios than the ANOVA approach. In practice, the hybrid approach will identify the same
number of genes as ANOVA but will tend to include more genes that are truly differentially
expressed than ANOVA alone. Though our simulation results show that all the hybrid methods
provided FDR control at better than nominal levels, ANOVA-SC outperformed other two-step
hybrid methods.
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In conclusion, we note that the ANOVA-SAIC and ANOVA-SBIC approaches recommended
for the test of interaction are also appropriate for the tests of genotype main effects and time
main effects. For the test of time main effects, however, the SKR method also controlled FDR
at nominal levels and provided longer gene lists than our hybrid procedures. Of the hybrid
procedures, ANOVA-SC incurred fewer type I errors than the other hybrids for the time test,
though the performance was quite similar to ANOVA-SAIC and ANOVA-SBIC.
2.12 Appendix D: Additional Simulation Studies
To assess the performance of our proposed analysis strategies under different scenarios, we
conducted additional simulation studies. In the first additional simulation study, we examine
the effect of the proportion of non-null genes. In the second addional simulation study, we
assess the effect of the heavy-tailed errors. And in the last additional simulation study, we
examine the effect of imbalance caused by missing data on ANOVA-based mixed linear model
analyses.
2.12.1 Assessing the Impact of Percentage of Non-null Genes in the Data
We repeated the simulation study described in Subsection 2.4.1 of the main paper under
two new scenarios. In the first case, we let only 1% of the genes in each of the 50 data sets
to have non-zero genotype, time, and interaction effects. In the second case, we increased the
portion of non-null genes from 1% to 20% in each data set.
The results of the simulation with different proportion of non-null genes – presented in Fig-
ures 2.12.3 through 2.12.3 and Tables 2.8 through 2.10 – show that the bottom-line conclusions
do not differ in a practically important way from the case of 10% of the genes are non-null.
For instance, consider the test of interacton between genotype and time. The top portion –
refering to 1% non-null genes – and the bottom portion – refering to 20% non-null genes – in
Table 2.10 provide similar conclusions as the middle portion – refering to 10% non-null genes
– of that table. The ANOVA approach identified the fewest genes on average, and it was the
only procedure that provided control of FDR at or below nominal levels. The SKR and SAIC
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approaches had estimated FDR levels more than twice the nominal rate. The performance of
our hybrid procedure remains essentially the same for the new simulations. Portions – refering
to 1% and 20 % non-null genes – summarizing the performance of hybrid methods in Table 2.10
provide similar conclusions as the portion corresponding to 10% of genes were non-null. These
tables show that each of the two-step hybrid methods improved on the ANOVA approach by
providing smaller false positive fractions than the ANOVA approach. All the hybrid methods
provided FDR control at better than nominal levels, ANOVA-SAIC and ANOVA-SBIC out-
performed ANOVA-SKR and, especially, ANOVA-SC. Thus, the conclusions of the simulation
study in the main paper do not appear to be sensitive to the proportion of non-null genes.
2.12.2 Assessing the Impact of Heavy-Tailed Errors
As mentioned in Subsection 2.6.1 of the main paper, the simulation study described in
Subsection 2.4.1 of the main paper was repeated using scaled t-distributed errors rather than
normal errors. For each gene, the ǫijk terms in model (2.1) were obtained by drawing 36
independent observations from a t distribution with five degrees of freedom. These observations
were then multiplied by the gene-specific error standard deviation that was estimated from the
original barley data.
The results of the simulation based on t-distributed errors – presented in Figures 2.12.3
through 2.12.3 and Tables 2.11 through 2.13 – show that, other than a decrease in power for
all methods, the bottom-line conclusions do not differ in a practically important way from the
case of normal errors. Our proposed model selection/ANOVA hybrid method still provides
conservative estimates of the false discovery rate while methods based on model selection
approaches alone are too liberal.
2.12.3 Assessing the Impact of Missing Data
As discussed in Subsection 2.6.2 of the main paper, we conducted two new variations of
the simulation study to examine the effect of imbalance caused by missing data on ANOVA-
based mixed linear model analyses described in Subsection 2.4.1 of the main paper. In the first
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version, three entire gene chips were randomly selected and removed from the data set so that
all genes were missing three of their 36 observations. In the second version, four genotype-by-
time combinations were randomly selected and two of the three observations for each selected
combination were randomly selected for removal from the data set. This process was done
separately for each gene. Thus, in the second version of the simulation study, a random eight
of the 36 observations were missing for each gene. The results of the simulation with missing
data are presented in Figures 2.12.3 through 2.12.3 and Tables 2.14 through 2.16.
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Table 2.1 AIC and BIC selected models for the Barley Data Set.
none=model involving no random factor, r=model involving
random replication factor, rg=model involving random repli-
cation-by-genotype factor, rt=model involving random replica-
tion-by-time factor.
Random factor none r rg rt r, rg r, rt rg, rt r, rg, rt
AIC count 8407 4277 5253 2001 38 671 2133 60
BIC count 11409 3787 4928 1449 1 219 1047 0
Table 2.2 Genotype-by-time Interaction Test: Results for the Complete
Data. The average false positive fraction (V/R) and the average
number of significant genes (R) for nominal control of FDR at the
0.01 and 0.05 levels over 50 simulated data sets for five methods
described in Section 3 and the hybrid methods introduced in
Section 5. V is the number of false positives and R is the number
of rejected null hypotheses.
F̂DR=0.01 F̂DR=0.05
Method V/R (S.E.) R (S.E.) V/R (S.E.) R (S.E.)
SKR 0.0255 (0.0010) 435.8 (3.3) 0.1186 (0.0018) 685.8 (5.1)
SC 0.0142 (0.0009) 295.0 (2.6) 0.0739 (0.0015) 512.9 (3.7)
SAIC 0.0237 (0.0009) 465.8 (3.3) 0.1021 (0.0017) 673.2 (4.1)
SBIC 0.0198 (0.0008) 447.1 (3.1) 0.0810 (0.0016) 625.2 (3.9)
ANOVA 0.0088 (0.0008) 229.4 (2.4) 0.0486 (0.0016) 393.6 (2.8)
ANOVA-SKR 0.0013 (0.0004) 229.4 (2.4) 0.0159 (0.0009) 393.6 (2.8)
ANOVA-SC 0.0058 (0.0008) 229.4 (2.4) 0.0351 (0.0014) 393.6 (2.8)
ANOVA-SAIC 0.0002 (0.0001) 229.4 (2.4) 0.0094 (0.0007) 393.6 (2.8)
ANOVA-SBIC 0.0002 (0.0001) 229.4 (2.4) 0.0101 (0.0007) 393.6 (2.8)
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Table 2.3 Application of the Hybrid Method to the Barley Data Set. The
number of barley genes identified as differentially expressed at
nominal FDR levels of 0.01 and 0.05 for the test of interaction
under the five standard methods and the four hybrid methods.
F̂DR 0.01 0.05
SKR 93 933
SC 52 598
SAIC 96 598
SBIC 75 438
ANOVA 37 311
ANOVA-SKR 37 311
ANOVA-SC 37 311
ANOVA-SAIC 37 311
ANOVA-SBIC 37 311
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Table 2.4 Genotype-by-time Interaction Test: Results for the Missing
Data. Performance of the methods when three entire microar-
ray chips are missing or eight observations per gene are missing.
Table values are average false positive fraction (V/R) and the
average number of significant genes (R) for nominal control of
FDR at the 0.01 and 0.05 levels over 50 simulated data sets,
where V = the number of type I errors when R tests with the
smallest p-values are declared to be non-null.
F̂DR=0.01 F̂DR=0.05
Method V/R (S.E.) R (S.E.) V/R (S.E.) R (S.E.)
SKR 0.0263 (0.0012) 335.5 (3.8) 0.1256 (0.0021) 574.6 (5.6)
SC 0.0122 (0.0016) 111.4 (3.4) 0.0651 (0.0021) 294.4 (5.1)
Missing SAIC 0.0266 (0.0011) 388.8 (3.6) 0.1165 (0.0020) 599.2 (5.1)
three SBIC 0.0225 (0.0010) 373.1 (3.5) 0.0956 (0.0017) 555.4 (4.7)
entire ANOVA 0.0091 (0.0019) 57.9 (2.8) 0.0434 (0.0023) 173.7 (4.6)
chips ANOVA-SKR 0.0000 (0.0000) 57.9 (2.8) 0.0025 (0.0007) 173.7 (4.6)
ANOVA-SC 0.0059 (0.0015) 57.9 (2.8) 0.0250 (0.0019) 173.7 (4.6)
ANOVA-SAIC 0.0000 (0.0000) 57.9 (2.8) 0.0006 (0.0003) 173.7 (4.6)
ANOVA-SBIC 0.0000 (0.0000) 57.9 (2.8) 0.0006 (0.0003) 173.7 (4.6)
SKR 0.0335 (0.0021) 142.4 (2.4) 0.1374 (0.0029) 300.7 (4.0)
Missing SC 0.0000 (0.0000) 0.5 (0.2) 0.0684 (0.0300) 1.7 (0.4)
eight SAIC 0.0420 (0.0045) 227.0 (3.4) 0.1578 (0.0041) 418.2 (5.0)
data SBIC 0.0391 (0.0043) 223.0 (3.4) 0.1381 (0.0043) 391.8 (4.6)
points ANOVA 0.0200 (0.0200) 0.4 (0.1) 0.0440 (0.0196) 1.2 (0.2)
per ANOVA-SKR 0.0000 (0.0000) 0.4 (0.1) 0.0000 (0.0000) 1.2 (0.2)
gene ANOVA-SC 0.0000 (0.0000) 0.4 (0.1) 0.0300 (0.0170) 1.2 (0.2)
ANOVA-SAIC 0.0000 (0.0000) 0.4 (0.1) 0.0000 (0.0000) 1.2 (0.2)
ANOVA-SBIC 0.0000 (0.0000) 0.4 (0.1) 0.0000 (0.0000) 1.2 (0.2)
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Table 2.5 AIC Selection for the Simulated Data with no Treatment Ef-
fect. none=model involving no random factor, r=model involv-
ing random replication factor, rg=model involving random repli-
cation-by-genotype factor, rt=model involving random replica-
tion-by-time factor.
True\Selected none r rg rt r, rg r, rt rg, rt r, rg, rt Total
none 7152 277 338 552 0 3 85 0 8407
r 2102 1522 298 211 7 92 41 4 4277
rg 2077 596 2122 185 16 19 231 7 5253
rt 997 90 53 786 0 18 57 0 2001
r, rg 26 5 1 6 0 0 0 0 38
r, rt 312 162 28 116 3 30 18 2 671
rg, rt 655 190 553 322 8 27 369 9 2133
r, rg, rt 35 4 8 6 0 2 5 0 60
Total 13356 2846 3401 2184 34 191 806 22 22840
Table 2.6 BIC selection for the Simulated Data with no Treatment Ef-
fect. none=model involving no random factor, r=model involv-
ing random replication factor, rg=model involving random repli-
cation-by-genotype factor, rt=model involving random replica-
tion-by-time factor.
True\Selected none r rg rt r, rg r, rt rg, rt r, rg, rt Total
none 7900 118 136 234 0 0 19 0 8407
r 2603 1322 194 116 0 27 15 0 4277
rg 2650 481 1936 88 1 6 91 0 5253
rt 1258 54 22 648 0 3 16 0 2001
r, rg 31 3 0 4 0 0 0 0 38
r, rt 388 161 19 92 0 9 2 0 671
rg, rt 891 164 560 270 2 6 240 0 2133
r, rg, rt 43 3 7 5 0 1 1 0 60
Total 15764 2306 2874 1457 3 52 384 0 22840
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Table 2.7 ANOVA Table
Source of
Variation d.f. Sum of Squares
Replication I − 1 JK
∑
i(Y i.. − Y ...)
2
Genotype J − 1 IK
∑
j(Y .j. − Y ...)
2
Replication-by-Genotype (I − 1)(J − 1) K
∑
i
∑
j(Y ij. − Y i.. − Y .j. + Y ...)
2
Time K − 1 IJ
∑
k(Y ..k − Y ..)
2
Genotype-by-Time (J − 1)(K − 1) I
∑
j
∑
k(Y .jk − Y .j. − Y ..k + Y ...)
2
Replication-by-Time (I − 1)(K − 1) J
∑
i
∑
k(Y i.k − Y i.. − Y ..k + Y ...)
2
Error (I − 1)(J − 1)(K − 1) “Subtraction”
Corrected Total IJK − 1
∑
i
∑
j
∑
k(Yijk − Y ...)
2
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Table 2.8 Genotype Test: Results for the Complete Data. Performance
of the methods described in Section 2.3 and in Section 2.5 of
the main paper for the test of genotype main effects when 1%,
10%, and 20% of genes are non-null. Table values are the actual
average false positive fraction (V/R) and the average number (R¯)
of significant genes for nominal control of FDR at the 0.1 and 0.2
level over 50 simulated data sets, where V = the number of type
I errors when R tests with the smallest p-values are declared to
be non-null.
F̂DR=0.1 F̂DR=0.2
Null Method V/R (S.E.) R¯ (S.E.) V/R (S.E.) R¯ (S.E.)
SKR 0.7468 (0.0060) 91.3 (2.2) 0.7904 (0.0045) 134.9 (2.9)
SC 0.0000 (0.0000) 0.0 (0.0) 0.0000 (0.0000) 0.0 (0.0)
SAIC 0.8534 (0.0035) 292.0 (5.0) 0.8854 (0.0027) 446.6 (7.0)
SBIC 0.8629 (0.0033) 324.4 (5.3) 0.8917 (0.0023) 495.3 (7.5)
1% ANOVA 0.1000 (0.0429) 0.1 (0.1) 0.1667 (0.0515) 0.4 (0.1)
ANOVA-SKR 0.0000 (0.0000) 0.1 (0.1) 0.0167 (0.0119) 0.4 (0.1)
ANOVA-SC 0.0000 (0.0000) 0.1 (0.1) 0.0267 (0.0210) 0.4 (0.1)
ANOVA-SAIC 0.0000 (0.0000) 0.1 (0.1) 0.0100 (0.0100) 0.4 (0.1)
ANOVA-SBIC 0.0000 (0.0000) 0.1 (0.1) 0.0100 (0.0100) 0.4 (0.1)
SKR 0.2838 (0.0033) 394.0 (3.8) 0.3523 (0.0027) 541.2 (4.5)
SC 0.0000 (0.0000) 0.0 (0.0) 0.0000 (0.0000) 0.0 (0.0)
SAIC 0.4222 (0.0022) 826.1 (4.8) 0.5003 (0.0020) 1159.1 (6.7)
SBIC 0.4375 (0.0021) 885.5 (4.9) 0.5138 (0.0020) 1234.0 (7.2)
10% ANOVA 0.0950 (0.0341) 1.1 (0.3) 0.1692 (0.0324) 3.7 (0.7)
ANOVA-SKR 0.0000 (0.0000) 1.1 (0.3) 0.0020 (0.0020) 3.7 (0.7)
ANOVA-SC 0.0000 (0.0000) 1.1 (0.3) 0.0000 (0.0000) 3.7 (0.7)
ANOVA-SAIC 0.0000 (0.0000) 1.1 (0.3) 0.0013 (0.0013) 3.7 (0.7)
ANOVA-SBIC 0.0000 (0.0000) 1.1 (0.3) 0.0000 (0.0000) 3.7 (0.7)
SKR 0.1881 (0.0018) 816.4 (5.5) 0.2526 (0.0017) 1137.0 (7.8)
SC 0.0000 (0.0000) 0.0 (0.0) 0.0000 (0.0000) 0.1 (0.1)
SAIC 0.2840 (0.0018) 1490.7 (6.0) 0.3636 (0.0017) 2048.2 (8.7)
SBIC 0.2938 (0.0017) 1567.4 (6.3) 0.3723 (0.0017) 2139.0 (8.4)
20% ANOVA 0.0887 (0.0313) 2.8 (0.5) 0.1623 (0.0142) 28.2 (4.3)
ANOVA-SKR 0.0000 (0.0000) 2.8 (0.5) 0.0056 (0.0021) 28.2 (4.3)
ANOVA-SC 0.0000 (0.0000) 2.8 (0.5) 0.0028 (0.0012) 28.2 (4.3)
ANOVA-SAIC 0.0000 (0.0000) 2.8 (0.5) 0.0009 (0.0005) 28.2 (4.3)
ANOVA-SBIC 0.0000 (0.0000) 2.8 (0.5) 0.0011 (0.0006) 28.2 (4.3)
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Table 2.9 Time Test: Results for the Complete Data. Performance of the
methods described in Section 2.3 and in Section 2.5 of the main
paper for the test of time main effects when 1%, 10%, and 20%
of genes are non-null. Table values are the actual average false
positive fraction (V/R) and the average number (R¯) of significant
genes for nominal control of FDR at the 0.01 and 0.05 level
over 50 simulated data sets, where V = the number of type I
errors when R tests with the smallest p-values are declared to be
non-null.
F̂DR=0.01 F̂DR=0.05
Null Method V/R (S.E.) R¯ (S.E.) V/R (S.E.) R¯ (S.E.)
SKR 0.0130 (0.0016) 79.9 (1.1) 0.0486 (0.0031) 101.0 (1.2)
SC 0.0000 (0.0000) 55.5 (1.1) 0.0023 (0.0008) 74.4 (1.1)
SAIC 0.0361 (0.0028) 101.4 (1.3) 0.1137 (0.0039) 128.1 (1.6)
SBIC 0.0390 (0.0029) 104.5 (1.3) 0.1249 (0.0042) 132.4 (1.7)
1% ANOVA 0.0082 (0.0016) 62.4 (1.1) 0.0518 (0.0029) 85.9 (1.2)
ANOVA-SKR 0.0034 (0.0010) 62.4 (1.1) 0.0214 (0.0019) 85.9 (1.2)
ANOVA-SC 0.0000 (0.0000) 62.4 (1.1) 0.0097 (0.0017) 85.9 (1.2)
ANOVA-SAIC 0.0007 (0.0005) 62.4 (1.1) 0.0139 (0.0023) 85.9 (1.2)
ANOVA-SBIC 0.0004 (0.0004) 62.4 (1.1) 0.0112 (0.0021) 85.9 (1.2)
SKR 0.0084 (0.0005) 972.7 (3.9) 0.0365 (0.0007) 1211.8 (3.5)
SC 0.0004 (0.0001) 780.8 (3.5) 0.0064 (0.0003) 1023.9 (3.6)
SAIC 0.0196 (0.0007) 1141.1 (4.0) 0.0713 (0.0010) 1400.0 (4.2)
SBIC 0.0212 (0.0007) 1164.6 (4.0) 0.0748 (0.0009) 1425.0 (4.4)
10% ANOVA 0.0103 (0.0005) 858.8 (3.5) 0.0506 (0.0009) 1156.1 (3.8)
ANOVA-SKR 0.0039 (0.0003) 858.8 (3.5) 0.0274 (0.0007) 1156.1 (3.8)
ANOVA-SC 0.0011 (0.0002) 858.8 (3.5) 0.0178 (0.0007) 1156.1 (3.8)
ANOVA-SAIC 0.0019 (0.0002) 858.8 (3.5) 0.0218 (0.0007) 1156.1 (3.8)
ANOVA-SBIC 0.0016 (0.0002) 858.8 (3.5) 0.0201 (0.0007) 1156.1 (3.8)
SKR 0.0073 (0.0003) 2130.8 (5.1) 0.0341 (0.0005) 2649.2 (4.8)
SC 0.0006 (0.0001) 1783.0 (5.4) 0.0084 (0.0003) 2325.0 (5.4)
SAIC 0.0161 (0.0004) 2441.9 (5.0) 0.0625 (0.0007) 2982.2 (5.4)
SBIC 0.0172 (0.0004) 2485.2 (5.0) 0.0655 (0.0007) 3027.0 (5.4)
20% ANOVA 0.0093 (0.0003) 1942.5 (5.6) 0.0476 (0.0006) 2583.6 (5.2)
ANOVA-SKR 0.0036 (0.0002) 1942.5 (5.6) 0.0291 (0.0005) 2583.6 (5.2)
ANOVA-SC 0.0014 (0.0001) 1942.5 (5.6) 0.0212 (0.0005) 2583.6 (5.2)
ANOVA-SAIC 0.0022 (0.0001) 1942.5 (5.6) 0.0247 (0.0005) 2583.6 (5.2)
ANOVA-SBIC 0.0019 (0.0001) 1942.5 (5.6) 0.0233 (0.0005) 2583.6 (5.2)
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Table 2.10 Genotype-by-time Interaction Test: Results for the Complete
Data. Performance of the methods described in Section 2.3 and
in Section 2.5 of the main paper for the test of genotype-by–
time interaction effects when 1%, 10%, and 20% of genes are
non-null. Table values are the actual average false positive frac-
tion (V/R) and the average number (R¯) of significant genes for
nominal control of FDR at the 0.01 and 0.05 level over 50 sim-
ulated data sets, where V = the number of type I errors when
R tests with the smallest p-values are declared to be non-null.
F̂DR=0.01 F̂DR=0.05
Null Method V/R (S.E.) R¯ (S.E.) V/R (S.E.) R¯ (S.E.)
SKR 0.0369 (0.0043) 27.8 (0.9) 0.1442 (0.0077) 44.7 (1.3)
SC 0.0145 (0.0041) 13.5 (0.7) 0.0849 (0.0085) 27.0 (1.2)
SAIC 0.0370 (0.0040) 33.7 (0.9) 0.1367 (0.0066) 48.6 (1.2)
SBIC 0.0346 (0.0039) 33.2 (0.9) 0.1254 (0.0066) 47.0 (1.1)
1% ANOVA 0.0071 (0.0035) 9.5 (0.6) 0.0708 (0.0092) 19.9 (0.9)
ANOVA-SKR 0.0000 (0.0000) 9.5 (0.6) 0.0121 (0.0029) 19.9 (0.9)
ANOVA-SC 0.0056 (0.0032) 9.5 (0.6) 0.0552 (0.0081) 19.9 (0.9)
ANOVAS-AIC 0.0000 (0.0000) 9.5 (0.6) 0.0013 (0.0013) 19.9 (0.9)
ANOVAS-BIC 0.0000 (0.0000) 9.5 (0.6) 0.0013 (0.0013) 19.9 (0.9)
SKR 0.0255 (0.0010) 435.8 (3.3) 0.1186 (0.0018) 685.8 (5.1)
SC 0.0142 (0.0009) 295.0 (2.6) 0.0739 (0.0015) 512.9 (3.7)
SAIC 0.0237 (0.0009) 465.8 (3.3) 0.1021 (0.0017) 673.2 (4.1)
SBIC 0.0198 (0.0008) 447.1 (3.1) 0.0810 (0.0016) 625.2 (3.9)
10% ANOVA 0.0088 (0.0008) 229.4 (2.4) 0.0486 (0.0016) 393.6 (2.8)
ANOVA-SKR 0.0013 (0.0004) 229.4 (2.4) 0.0159 (0.0009) 393.6 (2.8)
ANOVA-SC 0.0058 (0.0008) 229.4 (2.4) 0.0351 (0.0014) 393.6 (2.8)
ANOVA-SAIC 0.0002 (0.0001) 229.4 (2.4) 0.0094 (0.0007) 393.6 (2.8)
ANOVA-SBIC 0.0002 (0.0001) 229.4 (2.4) 0.0101 (0.0007) 393.6 (2.8)
SKR 0.0234 (0.0007) 1007.6 (5.2) 0.1120 (0.0012) 1606.7 (7.4)
SC 0.0131 (0.0007) 737.2 (4.7) 0.0744 (0.0011) 1267.9 (6.6)
SAIC 0.0213 (0.0006) 1044.5 (4.8) 0.0909 (0.0011) 1521.0 (6.1)
SBIC 0.0175 (0.0006) 997.1 (4.6) 0.0714 (0.0009) 1409.7 (5.5)
20% ANOVA 0.0085 (0.0004) 575.8 (4.3) 0.0476 (0.0011) 980.8 (5.6)
ANOVA-SKR 0.0018 (0.0002) 575.8 (4.3) 0.0211 (0.0009) 980.8 (5.6)
ANOVA-SC 0.0057 (0.0004) 575.8 (4.3) 0.0355 (0.0010) 980.8 (5.6)
ANOVA-SAIC 0.0009 (0.0002) 575.8 (4.3) 0.0159 (0.0007) 980.8 (5.6)
ANOVA-SBIC 0.0009 (0.0002) 575.8 (4.3) 0.0163 (0.0007) 980.8 (5.6)
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Table 2.11 Genotype Test: Results for the Non-Normal Data. Performance
of the methods described in Section 2.3 and in Section 2.5 of
the main paper for the test of genotype main effects when 10%
of genes are non-null and errors follow a Normal distribution
or t-distribution with five degrees of freedom. Table values are
the actual average false positive fraction (V/R) and the average
number (R¯) of significant genes for nominal control of FDR at
the 0.1 and 0.2 level over 50 simulated data sets, where V = the
number of type I errors when R tests with the smallest p-values
are declared to be non-null.
F̂DR=0.1 F̂DR=0.2
Method V/R (S.E.) R¯ (S.E.) V/R (S.E.) R¯ (S.E.)
SKR 0.2838 (0.0033) 394.0 (3.8) 0.3523 (0.0027) 541.2 (4.5)
SC 0.0000 (0.0000) 0.0 (0.0) 0.0000 (0.0000) 0.0 (0.0)
N SAIC 0.4222 (0.0022) 826.1 (4.8) 0.5003 (0.0020) 1159.1 (6.7)
o SBIC 0.4375 (0.0021) 885.5 (4.9) 0.5138 (0.0020) 1234.0 (7.2)
r ANOVA 0.0950 (0.0341) 1.1 (0.3) 0.1692 (0.0324) 3.7 (0.7)
m ANOVA-SKR 0.0000 (0.0000) 1.1 (0.3) 0.0020 (0.0020) 3.7 (0.7)
a ANOVA-SC 0.0000 (0.0000) 1.1 (0.3) 0.0000 (0.0000) 3.7 (0.7)
l ANOVA-SAIC 0.0000 (0.0000) 1.1 (0.3) 0.0013 (0.0013) 3.7 (0.7)
ANOVA-SBIC 0.0000 (0.0000) 1.1 (0.3) 0.0000 (0.0000) 3.7 (0.7)
SKR 0.3008 (0.0037) 297.3 (2.9) 0.3693 (0.0034) 418.5 (4.0)
SC 0.0000 (0.0000) 0.0 (0.0) 0.0000 (0.0000) 0.0 (0.0)
SAIC 0.4261 (0.0029) 643.3 (4.2) 0.5074 (0.0021) 928.1 (5.3)
SBIC 0.4401 (0.0027) 688.9 (4.5) 0.5188 (0.0022) 989.7 (5.9)
t5 ANOVA 0.0500 (0.0258) 0.4 (0.1) 0.1915 (0.0402) 1.8 (0.3)
ANOVA-SKR 0.0000 (0.0000) 0.4 (0.1) 0.0000 (0.0000) 1.8 (0.3)
ANOVA-SC 0.0000 (0.0000) 0.4 (0.1) 0.0029 (0.0029) 1.8 (0.3)
ANOVA-SAIC 0.0000 (0.0000) 0.4 (0.1) 0.0000 (0.0000) 1.8 (0.3)
ANOVA-SBIC 0.0000 (0.0000) 0.4 (0.1) 0.0000 (0.0000) 1.8 (0.3)
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Table 2.12 Time Test: Results for the Non-Normal Data. Performance
of the methods described in Section 2.3 and in Section 2.5 of
the main paper for the test of time main effects when 10%
of genes are non-null and errors follow a Normal distribution
or t-distribution with five degrees of freedom. Table values are
the actual average false positive fraction (V/R) and the average
number (R¯) of significant genes for nominal control of FDR at
the 0.01 and 0.05 level over 50 simulated data sets, where V =
the number of type I errors when R tests with the smallest
p-values are declared to be non-null.
F̂DR=0.01 F̂DR=0.05
Method V/R (S.E.) R¯ (S.E.) V/R (S.E.) R¯ (S.E.)
SKR 0.0084 (0.0005) 972.7 (3.9) 0.0365 (0.0007) 1211.8 (3.5)
SC 0.0004 (0.0001) 780.8 (3.5) 0.0064 (0.0003) 1023.9 (3.6)
N SAIC 0.0196 (0.0007) 1141.1 (4.0) 0.0713 (0.0010) 1400.0 (4.2)
o SBIC 0.0212 (0.0007) 1164.6 (4.0) 0.0748 (0.0009) 1425.0 (4.4)
r ANOVA 0.0103 (0.0005) 858.8 (3.5) 0.0506 (0.0009) 1156.1 (3.8)
m ANOVA-SKR 0.0039 (0.0003) 858.8 (3.5) 0.0274 (0.0007) 1156.1 (3.8)
a ANOVA-SC 0.0011 (0.0002) 858.8 (3.5) 0.0178 (0.0007) 1156.1 (3.8)
l ANOVA-SAIC 0.0019 (0.0002) 858.8 (3.5) 0.0218 (0.0007) 1156.1 (3.8)
ANOVA-SBIC 0.0016 (0.0002) 858.8 (3.5) 0.0201 (0.0007) 1156.1 (3.8)
SKR 0.0074 (0.0005) 764.4 (3.5) 0.0315 (0.0007) 983.4 (3.7)
SC 0.0002 (0.0001) 575.7 (3.2) 0.0037 (0.0003) 799.7 (3.7)
SAIC 0.0162 (0.0006) 930.4 (3.4) 0.0631 (0.0010) 1164.6 (4.0)
SBIC 0.0171 (0.0006) 950.4 (3.5) 0.0654 (0.0010) 1186.9 (3.9)
t5 ANOVA 0.0088 (0.0005) 645.6 (3.4) 0.0455 (0.0009) 916.4 (4.2)
ANOVA-SKR 0.0025 (0.0003) 645.6 (3.4) 0.0217 (0.0007) 916.4 (4.2)
ANOVA-SC 0.0006 (0.0001) 645.6 (3.4) 0.0117 (0.0006) 916.4 (4.2)
ANOVA-SAIC 0.0009 (0.0002) 645.6 (3.4) 0.0151 (0.0006) 916.4 (4.2)
ANOVA-SBIC 0.0005 (0.0001) 645.6 (3.4) 0.0136 (0.0006) 916.4 (4.2)
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Table 2.13 Genotype-by-time Interaction Test: Results for the Non-Nor-
mal Data. Performance of the methods described in Section 2.3
and in Section 2.5 of the main paper for the test of genotype-
-by-time interaction effects when 10% of genes are non-null and
errors follow a Normal distribution or t-distribution with five
degrees of freedom. Table values are the actual average false
positive fraction (V/R) and the average number (R¯) of signifi-
cant genes for nominal control of FDR at the 0.01 and 0.05 level
over 50 simulated data sets, where V = the number of type I
errors when R tests with the smallest p-values are declared to
be non-null.
F̂DR=0.01 F̂DR=0.05
Method V/R (S.E.) R¯ (S.E.) V/R (S.E.) R¯ (S.E.)
SKR 0.0255 (0.0010) 435.8 (3.3) 0.1186 (0.0018) 685.8 (5.1)
SC 0.0142 (0.0009) 295.0 (2.6) 0.0739 (0.0015) 512.9 (3.7)
N SAIC 0.0237 (0.0009) 465.8 (3.3) 0.1021 (0.0017) 673.2 (4.1)
o SBIC 0.0198 (0.0008) 447.1 (3.1) 0.0810 (0.0016) 625.2 (3.9)
r ANOVA 0.0088 (0.0008) 229.4 (2.4) 0.0486 (0.0016) 393.6 (2.8)
m ANOVA-SKR 0.0013 (0.0004) 229.4 (2.4) 0.0159 (0.0009) 393.6 (2.8)
a ANOVA-SC 0.0058 (0.0008) 229.4 (2.4) 0.0351 (0.0014) 393.6 (2.8)
l ANOVA-SAIC 0.0002 (0.0001) 229.4 (2.4) 0.0094 (0.0007) 393.6 (2.8)
ANOVA-SBIC 0.0002 (0.0001) 229.4 (2.4) 0.0101 (0.0007) 393.6 (2.8)
SKR 0.0231 (0.0011) 279.9 (2.2) 0.1088 (0.0020) 469.7 (3.4)
SC 0.0129 (0.0013) 169.2 (2.2) 0.0676 (0.0021) 325.3 (3.2)
SAIC 0.0202 (0.0010) 308.4 (2.3) 0.0936 (0.0020) 467.6 (3.3)
SBIC 0.0172 (0.0012) 294.1 (2.3) 0.0753 (0.0018) 432.9 (2.9)
t5 ANOVA 0.0097 (0.0013) 124.6 (1.8) 0.0464 (0.0019) 238.2 (2.8)
ANOVA-SKR 0.0008 (0.0003) 124.6 (1.8) 0.0120 (0.0010) 238.2 (2.8)
ANOVA-SC 0.0061 (0.0010) 124.6 (1.8) 0.0325 (0.0015) 238.2 (2.8)
ANOVA-SAIC 0.0000 (0.0000) 124.6 (1.8) 0.0060 (0.0007) 238.2 (2.8)
ANOVA-SBIC 0.0000 (0.0000) 124.6 (1.8) 0.0058 (0.0007) 238.2 (2.8)
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Table 2.14 Genotype Test: Results for the Missing Data. Performance
of the methods described in Section 2.3 and in Section 2.5 of
the main paper for the test of genotype main effects when 10%
of genes are non-null and no data are missing or three entire
microarray chips are missing or random eight observations are
missing for every gene. Table values are the actual average
false positive fraction (V/R) and the average number (R¯) of
significant genes for nominal control of FDR at the 0.1 and 0.2
level over 50 simulated data sets, where V = the number of type
I errors when R tests with the smallest p-values are declared to
be non-null.
F̂DR=0.1 F̂DR=0.2
Method V/R (S.E.) R¯ (S.E.) V/R (S.E.) R¯ (S.E.)
SKR 0.2838 (0.0033) 394.0 (3.8) 0.3523 (0.0027) 541.2 (4.5)
SC 0.0000 (0.0000) 0.0 (0.0) 0.0000 (0.0000) 0.0 (0.0)
SAIC 0.4222 (0.0022) 826.1 (4.8) 0.5003 (0.0020) 1159.1 (6.7)
Full SBIC 0.4375 (0.0021) 885.5 (4.9) 0.5138 (0.0020) 1234.0 (7.2)
ANOVA 0.0950 (0.0341) 1.1 (0.3) 0.1692 (0.0324) 3.7 (0.7)
Data ANOVA-SKR 0.0000 (0.0000) 1.1 (0.3) 0.0020 (0.0020) 3.7 (0.7)
ANOVA-SC 0.0000 (0.0000) 1.1 (0.3) 0.0000 (0.0000) 3.7 (0.7)
ANOVA-SAIC 0.0000 (0.0000) 1.1 (0.3) 0.0013 (0.0013) 3.7 (0.7)
ANOVA-SBIC 0.0000 (0.0000) 1.1 (0.3) 0.0000 (0.0000) 3.7 (0.7)
SKR 0.2943 (0.0029) 354.7 (4.7) 0.3639 (0.0025) 494.4 (5.7)
SC 0.0000 (0.0000) 0.0 (0.0) 0.0000 (0.0000) 0.0 (0.0)
Missing SAIC 0.4302 (0.0026) 773.2 (7.2) 0.5131 (0.0024) 1106.5 (8.2)
three SBIC 0.4434 (0.0026) 826.2 (7.0) 0.5239 (0.0023) 1173.3 (8.5)
entire ANOVA 0.1000 (0.0404) 0.5 (0.1) 0.1432 (0.0388) 1.8 (0.4)
chips ANOVA-SKR 0.0000 (0.0000) 0.5 (0.1) 0.0000 (0.0000) 1.8 (0.4)
ANOVA-SC 0.0000 (0.0000) 0.5 (0.1) 0.0000 (0.0000) 1.8 (0.4)
ANOVA-SAIC 0.0000 (0.0000) 0.5 (0.1) 0.0000 (0.0000) 1.8 (0.4)
ANOVA-SBIC 0.0000 (0.0000) 0.5 (0.1) 0.0000 (0.0000) 1.8 (0.4)
SKR 0.2745 (0.0045) 221.5 (3.1) 0.3663 (0.0039) 344.2 (4.1)
Missing SC 0.0000 (0.0000) 0.0 (0.0) 0.0000 (0.0000) 0.0 (0.0)
eight SAIC 0.4327 (0.0033) 573.5 (4.8) 0.5386 (0.0026) 926.6 (7.0)
data SBIC 0.4420 (0.0033) 612.7 (5.1) 0.5438 (0.0026) 972.6 (7.5)
points ANOVA 0.0670 (0.0300) 0.3 (0.1) 0.1736 (0.0421) 1.5 (0.3)
per ANOVA-SKR 0.0000 (0.0000) 0.3 (0.1) 0.0022 (0.0022) 1.5 (0.3)
gene ANOVA-SC 0.0000 (0.0000) 0.3 (0.1) 0.0050 (0.0050) 1.5 (0.3)
ANOVA-SAIC 0.0000 (0.0000) 0.3 (0.1) 0.0000 (0.0000) 1.5 (0.3)
ANOVA-SBIC 0.0000 (0.0000) 0.3 (0.1) 0.0000 (0.0000) 1.5 (0.3)
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Table 2.15 Time Test: Results for the Missing Data. Performance of the
methods described in Section 2.3 and in Section 2.5 of the main
paper for the test of time main effects when 10% of genes are
non-null and no data are missing or three entire microarray
chips are missing or random eight observations are missing for
every gene. Table values are the actual average false positive
fraction (V/R) and the average number (R¯) of significant genes
for nominal control of FDR at the 0.01 and 0.05 level over
50 simulated data sets, where V = the number of type I er-
rors when R tests with the smallest p-values are declared to be
non-null.
F̂DR=0.01 F̂DR=0.05
Method V/R (S.E.) R¯ (S.E.) V/R (S.E.) R¯ (S.E.)
SKR 0.0084 (0.0005) 972.7 (3.9) 0.0365 (0.0007) 1211.8 (3.5)
SC 0.0004 (0.0001) 780.8 (3.5) 0.0064 (0.0003) 1023.9 (3.6)
SAIC 0.0196 (0.0007) 1141.1 (4.0) 0.0713 (0.0010) 1400.0 (4.2)
Full SBIC 0.0212 (0.0007) 1164.6 (4.0) 0.0748 (0.0009) 1425.0 (4.4)
ANOVA 0.0103 (0.0005) 858.8 (3.5) 0.0506 (0.0009) 1156.1 (3.8)
Data ANOVA-SKR 0.0039 (0.0003) 858.8 (3.5) 0.0274 (0.0007) 1156.1 (3.8)
ANOVA-SC 0.0011 (0.0002) 858.8 (3.5) 0.0178 (0.0007) 1156.1 (3.8)
ANOVA-SAIC 0.0019 (0.0002) 858.8 (3.5) 0.0218 (0.0007) 1156.1 (3.8)
ANOVA-SBIC 0.0016 (0.0002) 858.8 (3.5) 0.0201 (0.0007) 1156.1 (3.8)
SKR 0.0086 (0.0005) 874.2 (5.4) 0.0367 (0.0008) 1119.1 (6.2)
SC 0.0006 (0.0001) 737.0 (5.6) 0.0087 (0.0004) 983.7 (6.1)
Missing SAIC 0.0198 (0.0006) 1063.3 (5.7) 0.0751 (0.0011) 1332.5 (6.2)
three SBIC 0.0213 (0.0007) 1085.3 (5.8) 0.0791 (0.0011) 1357.1 (6.3)
entire ANOVA 0.0081 (0.0005) 763.7 (7.9) 0.0420 (0.0010) 1044.8 (8.4)
chips ANOVA-SKR 0.0041 (0.0003) 763.7 (7.9) 0.0247 (0.0008) 1044.8 (8.4)
ANOVA-SC 0.0012 (0.0002) 763.7 (7.9) 0.0145 (0.0007) 1044.8 (8.4)
ANOVA-SAIC 0.0014 (0.0002) 763.7 (7.9) 0.0174 (0.0008) 1044.8 (8.4)
ANOVA-SBIC 0.0010 (0.0002) 763.7 (7.9) 0.0161 (0.0008) 1044.8 (8.4)
SKR 0.0105 (0.0006) 651.8 (3.1) 0.0465 (0.0010) 905.3 (3.8)
Missing SC 0.0026 (0.0003) 556.5 (3.2) 0.0229 (0.0008) 817.9 (3.8)
eight SAIC 0.0242 (0.0032) 847.5 (5.0) 0.0896 (0.0032) 1142.3 (5.4)
data SBIC 0.0244 (0.0032) 858.2 (4.9) 0.0872 (0.0032) 1145.0 (5.4)
points ANOVA 0.0059 (0.0005) 479.5 (3.0) 0.0312 (0.0009) 724.6 (3.7)
per ANOVA-SKR 0.0022 (0.0003) 479.5 (3.0) 0.0167 (0.0007) 724.6 (3.7)
gene ANOVA-SC 0.0013 (0.0002) 479.5 (3.0) 0.0124 (0.0007) 724.6 (3.7)
ANOVA-SAIC 0.0039 (0.0032) 479.5 (3.0) 0.0118 (0.0031) 724.6 (3.7)
ANOVA-SBIC 0.0034 (0.0030) 479.5 (3.0) 0.0112 (0.0030) 724.6 (3.7)
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Table 2.16 Genotype-by-time Interaction Test: Results for the Missing
Data. Performance of the methods described in Section 2.3
and in Section 2.5 of the main paper for the test of genotype-
-by-time interaction effects when 10% of genes are non-null and
no data are missing or three entire microarray chips are missing
or random eight observations are missing for every gene. Table
values are the actual average false positive fraction (V/R) and
the average number (R¯) of significant genes for nominal control
of FDR at the 0.01 and 0.05 level over 50 simulated data sets,
where V = the number of type I errors when R tests with the
smallest p-values are declared to be non-null.
F̂DR=0.01 F̂DR=0.05
Method V/R (S.E.) R¯ (S.E.) V/R (S.E.) R¯ (S.E.)
SKR 0.0255 (0.0010) 435.8 (3.3) 0.1186 (0.0018) 685.8 (5.1)
SC 0.0142 (0.0009) 295.0 (2.6) 0.0739 (0.0015) 512.9 (3.7)
SAIC 0.0237 (0.0009) 465.8 (3.3) 0.1021 (0.0017) 673.2 (4.1)
Full SBIC 0.0198 (0.0008) 447.1 (3.1) 0.0810 (0.0016) 625.2 (3.9)
ANOVA 0.0088 (0.0008) 229.4 (2.4) 0.0486 (0.0016) 393.6 (2.8)
Data ANOVA-SKR 0.0013 (0.0004) 229.4 (2.4) 0.0159 (0.0009) 393.6 (2.8)
ANOVA-SC 0.0058 (0.0008) 229.4 (2.4) 0.0351 (0.0014) 393.6 (2.8)
ANOVA-SAIC 0.0002 (0.0001) 229.4 (2.4) 0.0094 (0.0007) 393.6 (2.8)
ANOVA-SBIC 0.0002 (0.0001) 229.4 (2.4) 0.0101 (0.0007) 393.6 (2.8)
SKR 0.0263 (0.0012) 335.5 (3.8) 0.1256 (0.0021) 574.6 (5.6)
SC 0.0122 (0.0016) 111.4 (3.4) 0.0651 (0.0021) 294.4 (5.1)
Missing SAIC 0.0266 (0.0011) 388.8 (3.6) 0.1165 (0.0020) 599.2 (5.1)
three SBIC 0.0225 (0.0010) 373.1 (3.5) 0.0956 (0.0017) 555.4 (4.7)
entire ANOVA 0.0091 (0.0019) 57.9 (2.8) 0.0434 (0.0023) 173.7 (4.6)
chips ANOVA-SKR 0.0000 (0.0000) 57.9 (2.8) 0.0025 (0.0007) 173.7 (4.6)
ANOVA-SC 0.0059 (0.0015) 57.9 (2.8) 0.0250 (0.0019) 173.7 (4.6)
ANOVA-SAIC 0.0000 (0.0000) 57.9 (2.8) 0.0006 (0.0003) 173.7 (4.6)
ANOVA-SBIC 0.0000 (0.0000) 57.9 (2.8) 0.0006 (0.0003) 173.7 (4.6)
SKR 0.0335 (0.0021) 142.4 (2.4) 0.1374 (0.0029) 300.7 (4.0)
Missing SC 0.0000 (0.0000) 0.5 (0.2) 0.0684 (0.0300) 1.7 (0.4)
eight SAIC 0.0420 (0.0045) 227.0 (3.4) 0.1578 (0.0041) 418.2 (5.0)
data SBIC 0.0391 (0.0043) 223.0 (3.4) 0.1381 (0.0043) 391.8 (4.6)
points ANOVA 0.0200 (0.0200) 0.4 (0.1) 0.0440 (0.0196) 1.2 (0.2)
per ANOVA-SKR 0.0000 (0.0000) 0.4 (0.1) 0.0000 (0.0000) 1.2 (0.2)
gene ANOVA-SC 0.0000 (0.0000) 0.4 (0.1) 0.0300 (0.0170) 1.2 (0.2)
ANOVA-SAIC 0.0000 (0.0000) 0.4 (0.1) 0.0000 (0.0000) 1.2 (0.2)
ANOVA-SBIC 0.0000 (0.0000) 0.4 (0.1) 0.0000 (0.0000) 1.2 (0.2)
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Figure 2.1 Genotype-by-time Interaction: Results for the Complete Data.
ROC curves (left panel) and average actual false positive frac-
tion (V/R) vs. the average estimated FDR level (F̂DR) (right
panel) corresponding to the five analysis methods of Section 2.3
for testing interaction between genotype and time. Each curve
was averaged over 50 simulated data sets.
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Figure 2.2 Genotype Test: Results for the Full Data Sets. Left: ROC
curves corresponding to the five standard analysis methods for
testing genotype main effects when 1% (top) and 10% (bottom)
of the genes are non-null. Each ROC curve was averaged over
50 simulated data sets. Right: The average actual false posi-
tive fraction (V/R) vs. the average estimated FDR level (F̂DR)
corresponding to the five standard analysis methods for testing
genotype main effects when 1% (top) and 10% (bottom) of the
genes are non-null. Each curve was averaged over 50 simulated
data sets.
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Figure 2.2 (Continued)
Genotype Test: Results for the Full Data Sets. Left: ROC curves corresponding to the five
standard analysis methods for testing genotype main effects when 20% of the genes are non-
null. Each ROC curve was averaged over 50 simulated data sets. Right: The average actual
false positive fraction (V/R) vs. the average estimated FDR level (F̂DR) corresponding to the
five standard analysis methods for testing genotype main effects when 20% of the genes are
non-null. Each curve was averaged over 50 simulated data sets.
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Figure 2.3 Time Test: Results for the Full Data Sets. Left: ROC curves
corresponding to the five standard analysis methods for test-
ing time main effects when 1% (top) and 10% (bottom) of the
genes are non-null. Each ROC curve was averaged over 50 sim-
ulated data sets. Right: The average actual false positive frac-
tion (V/R) vs. the average estimated FDR level (F̂DR) corre-
sponding to the five standard analysis methods for testing time
main effects when 1% (top) and 10% (bottom) of the genes are
non-null. Each curve was averaged over 50 simulated data sets.
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Figure 2.3 (Continued)
Time Test: Results for the Full Data Sets. Left: ROC curves corresponding to the five standard
analysis methods for testing time main effects when 20% of the genes are non-null. Each ROC
curve was averaged over 50 simulated data sets. Right: The average actual false positive
fraction (V/R) vs. the average estimated FDR level (F̂DR) corresponding to the five standard
analysis methods for testing time main effects when 20% of the genes are non-null. Each curve
was averaged over 50 simulated data sets.
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Figure 2.4 Genotype-by-time Interaction Test: Results for the Full Data
Sets. Left: ROC curves corresponding to the five standard anal-
ysis methods for testing interaction between genotype and time
when 1% (top) and 10% (bottom) of the genes are non-null.
Each ROC curve was averaged over 50 simulated data sets.
Right: The average actual false positive fraction (V/R) vs. the
average estimated FDR level (F̂DR) corresponding to the five
standard analysis methods for testing interaction between geno-
type and time when 1% (top) and 10% (bottom) of the genes
are non-null. Each curve was averaged over 50 simulated data
sets.
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Figure 2.4 (Continued)
Genotype-by-time Interaction Test: Results for the Full Data Sets. Left: ROC curves corre-
sponding to the five standard analysis methods for testing interaction between genotype and
time when 20% of the genes are non-null. Each ROC curve was averaged over 50 simulated
data sets. Right: The average actual false positive fraction (V/R) vs. the average estimated
FDR level (F̂DR) corresponding to the five standard analysis methods for testing interaction
between genotype and time when 20% of the genes are non-null. Each curve was averaged over
50 simulated data sets.
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Figure 2.5 Genotype Test: Results for the non-normal Data. Left: ROC
curves corresponding to the five standard analysis methods
for testing genotype main effects when 10% of the genes
are non-null and errors follow a Normal distribution (a) or
t-distribution with five degrees of freedom (c). Each ROC curve
was averaged over 50 simulated data sets. Right: The average
actual false positive fraction (V/R) vs. the average estimated
FDR level (F̂DR) corresponding to the five standard analysis
methods for testing genotype main effects when 10% of the
genes are non-null and errors follow a Normal distribution (b)
or t-distribution with five degrees of freedom (d). Each curve
was averaged over 50 simulated data sets.
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Figure 2.6 Time Test: Results for the non-normal Data. Left: ROC curves
corresponding to the five standard analysis methods for testing
time main effects when 10% of the genes are non-null and er-
rors follow a Normal distribution (a) or t-distribution with five
degrees of freedom (b). Each ROC curve was averaged over
50 simulated data sets. Right: The average actual false posi-
tive fraction (V/R) vs. the average estimated FDR level (F̂DR)
corresponding to the five standard analysis methods for test-
ing time main effects when 10% of the genes are non-null and
errors follow a Normal distribution (b) or t-distribution with
five degrees of freedom (d). Each curve was averaged over 50
simulated data sets.
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Figure 2.7 Genotype-by-time interaction Test: Results for the non-normal
Data. Left: ROC curves corresponding to the five standard
analysis methods for testing interaction between genotype and
time when 10% of the genes are non-null and errors follow a
Normal distribution (a) or t-distribution with five degrees of
freedom (c). Each ROC curve was averaged over 50 simulated
data sets. Right: The average actual false positive fraction
(V/R) vs. the average estimated FDR level (F̂DR) correspond-
ing to the five standard analysis methods for testing interaction
between genotype and time when 10% of the genes are non-null
and errors follow a Normal distribution (b) or t-distribution
with five degrees of freedom (d). Each curve was averaged over
50 simulated data sets.
65
0.00 0.05 0.10 0.15 0.20
0.
0
0.
1
0.
2
0.
3
0.
4
0.
5
1−specificity
se
n
si
tiv
ity
SKR
SC
SAIC
SBIC
ANOVA
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
V R
FD
R
SKR
SC
SAIC
SBIC
ANOVA
0.00 0.05 0.10 0.15 0.20
0.
0
0.
1
0.
2
0.
3
0.
4
0.
5
1−specificity
se
n
si
tiv
ity
SKR
SC
SAIC
SBIC
ANOVA
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
V R
FD
R
SKR
SC
SAIC
SBIC
ANOVA
Figure 2.8 Genotype Test: Results for the Missing Data. Left: ROC curves
corresponding to the five standard analysis methods for testing
genotype main effects when 10% of the genes are non-null and
no data are missing (top) or three microarray chips are miss-
ing (bottom). Each ROC curve was averaged over 50 simulated
data sets. Right: The average actual false positive fraction
(V/R) vs. the average estimated FDR level (F̂DR) correspond-
ing to the five standard analysis methods for testing genotype
main effects when 10% of the genes are non-null and no data are
missing (top) or three microarray chips are missing (bottom).
Each curve was averaged over 50 simulated data sets.
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Figure 2.8 (Continued)
Genotype Test: Results for the Missing Data. Left: ROC curves corresponding to the five
standard analysis methods for testing genotype main effects when 10% of the genes are non-
null and random eight observations are missing for every gene. Each ROC curve was averaged
over 50 simulated data sets. Right: The average actual false positive fraction (V/R) vs. the
average estimated FDR level (F̂DR) corresponding to the five standard analysis methods for
testing genotype main effects when 10% of the genes are non-null and random eight observations
are missing for every gene. Each curve was averaged over 50 simulated data sets.
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Figure 2.9 Time Test: Results for the Missing Data. Left: ROC curves
corresponding to the five standard analysis methods for testing
time main effects when 10% of the genes are non-null and no
data are missing (top) or three microarray chips are missing
(bottom). Each ROC curve was averaged over 50 simulated
data sets. Right: The average actual false positive fraction
(V/R) vs. the average estimated FDR level (F̂DR) correspond-
ing to the five standard analysis methods for testing time main
effects when 10% of the genes are non-null and no data are miss-
ing (top) or three microarray chips are missing (bottom). Each
curve was averaged over 50 simulated data sets.
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Figure 2.9 (Continued)
Time Test: Results for the Missing Data. Left: ROC curves corresponding to the five standard
analysis methods for testing time main effects when 10% of the genes are non-null and random
eight observations are missing for every gene. Each ROC curve was averaged over 50 simulated
data sets. Right: The average actual false positive fraction (V/R) vs. the average estimated
FDR level (F̂DR) corresponding to the five standard analysis methods for testing time main
effects when 10% of the genes are non-null and random eight observations are missing for every
gene. Each curve was averaged over 50 simulated data sets.
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Figure 2.10 Genotype-by-time Interaction Test: Results for the Missing
Data. Left: ROC curves corresponding to the five standard
analysis methods for testing interaction between genotype and
time when 10% of the genes are non-null and no data are
missing (top) or three microarray chips are missing (bottom).
Each ROC curve was averaged over 50 simulated data sets.
Right: The average actual false positive fraction (V/R) vs.
the average estimated FDR level (F̂DR) corresponding to the
five standard analysis methods for testing interaction between
genotype and time when 10% of the genes are non-null and no
data are missing (top) or three microarray chips are missing
(bottom). Each curve was averaged over 50 simulated data
sets.
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Figure 2.10 (Continued)
Genotype-by-time Interaction Test: Results for the Missing Data. Left: ROC curves corre-
sponding to the five standard analysis methods for testing interaction between genotype and
time when 10% of the genes are non-null and random eight observations are missing for every
gene. Each ROC curve was averaged over 50 simulated data sets. Right: The average actual
false positive fraction (V/R) vs. the average estimated FDR level (F̂DR) corresponding to the
five standard analysis methods for testing interaction between genotype and time when 10% of
the genes are non-null and random eight observations are missing for every gene. Each curve
was averaged over 50 simulated data sets.
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CHAPTER 3. Bayesian Analysis of Microarray Experiments with
Multiple Sources of Variation: A Mixed Model Approach
Cumhur Yusuf Demirkale, Tapabrata Maiti, and Dan Nettleton
Abstract: Some microarray experiments have complex experimental designs that call for
modeling of multiple sources of variation through the inclusion of multiple random factors.
While large amounts of data on thousands of genes are collected in these experiments, the
sample size for each gene is usually small. Therefore, in a classical gene-by-gene mixed linear
model analysis, there will be very few degrees of freedom to estimate the variance components
of all random factors considered in the model and low statistical power for testing fixed effects
of interest. To address these challenges, we propose a hierarchical Bayesian modeling strategy
to account for important experimental factors and complex correlation structure among the
expression measurements for each gene. We use half-Cauchy priors for the standard deviation
parameters of the random factors with few effects. We rank genes with respect to evidence
of differential expression across the levels of a factor of interest by calculating a single sum-
mary statistic per gene from the posterior distribution of the treatment effects considered in
the model. Simulation shows that our hierarchical Bayesian approach is much better than a
traditional gene-by-gene mixed linear model analysis at distinguishing differentially expressed
genes from non-differentially expressed genes.
KEY WORDS: Hierarchical Model; Linear Mixed Models; Markov chain Monte Carlo.
3.1 Introduction
Microarray technology provides a means for simultaneously measuring the abundance of
thousands of mRNA transcripts in multiple biological samples. These measurements are used
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to detect differentially expressed genes over different experimental conditions, time points,
tissue samples, etc. Many statistical methods for identifying differentially expressed genes
have been proposed in the statistics literature in recent years.
One popular strategy involves conducting a linear mixed model analysis for each of thou-
sands of genes. The basic approach was first proposed by Wolfinger et al. (2001) and has been
applied in various forms by many researchers. The use of mixed linear modeling is convenient
because such models allow for a natural and principled accounting for multiple sources of vari-
ation. Because all the observations from a single microarray slide or chip share the same levels
of all factors in a microarray experiment, the same experimental design applies to every gene.
Thus, it is customary to fit the same linear mixed model for each gene. The common model
is fit separately to the data from each gene to allow model parameters to be gene-specific.
Tests for fixed effects of interest are carried out for each gene, and some correction for multiple
testing is employed to help focus attention on the most relevant results.
False Discovery Rate (FDR) has become the most common error measure to control or
estimate when declaring genes to be differentially expressed. FDR was first introduced by
Benjamini and Hochberg (1995) and is formally defined as E(Q) where Q is the proportion of
mistakenly rejected null hypotheses among all rejected null hypotheses or 0 if no hypotheses
are rejected. Among many other approaches, Storey and Tibshirani’s (2003) method for FDR
estimation has become a popular procedure that is less conservative than the original proposal
of Benjamini and Hochberg.
Some microarray experiments have complex experimental designs that call for modeling of
multiple sources of variation through the inclusion of multiple random factors. While large
amounts of data on thousands of genes are collected in these experiments, the sample size for
each gene is usually small. Therefore, in a classical gene-by-gene mixed linear model analysis,
there will be very few degrees of freedom to estimate the variance components of all random
factors considered in the model and low statistical power for testing fixed effect(s) of interest.
To address these challenges, in this article we propose a hierarchical Bayesian modeling
strategy to account for important experimental factors and complex correlation structure
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among the expression measurements for each gene. Our method estimates treatment effects
in the model with fully Bayesian approaches by Markov Chain Monte Carlo (MCMC). We
use half-Cauchy priors for the standard deviation parameters of the random factors with few
effects. We rank genes with respect to evidence of differential expression across the levels of a
factor of interest by calculating a single summary statistic per gene from the posterior distri-
bution of the treatment effects considered in the model. Simulation shows that our hierarchical
Bayesian approach is much better than a traditional gene-by-gene mixed linear model analysis
at distinguishing differentially expressed genes from non-differentially expressed genes.
This paper is organized as follows. In Section 3.2, we introduce the motivating barley
microarray experiment and gene-by-gene linear mixed model analysis. Section 3.3 proposes a
hierarchical model for the microarray experiment and discusses in detail the choice of prior
distribution, and explains Bayesian inference for the factor(s) of interest. In Section 3.4, we
compare the performance of the classical gene-by-gene linear mixed model analysis with the
hierarchical Bayesian analysis through different simulation scenarios. In Section 3.5, we apply
hierarchical Bayesian analysis to the barley data set, and Section 3.6 gives a few concluding
comments and explains the future direction of this research.
3.2 Example: Gene Expression in Barley
Caldo, Nettleton and Wise (2004) conducted a microarray experiment to identify barley
genes that play a role in resistance to a fungal pathogen. To illustrate our methods, we describe
the analysis of a subset of the data they considered.
3.2.1 Data
Two genotypes of barley seedlings, one resistant and one susceptible to a fungal pathogen,
were grown in separate trays randomly positioned in a growth chamber. Each tray contained
six rows of 15 seedings each. The six rows in each tray were randomly assigned to six tissue
collection times: 0, 8, 16, 20, 24, and 32 hours after fungal inoculation. After simultaneously
inoculating plants with the pathogen, each row of plants was harvested at its randomly assigned
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time. One Affymetrix GeneChip was used to measure gene expression in the plant material
from a pool of the 15 seedlings in each row. The entire process was independently repeated a
total of three times, yielding data on 22,840 probe sets (corresponding to barley genes) for each
of the 36 GeneChips (2 genotypes × 6 time points × 3 replications). Note that the complete
experiment involved a third barley genotype as well as a second infection type, but we focus
on the reduced data set here to simplify the presentation of our main ideas. The expression
levels in the reduced data were log-transformed and median centered before an analysis was
performed.
3.2.2 Linear Mixed Model Analysis of the Barley Data
The design of the experiment can be viewed as split-plot with replications as blocks, trays
as whole plots and rows of seedlings as split plots. Note that although time is a factor in this
experiment, this is not a repeated-measures design because no one plant or pool of plants is
measured at multiple time points. Instead, because the measurement process is destructive,
different randomly selected plants are sampled at each time. Therefore the following linear
mixed model corresponding to the split-plot design was considered as a base model for each
gene. Let
Yijk = µ+ γj + τk + θjk + αi + βij + δik + ǫijk (3.1)
i = 1, 2, 3; j = 1, 2; k = 1, . . . , 6;
where Yijk is the observed intensity of a gene at the k
th harvesting time for the jth genotype
during the ith replication, γj is the fixed genotype effect, τk is the fixed tissue collection time
effect, θjk is the genotype-by-time interaction effect, αi ∼ NID(0, σ
2
α) is the random replica-
tion effect, βij ∼ NID(0, σ
2
β) is the replication-by-genotype interaction effect (corresponding to
trays) , δik ∼ NID(0, σ
2
δ ) is the replication-by-time interaction effect, and ǫijk ∼ NID(0, σ
2
ǫ )
is the error (NID=Normally and Independently Distributed). Though not standard for a
split-plot design, the replication-by-time interaction effects were included to account for the
possibility of variation across harvest events; one random effect was included for each combi-
nation of replication and time so that the two observations for the two samples (one of the
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each genotype) collected at any one time in any one replication were allowed to be correlated
due to the shared replication-by-time random effect. All the random effects are assumed to be
jointly independently distributed and to be independent of the residual errors.
For each gene, this linear mixed model was fit to the 36 log-scale measures of expression by
the SAS PROC MIXED procedure. In this experiment, scientists were interested in identifying
barley genes that play a role in resistance to the fungal pathogen. Such genes were expected
to show patterns of expression over time that differed between the two genotypes. Therefore,
the hypothesis test for interaction between genotype and time was considered to be of primary
importance for each linear mixed model analysis, though tests for genotype main effects and
time main effects were conducted also. When the Restricted Maximum Likelihood (REML)
method was used to estimate the variance components, the Kenward-Roger (KR) method
(Kenward and Roger, 1997) was used to determine the denominator degrees of freedom and
F -statistics for test of fixed effects. Applying the method of Storey and Tibshirani (2003) to
obtain nominal control of FDR at 1% yielded a total of 399 genes for the test of genotype
effect, 13202 genes for the test of time effect, and 93 genes for the test of interaction between
genotype and time.
For each of the 22,840 genes, SAS PROC MIXED also produced REML estimates of the
three variance components corresponding to three random factors. The variance component
estimate for replication, replication-by-genotype, and replication-by-time was reported as zero
for a total of 8153, 7824, and 7235 genes, respectively. In other words, almost one third of
variance components for each random factor were estimated to be zero across all the genes in
the data set. Accounting the high variation in estimate of variance components due to small
sample size for each gene, the inference for fixed treatment effects is questionable under gene-
by-gene linear mixed model analysis. Therefore we need to consider the important practical
problem of conducting fixed-effects inference in linear mixed model analysis of microarray data
when there are very few degrees of freedom to estimate the variance components of all random
factors considered in the model.
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3.3 Bayesian Hierarchical Analysis
We will start this section by introducing another possible linear mixed model for the barley
microrray data set. To borrow information across genes and to express the natural hierarchy
of the random factors considered in the design of the experiment, this model will be formalized
in a hierarchical setup. Later, we will introduce reasonable priors for the variance parameters
of the fixed and the random factors considered in the model. Finally, we will define several
summary statistics for each gene. They can be used for ordering genes from most significant
to least significant with respect to a test of interest.
3.3.1 Hierarchical Model
The following model is an alternative linear mixed model, which also accounts for the fixed
and the random effects considered in the design of the Barley experiment.
Ygijk = µg +Rgi +RGgij + τgjk + ǫgijk (3.2)
g = 1, . . . , N ; i = 1, 2, 3; j = 1, 2; k = 1, . . . , 6.
where Ygijk is the observed intensity of gene g at the k
th harvesting time for jth genotype during
ith replication, µg ∼ NID(0, α
2
g) is the mean for gene g, Rgi ∼ NID(0, β
2
g) is the replication
effect, RGgij ∼ NID(0, δ
2
g) is the replication-by-genotype interaction, τgjk ∼ NID(0, θ
2
g) is
the genotype-by-time interaction. All these random effects are assumed to be independently
distributed from each other and the residual-error components ǫgijk ∼ NID(0, σ
2
g). We can
rewrite this model as sum of two parts: the hierarchical random effects part and the fixed
treatment effects part.
Ygijk = µ
(0)
gijk + ǫ
(0)
gijk
µ
(0)
gijk = µ
(1)
gij + τgjk
µ
(1)
gij = µ
(2)
gi + ǫ
(1)
gij (3.3)
77
µ
(2)
gi = µ
(3)
g + ǫ
(2)
gi
µ(3)g = µ+ ǫ
(3)
g
where ǫ
(0)
gijk ∼ N(0, σ
2
g) is the residual-error components, τgjk ∼ N(0, θ
2
g) is the genotype-by-
time interaction, ǫ
(1)
gij ∼ N(0, δ
2
g) is the replication-by-genotype interaction, ǫ
(2)
gi ∼ N(0, β
2
g) is
the replication effect, ǫ
(3)
g ∼ N(0, α2g) is the gene effect, and µ ∼ N(0,K) is the overall mean.
3.3.2 Prior Specification
A full Bayesian analysis requires introducing prior distributions on model parameters to
express uncertainty about their values, combining these with the data to obtain posterior
distributions, and drawing inference based on the posterior samples. Several kinds of priors for
the mean and variance of a normal distribution have been studied in the literature, including
the non informative improper prior and the conjugate prior.
Several non informative prior distributions have been suggested for scale parameters in
Bayesian literature. Among all, two commonly-considered improper densities are inverse-
gamma(ǫ,ǫ), as ǫ → 0, and uniform(0,κ), as κ → ∞. But these priors do not necessarily
lead to proper posterior distributions in some cases for hierarchical models. When ǫ → 0,
the inverse-gamma(ǫ,ǫ) prior yields an improper density. Thus, ǫ must be set to a reasonable
value. In datasets where the standard deviation parameter is estimated to be near zero, the
posterior inferences are sensitive to ǫ under this prior specification. The uniform(0,κ) model
yields a limiting proper posterior density as κ → ∞, as long as the number of effects of the
corresponding random factor is at least 3 (Gelman 2006). If the number of effects of the
random factor is smaller than 3, this non informative prior can lead to an improper posterior
or a proper posterior with an unrealistically broad range. In datasets where random factors
with large numbers of effects and for a finite but sufficiently large κ, inferences are not sensitive
to the choice of κ.
For hierarchical standard deviation parameters, Gelman(2006) illustrated that the choice
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of non informative prior distribution can have a big effect on inferences when the number
of effects of the random factor is small or the variance component of the random factor is
close to zero. Our prior choice for the variance parameter of each random factor in the model
is based on the distribution of REML estimates of the variance components from the linear
mixed model analysis described in Section 3.2.2. Under that analysis, the variance component
for replication, replication-by-genotype, and replication-by-time was estimated zero for a total
of 8153, 7824, and 7235 genes, respectively and the standard deviation parameter of residual
error is estimated substantially greater than zero for all the genes. Note also that there were
only three replications and two genotypes in the barley experiment. These results imply that
we should not consider an inverse-gamma or uniform prior for the variance parameters of the
replication and replication-by-genotype random factors in our hierarchical model.
As an alternative to these two non informative priors, Gelman (2006) proposed a folded-
noncentral-t family of conditionally conjugate priors when the number of effects of the random
factor is small or the random factor variance is close to zero. These distributions are simply a
ratio of the absolute value of a normal random variable and the square root of a gamma random
variable. This family of distributions has many special cases. For example, when restricting
mean of the normal distribution to zero, the distribution becomes simply a half-t, that is,
the absolute value of a Student-t distribution centered at zero. Further, if the denominator
degrees of freedom equals 1, it becomes the half-Cauchy distribution. This very special prior is
more flexible and has better behavior near zero compared to the inverse-gamma prior. Thus,
a half-Cauchy prior distribution with a peak at zero and scale equal to a constant A was used
for the standard deviation parameters of the replication and replication-by-genotype random
factors. For computational consistency, we also consider similar half-Cauchy prior distribution
as a prior for the standard deviation parameter of the gene effects.
A non informative inverse-gamma was taken as a prior distribution for the variance param-
eter of the residual error because this prior distribution leads to posterior conjugacy, which
makes the computations more efficient. For some genes, variation due to genotype-by-time
effects is assumed to be close to zero. As discussed before, it is not appropriate to consider an
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inverse-gamma prior for the variance parameter of this factor. As suggested in Gelman (2006),
we used a positive uniform distribution on (0, κ) for the standard deviation parameter of the
genotype-by-time factor.
Finally, the following equations summarize the formulation of the priors for the standard
deviation or variance parameters,
• Gene effects: αg ∼ Half − Cauchy(0, A1)
• Replication effects: βg ∼ Half − Cauchy(0, A2)
• Replication-by-genotype effects: δg ∼ Half − Cauchy(0, A3)
• Genotype-by-time effects: θg ∼ Unif(0, κ)
• Error variance: σ2g ∼ Inv −Gamma(a, b)
We set different values for the hyper-parameters A1, A2, A3, κ, a, and b in a simulation study,
which showed that the ranking of the genes is not affected. Therefore, any reasonable values
from data can be used for these hyper-parameters.
3.3.3 Inference
The aim of the barley experiment is to identify genes showing different time patterns over
two genotypes. We would also like to identify significantly differentially expressed genes with
respect to genotype effect and time effect. We proposed four different statistics to order the
genes from the most significant to the least significant with respect to these fixed effects. They
are calculated by a similar formula of the classical F statistic.
For gene g, let τg be twelve a dimensional treatment vector corresponding to the combi-
nations of two genotypes and six time points. By using the hierarchical model and the prior
distributions, WinBUGS or some other software can be used to generate M realizations from
the posterior distributions of each of the twelve components, τgjk. For each gene, each statistic
is calculated by using the posterior sample (τ
(1)
g , τ
(2)
g , . . . , τ
(M)
g ).
For gene g, the following are definitions of the four statistics:
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1.
F1 = (Cτ¯g)
′
[
CΣˆgC
′
]−1
(Cτ¯g) (3.4)
where
• τ¯g is the average vector over (τ
(1)
g , τ
(2)
g , . . . , τ
(M)
g ).
• Σˆg is the sample variance-covariance matrix estimate over (τ
(1)
g , τ
(2)
g , . . . , τ
(M)
g ).
• C is the contrast vector or matrix. For testing genotype effect, vector C is defined
as
C = [1, 1, 1, 1, 1, 1,−1,−1,−1,−1,−1,−1]
When testing for time effect, C matrix is defined to be
C =

1 −1 0 0 0 0 1 −1 0 0 0 0
0 1 −1 0 0 0 0 1 −1 0 0 0
0 0 1 −1 0 0 0 0 1 −1 0 0
0 0 0 1 −1 0 0 0 0 1 −1 0
0 0 0 0 1 −1 0 0 0 0 1 −1

and for the test of genotype-by-time interaction, C matrix is defined as
C =

1 −1 0 0 0 0 −1 1 0 0 0 0
1 0 −1 0 0 0 −1 0 1 0 0 0
1 0 0 −1 0 0 −1 0 0 1 0 0
1 0 0 0 −1 0 −1 0 0 0 1 0
1 0 0 0 0 −1 −1 0 0 0 0 1

2.
F2 = (Cτ˜g)
′
[
CΣˆgC
′
]−1
(Cτ˜g) (3.5)
where
• τ˜g is the median vector over (τ
(1)
g , τ
(2)
g , . . . , τ
(M)
g ).
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• Σˆg and C are the same as before.
3.
F3 =
1
n
n∑
i=1
F (i) (3.6)
where
•
F (i) = (Cτ (i)g )
′
[
CΣˆgC
′
]−1
(Cτ (i)g )
• Σˆg and C are the same as before.
4.
F4 = median
(
F (i), i = 1, . . . , n
)
(3.7)
where F (i), C, and Σˆg are the same as before.
After calculating F1, . . . , F4, any of these statistics can be used to order genes. For example,
we can employ F4 to identify highly differentially expressed genes with respect to genotype
effect. The gene with the largest F4 value is declared to be the most significant gene with
respect to genotype effect. In the following section, we will use ROC curves to compare the
power of these statistics for ordering genes with respect to effects of interest.
3.4 Simulation
Two data sets, each having one thousand genes, were simulated by using the linear mixed
model (3.1) described in Section 3.2. We tried to mimic the original barley data when gen-
erating both data sets. Therefore, the first step in data generation was to select a set of one
thousand genes randomly from the original barley data set. These genes were analyzed by fit-
ting the linear mixed model (3.1) separately for each gene and estimating variance components
for random factors (replication, replication-by-genotype, and replication-by-time) in the model
by the REML method. Later, these variance component estimates were used for generating
data from the random part of the linear mixed model for each gene in the simulated data set.
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3.4.1 Simulation 1
For the first simulated data set, we chose a list of one thousand genes randomly in a
way that variance component estimates for all three random factors were nonzero for each
gene in this list. We start generating data for these genes by using the random part of the
linear mixed model (3.1). Random effects for a gene were simulated by sampling from Normal
distributions with mean zero and variance equal to the variance component estimate of the
corresponding random factor for that gene from the original barley data. Residual errors were
generated similarly by using the variance estimates of the residual error. After simulating
from the random part of the model (3.1) for each of the one thousand genes, ten percent of
the genes were set to have fixed treatment effects. Therefore, a set of hundred genes were
selected randomly among previously chosen one thousand genes. For those hundred genes,
intensities were changed by adding fixed treatment effects, which were the twelve genotype-
by-time interaction means of the corresponding gene from the original barley data. After
simulation, the data set was analyzed by two methods: the analysis by fitting the generating
linear mixed model for each gene independently and the analysis by fitting the hierarchical
Bayesian model described in the previous section.
We used the SAS PROC MIXED procedure to fit the full mixed linear model 3.1 for each
gene independently. Variance components were estimated under REML method, and the KR
method was set to determine the denominator degrees of freedom and F -statistics for the
test of fixed effects. By applying the method of Storey and Tibshirani (2003), the number
of significant genes with respect to fixed effects are reported in Table 3.1 at four nominal
control levels of False Discovery Rate (FDR). For example, when FDR is controlled under 0.1,
twenty five genes are declared to have significant genotype effect. Sixteen of these genes are
correctly identified (Table 3.2). Controlling the FDR at same nominal level, fifty seven genes
are declared to be significant for changing expression levels over time. Fifty six of them are
correctly identified (Table 3.2). Twenty one genes are declared to have significantly different
time patterns over two genotypes. Nineteen of them were correctly identified for significant
interaction between genotype and time (Table 3.2).
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The first simulated data set was also analyzed by fitting the hierarchical Bayesian model
described in Section 3.3. Four statistics (3.4, 3.5, 3.6, and 3.7) were calculated for each gene by
using the posterior distribution of each treatment effect. Genes were ordered for significance
with respect to genotype, time, and genotype-by-time effects by using the values of F1, F2, F3,
or F4. Table 3.2 reports the number of correctly identified genes under hierarchical Bayesian
analysis when F4 is used for ranking the genes. For example, all of the most significant 25
genes with respect to genotype effect were correctly identified. Similarly, 55 genes among the
most significant 57 genes with respect to time effect, have true time effect, and 20 out of top
21 genes with the highest F4 value for interaction effect, were correctly identified for having
true different time patterns over two genotypes. If we looked at the most significant 100 genes
under both analyses, the hierarchical Bayesian method identifies many more significant genes
correctly than the classical mixed linear model analysis (Table 3.2). For example, when testing
for genotype effect, the classical mixed linear model analysis identified 30 genes correctly among
the most significant 100 genes whereas the hierarchical Bayesian analysis identified sixty five
genes correctly among the most significant 100 genes. These sixty five genes includes all of
the 30 genes, which were correctly identified by the classical mixed linear analysis. These
observations imply that the hierarchical Bayesian approach will be superior to a traditional
full linear mixed model analysis with regard to identification of differentially expressed genes.
Formally, we can use receiver operator characteristic (ROC) curves to compare the effec-
tiveness of the methods for separating differentially and non-differentially expressed genes. The
p-values produced by each method provide a rank order of genes from most evidence for differ-
ential expression to least evidence. The quality of the ranking varies from method to method
and can be judged by comparing ROC curves. The greater the area under an ROC curve the
better the corresponding method is at distinguishing null genes from non-null genes. In Fig-
ure 3.7 and Figure 3.7, we observe that hierarchical Bayesian analysis with F4 statistic has the
highest power for separating differentially and non differentially expressed genes with respect
to the genotype effect and the genotype-by-time interaction, respectively. For genotype, time,
and interaction effects, the hierarchical Bayesian analysis with F1 and F3 statistics produced
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the same rank order of genes. As a last observation, we should also mention that the simulated
data set was analyzed by fitting the true generating linear mixed model for each gene under
the classical approach. But the hierarchical Bayesian analysis provided much better rank order
of the genes with respect to genotype, time, and interaction effects (Figures 3.7, 3.7, and 3.7).
3.4.2 Simulation 2
In classical gene-by-gene mixed linear analysis of the original barley data set in Section 3.2,
the variance components of some random factors were estimated to be zero under the REML
method for many genes. Based on this observation, we assumed that the true underlying
random part of the model (3.1) may differ from gene to gene, and totally, 23 = 8 versions
of the model (3.1) can be considered for the barley data set. Therefore, when generating
the second data set, we try to mimic the original barley data set by allowing some variance
components to be zero for some genes.
Similar to first simulation, a random set of one thousand genes were chosen from the original
barley data set such that not all the variance component estimates were nonzero for some genes
in that list. All eight models were equally represented in this simulation. In other words, under
each of the eight models, data for 125 genes were generated, respectively. Random effects and
residual errors were simulated similar to first simulated data set. Again we let only 10 percent
of the genes to have fixed treatment effects. After generating the data set, it is also analyzed
by the classical linear mixed model approach and the hierarchical Bayesian modeling approach.
Similar to analysis of the first data set, we used the SAS PROC MIXED procedure to fit
the full linear mixed model (3.1) for each gene in this data set. Variance components were
estimated under REML method, and the KR method was set to determine the denominator
degrees of freedom and F -statistics for the test of fixed effects. Again by applying the method
of Storey and Tibshirani (2003), the number of significant genes with respect to fixed effects
are determined for four nominal control levels of FDR (Table 3.3). For example, when FDR is
controlled under 0.1, twenty genes are declared to have significant genotype effect. Fourteen of
these genes are correctly identified with the true genotype effect by this analysis (Table 3.4).
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Controlling the FDR at the same nominal level, forty six genes are declared to be significant
for changing expression levels over time, and thirty eight genes are declared to have significant
interaction between genotype and time (Table 3.4). Again in this analysis, forty four genes
among the most significant 46 genes were correctly identified with the true time effect, and
twenty six genes among the most significant 38 genes were correctly identified with the true
interaction effect (Table 3.4).
We also analyzed the second simulated data set with the hierarchical Bayesian model
described in Section 3.3. Four (3.4, 3.5, 3.6, and 3.7) statistics were calculated for each gene
by using the posterior distribution of each treatment effect. Genes were ordered for significance
with respect to genotype, time, and interaction effects by using the values of F1, F2, F3, or
F4. Table 3.4 reports the number of correctly identified genes under hierarchical Bayesian
analysis when F4 is used for ranking the genes. For example, all of the of the most significant
20 genes with respect to genotype effect were correctly identified with the true genotype effect.
Similarly, 42 genes among the most significant 46 genes with respect to time effect were truly
differentially expressed, and 31 genes among the most significant 38 genes with interaction effect
were correctly identified for having different time patterns over two genotypes (Table 3.4).
If we looked at the most significant 100 genes under both analyses, the hierarchical Bayesian
method identified many more significant genes correctly than the classical mixed linear model
analysis (Table 3.4). For example, when testing for genotype effect, the classical mixed linear
model analysis identified 31 genes correctly whereas the hierarchical Bayesian analysis identified
61 genes correctly. These 65 genes includes 26 of the the 31 genes, which were correctly
identified by the classical analysis. Similarly, for genotype-by-time interaction, classical mixed
linear model analysis identified 37 genes correctly. Hierarchical mixed model analysis identified
54 genes correctly (Table 3.4). These observations show some evidence that the hierarchical
Bayesian approach provides a better order rank of the genes than the classical mixed linear
model analysis of fitting the same model for every gene.
We also used ROC curves to compare the power of the method for distinguishing differen-
tially and non differentially expressed genes with respect to fixed effects. In Figures 3.7 – 3.7,
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we plot ROC curves corresponding to the analysis by fitting the true underlying linear mixed
model for each gene, the analysis by fitting full linear mixed model (3.1), and the analysis with
the hierarchical Bayesian approach. In Figure 3.7 and Figure 3.7, we observe that hierarchi-
cal Bayesian analysis with the F4 statistic has the highest power to distinguish differentially
and non differentially expressed genes with respect to genotype effect, and genotype-by-time
interaction, respectively. For all the fixed effects, hierarchical Bayesian analysis with F1 and
F3 statistics produced the same ordering for genes (Figures 3.7, 3.7, and 3.7). In addition,
both statistics have the best ranking of the genes with respect to time effect (Figure 3.7). In
all figures, it can be concluded that an analysis by hierarchical Bayesian modeling with any
F statistic is better for rank ordering genes than the analysis by fitting the same mixed linear
model for each gene or the analysis by fitting the true underlying model for each gene.
3.4.3 Simulation 3
In simulation 1 and 2, our aim was to show that an analysis by hierarchical Bayesian
modeling is better than an analysis by fitting the same mixed linear model for every gene
when ordering the genes with respect to a fixed effect. In this simulation study, we will
discuss how to deal with the computational problems when analyzing thousands of genes in a
microarray data set by hierarchical Bayesian modeling.
A typical microarray data set includes thousands of genes. Due to memory restrictions,
it may not be possible to simulate from the posterior distribution of the treatment effects of
interest for every gene in the whole data set at one time. To deal with this problem, we can
partition the whole data set into smaller data sets with reasonable number of genes so that it
will be feasible to generate samples from the posterior distributions of the treatment effects of
interest. After applying the hierarchical Bayesian analysis to each partition data set separately,
we can combine the list of summary statistics (F values) for each partition data set into one
single file, and get the order of each gene in the whole data set.
In this simulation study, we will show that the significance rank of a gene within the whole
data set does not depend on the other genes in its partition data set. In other words, we can
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randomly assign the genes into the partition groups, and this will not change the ordering of
any gene within the whole data set. As an example, we considered the second simulated data
set. First, it was divided into 10 partial data sets randomly such that each was containing 100
genes. Then each partial data set was analyzed by hierarchical Bayesian approach separately.
Finally, summary F statistic for every gene in each partial data set were put together in a
single file. We repeated this procedure five times. As a sixth analysis, we again partitioned
the full data set into 10 partial data sets but this time, all the genes simulated with treatment
effect were put in one partial group, and the other genes simulated without treatment effect
were randomly partitioned into nine data sets. We have lists of F4 values from analyzing the
data in six different partitioning and the list of F4 values by analysis without partitioning the
same data from simulation 2. In Tables 3.5 through 3.7, we report the correlations between
the seven lists of F4 values for genotype, time, and genotype-by-time interaction, respectively.
In each Table, correlation values are almost one. This shows that the order of the genes does
not depend on the way of partitioning when hierarchical Bayesian analysis is applied.
3.5 Application of the Hierarchical Bayesian Method to the Barley Data
Scientist were interested in identifying barley genes that play a role in resistance to a
fungal pathogen. Such genes are believed to have patterns of expression over time following
infection that differ between susceptible and resistant genotypes. Therefore, we are particularly
interested in identifying genes that exhibit interaction between genotype and time. We also
provided results for the genotype test and the time test to show the performance of the discussed
methods in the previous sections.
Table 3.8 shows the number of genes identified as differentially expressed at nominal FDR
levels at 0.01 and 0.05 using the linear mixed model analysis that we introduced in Section 3.2.
For the genotype-by-time interaction test, the gene lists produced by the linear mixed model
and the hierarchical Bayesian method differed from each other by 43 and 395 genes at nominal
control of FDR of 0.01 and 0.05, respectively. Similarly, for the genotype test, the gene lists
produced by the linear mixed model and the hierarchical Bayesian method differed from each
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other by 278 and 503 genes at nominal control of FDR of 0.01 and 0.05, respectively. Finally,
for the time test, the gene lists produced by the linear mixed model and the hierarchical
Bayesian method differed from each other by 1046 and 1011 genes at nominal control of FDR
of 0.01 and 0.05, respectively.
3.6 Concluding Remarks
We have introduced a hierarchical Bayesian analysis method for discovering differentially
expressed genes when a microarray experiment involves multiple sources of variation through
the inclusion of multiple random factors. Since sample size is usually small for microarray
experiment, there will be very few degrees of freedom to estimate the variance components of
all random factors considered in the linear mixed model. But Hierarchical formulation allow
us to borrow strength across genes for making inference. The simulation studies show that our
hierarchical Bayesian approach is more powerful than a traditional gene-by-gene mixed linear
model analysis at distinguishing differentially expressed genes from non-differentially expressed
genes.
We have illustrated several advantages of working in Bayesian framework. It is shown that
posterior samples of model parameters are directly used to draw inference by forming functions
of these parameters. Another benefit of the Bayesian approach is that the parameters for one
gene are estimated using the information of all genes in the data through the hierarchical
specification. Finally, the Bayesian method will allow formal incorporation of the knowledge
through prior densities (Tadesse et al. (2003)).
Although the inverse-gamma prior distribution can be formalized as a non informative
prior for the standard deviation parameters of the random factors with few effects, this condi-
tionally conjugate prior distribution yields an improper posterior density under some common
conditions in microarray experiments. As recommended in Gelman 2006, we used half-Cauchy
priors for the standard deviation parameters of the random factors. Under this prior elicitation,
posterior distribution of the treatment effects of interest in our model ranged in reasonable
boundaries. By calculating a single summary statistic per gene from the posterior distribution
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of the treatment effects considered in the model, we rank genes with respect to evidence of
differential expression across the levels of a factor of interest.
Although our proposed methodology provides better ordering of the genes, further work
needs to be done in developing the next level of hierarchical models, in which we should be
able to estimate the false discovery rate to find a reasonable cutoff point on the list.
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Table 3.1 MMA Results for the First Simulated Data. The number of
genes declared to be non-null at different nominal FDR levels.
Test F̂DR <= 0.001 F̂DR <= 0.01 F̂DR <= 0.05 F̂DR <= 0.1
genotype 9 13 20 25
time 37 45 51 57
genotype-by-time 7 12 18 21
Table 3.2 MMA and HBA results for the First Simulated Data. MMA: The
number of correctly identified non-null genes under the linear
mixed model analysis. HBA: The number of correctly identified
non-null genes under the hierarchical Bayesian analysis with F4.
Common: The number of genes common to all the collections
of genes represented by MMA and HBA. Common Among Top
Genes: The number of genes common to MMA and HBA when
25, 100 genes are declared to be differentially expressed with
respect to genotype effects; 57, 100 genes are declared to be dif-
ferentially expressed with respect time effects; 21, 100 genes are
declared to be differentially expressed with respect genotype-by–
time interaction effects.
Genotype Time Genotype-by-Time
Cut off level from Top 25 100 57 100 21 100
MMA 16 30 56 64 19 41
Correctly HBA 25 65 55 68 20 66
Identified Common 15 30 55 63 14 39
Common Among Top Genes 15 35 55 83 14 55
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Table 3.3 MMA Analysis Results for the Second Simulated Data. The
number of genes declared to be non-null at different nominal
FDR levels.
Test F̂DR <= 0.001 F̂DR <= 0.01 F̂DR <= 0.05 F̂DR <= 0.1
genotype 3 9 12 20
time 22 25 35 46
genotype-by-time 8 16 19 38
Table 3.4 MMA and HBA results for the Second Simulated Data. MMA:
The number of correctly identified non-null genes under the
mixed linear model analysis. HBA: The number of correctly
identified non-null genes under the hierarchical Bayesian analy-
sis with F4. Common: The number of genes common to all the
collections of genes represented by MMA and HBA. Common
Among Top Genes: The number of genes common to MMA
and HBA when 20, 100 genes are declared to be differentially
expressed with respect to genotype effects; 46, 100 genes are de-
clared to be differentially expressed with respect time effects; 38,
100 genes are declared to be differentially expressed with respect
genotype-by-time interaction effects.
Genotype Time Genotype-by-Time
Cut off level from Top 20 100 46 100 38 100
MMA 14 31 44 59 26 37
Correctly HBA 20 61 42 66 31 54
Identified Common 10 26 40 58 25 34
Common Among Top Genes 10 40 41 78 30 60
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Table 3.5 Genotype Test: Correlations between F4 statistics corresponding
to six analyses corresponding to five different way of partitioning
and no partitioning.
full part1 part2 part3 part4 part5 part6
full 1.0000 0.9903 0.9813 0.9756 0.9831 0.9906 0.9809
part1 0.9903 1.0000 0.9900 0.9727 0.9897 0.9908 0.9866
part2 0.9813 0.9900 1.0000 0.9778 0.9729 0.9859 0.9822
part3 0.9756 0.9727 0.9778 1.0000 0.9434 0.9712 0.9782
part4 0.9831 0.9897 0.9729 0.9434 1.0000 0.9884 0.9747
part5 0.9906 0.9908 0.9859 0.9712 0.9884 1.0000 0.9866
part6 0.9809 0.9866 0.9822 0.9782 0.9747 0.9866 1.0000
Table 3.6 Time Test: Correlations between F4 statistics corresponding to
six analyses corresponding to five different way of partitioning
and no partitioning.
full part1 part2 part3 part4 part5 part6
full 1.0000 0.9990 0.9988 0.9974 0.9993 0.9990 0.9997
part1 0.9990 1.0000 0.9991 0.9980 0.9992 0.9991 0.9990
part2 0.9988 0.9991 1.0000 0.9968 0.9992 0.9985 0.9991
part3 0.9974 0.9980 0.9968 1.0000 0.9985 0.9990 0.9969
part4 0.9993 0.9992 0.9992 0.9985 1.0000 0.9994 0.9992
part5 0.9990 0.9991 0.9985 0.9990 0.9994 1.0000 0.9988
part6 0.9997 0.9990 0.9991 0.9969 0.9992 0.9988 1.0000
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Table 3.7 Correlations between F4 statistics corresponding to six analyses
corresponding to five different way of partitioning and no parti-
tioning.
full part1 part2 part3 part4 part5 part6
full 1.0000 0.9977 0.9990 0.9979 0.9992 0.9987 0.9993
part1 0.9977 1.0000 0.9977 0.9992 0.9969 0.9984 0.9967
part2 0.9990 0.9977 1.0000 0.9986 0.9992 0.9990 0.9994
part3 0.9979 0.9992 0.9986 1.0000 0.9977 0.9989 0.9976
part4 0.9992 0.9969 0.9992 0.9977 1.0000 0.9990 0.9995
part5 0.9987 0.9984 0.9990 0.9989 0.9990 1.0000 0.9988
part6 0.9993 0.9967 0.9994 0.9976 0.9995 0.9988 1.0000
Table 3.8 Identifying Significant Genes in the Barley Data Set. MMA: Lin-
ear mixed model analysis; HBA: Hierarchical Bayesian Analysis.
Table entries are the number of genes declared to be differen-
tially expressed. The bottom row of the table give the number
of genes common to all the collections of genes represented in
each column.
Genotype Time Genotype-by-Time
Method F̂DR=0.01 F̂DR=0.05 F̂DR=0.01 F̂DR=0.05 F̂DR=0.01 F̂DR=0.05
MMA 399 782 13202 17832 93 933
HBA 399 782 13202 17832 93 933
Common 121 279 12156 16821 50 538
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Figure 3.1 Genotype Test: ROC Curves for the First Simulated Data.
ROC curves corresponding to the five analysis methods for test-
ing genotype main effects. MMA: the analysis by fitting the
mixed linear model for each gene. F1, F2, F3, and F4: the anal-
ysis with hierarchical Bayesian model by calculating different
summary statistics.
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Figure 3.2 Time Test: ROC Curves for the First Simulated Data. ROC
curves corresponding to the five analysis methods for testing
time main effects. MMA: the analysis by fitting the mixed
linear model for each gene. F1, F2, F3, and F4: the analysis with
hierarchical Bayesian model by calculating different summary
statistics.
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Figure 3.3 Genotype-by-Time Interaction Test: ROC Curves for the First
Simulated Data. ROC curves corresponding to the five analysis
methods for testing genotype-by-time interaction. MMA: the
analysis by fitting the mixed linear model for each gene. F1,
F2, F3, and F4: the analysis with hierarchical Bayesian model
by calculating different summary statistics.
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Figure 3.4 Genotype Test: ROC Curves for the Second Simulated Data.
ROC curves corresponding to the six analysis methods for test-
ing genotype main effects. MMA-F: the analysis by fitting the
full mixed linear model (3.1) for each gene. MMA-T: the anal-
ysis by fitting the generating mixed linear model (true model)
for each gene. F1, F2, F3, and F4: the analysis with hierarchical
Bayesian model by calculating different summary statistics.
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Figure 3.5 Time Test: ROC Curves for the Second Simulated Data. ROC
curves corresponding to the six analysis methods for testing
time main effects. MMA-F: the analysis by fitting the mixed
linear model (3.1) for each gene. MMA-T: the analysis by fit-
ting the generating mixed linear model (true model) for each
gene. F1, F2, F3, and F4: the analysis with hierarchical
Bayesian model by calculating different summary statistics.
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Figure 3.6 Genotype-by-Time Interaction Test: ROC Curves for the
Second Simulated Data. ROC curves corresponding to the
six analysis methods for testing genotype-by-time interaction.
MMA-F: the analysis by fitting the mixed linear model (3.1)
for each gene. MMA-T: the analysis by fitting the generating
mixed linear model (true model) for each gene. F1, F2, F3, and
F4: the analysis with hierarchical Bayesian model by calculating
different summary statistics.
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CHAPTER 4. Identifying Single Feature Polymorphisms Using
Affymetrix Gene Expression Data
Cumhur Yusuf Demirkale and Dan Nettleton
Abstract: In microarray data analysis, the identification of Single Feature Polymorphisms
(SFPs) is important for producing more accurate expression measurements when comparing
samples of different genotypes. Also, portions of DNA that differ between parental lines can
serve as markers for tracking DNA inheritance in offspring. We summarize several SFPs
discovery methods in the literature. To identify single probes defining SFPs in the data, we
developed two new algorithms where a difference value is defined for each probe after accounting
for the overall gene expression level differences in the probe set. First method contrast the
difference value of each probe with the average of the difference values for the rest of the probes
in that probe set. Second method is a robust version of the first method. The performance
of all methods are compared through two publicly available published data sets, where truth
about the sequence polymorphism is known for some “Gold Standard” probes.
KEY WORDS: Affymetrix GeneChips; Linear Mixed Models; Microarrays; Outliers; Robust
Methods; Single Feature Polymorphisms.
4.1 Introduction
Microarray technology provides a means for simultaneously measuring the abundance of
thousands of mRNA transcripts in multiple biological samples. Mainly, these measurements
are used to detect differentially expressed genes over different experimental conditions, time
points, tissue samples, etc. High-density oligonucleotide arrays are often used for measur-
ing gene expression levels. These arrays are also used for identifying possible DNA differ-
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ences between genotypes, which include single nucleotide polymorphisms (SNPs) and inser-
tion/deletions polymorphisms (IDPs) (Cui et al., 2005). Polymorphisms detected by a single
probe in an oligonucleotide array are called a single-feature polymorphism (SFPs), where a
feature refers to a probe in the array (Borevitz et al., 2003). The identification of SFPs is
important for producing more accurate expression measurements when comparing samples of
different genotypes. Also, portions of DNA that differ between parental lines can serve as
markers for tracking DNA inheritance in offspring. Therefore, several statistical methods for
identification of possible SFPs between genotypes have been proposed in the literature in recent
years.
Winzeler et al. (1998) pioneered the idea of identifying sequence polymorphisms by the
direct hybridization of labeled genomic DNA to oligonucleotide yeast microarrays. Borevitz et
al. (2003) applied this approach to organisms with more complex genomes, such as Arabidopsis
thaliana. Cui et al. (2005) considered using RNA as a surrogate for DNA, and proposed a
statistical method for identifying SFPs in barley from Affymetrix GeneChip RNA hybridization
signals. Similarly, with RNA-derived barley data, Rostoks et al. (2005) proposed a statistical
algorithm for identifying SFPs by distinguishing genotype-dependent hybridization differences
after accounting for overall gene expression level. Ronald et al. (2005) extended the idea by
hybridizing mRNA to oligonucleotide arrays for simultaneously discovering polymorphic loci
and analyzing gene expression in yeast. West et al. (2006) demonstrated that hybridization of
gene expression microarrays with RNA allows simultaneous phenotyping with gene expression
markers and genotyping with SFP markers. In contrast to previous studies, Greenhall et al.
(2007) demonstrated the performance of their algorithm in identification of possible sequence
differences between strains, species, or individuals. They identified SFPs for the data obtained
from inbred mice and from humans and chimpanzees.
Except Greenhall et al. (2007), none of the previously published papers mentioned above
provided a performance comparison across multiple methods. The methods were evaluated
separately using, for the most part, distinct data sets. In this paper, we compare the per-
formance of these methods for detecting SFPs from oligonucleotide array data using multiple
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gold-standard data sets. Additionally, we include in our comparison three new algorithms that
exhibit advantages over the existing techniques.
This paper is organized as follows. In Section 4.2, we provide background information
on Affymetrix GeneChips and describe the concept of an SFP in greater detail. Section 4.3
presents three microarray data sets and summarizes several SFP discovery methods in the
literature. Further, we introduce two new algorithms in that section. In Section 4.4, we
compare the performance of all methods through two publicly available published data sets,
where truth about the sequence polymorphism is known for some “Gold Standard” probes.
Results of the application of selected methods to soybean data is also summarized in that
section. Finally, section 4.5 gives a few concluding comments and explains the future direction
of this research.
4.2 Background
4.2.1 Affymetrix GeneChips
An oligonucleotide is a short sequence of nucleotides. Affymetrix GeneChips are oligonu-
cleotide arrays, where each oligo is intended to be 25 nucleotides in length. On a Affymetrix
oligonucleotide array, each gene (more accurately sequence of interest or feature) is represented
by a probe set which consists of multiple probe cells that contains millions of copies of one
oligo. Probe cells in a probe set are arranged in 11∼20 different oligonucleotide probe pairs.
Each probe pair contains a perfect match (PM) probe cell and a mismatch (MM) probe cell.
A PM oligo perfectly matches part of a gene sequence. A MM oligo is identical to a PM
oligo except that the middle nucleotide (13th of 25) is intentionally replaced by its comple-
mentary nucleotide. The MM serves as a measure of non-specific background binding and
noise. Although Affymetrix GeneChips were not designed to detect sequence differences, they
do provide individual probe hybridization values that are sensitive to small regions of sequence
mismatch. Thus, Affymetrix GeneChips are useful for SFP detection.
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4.2.2 Description of Single Feature Polymorphism
The sequence variation detected by a single probe in an oligonucleotide array is called a
Single Feature Polymorphism (SFP), where a feature refers to a probe in the array. When
an SFP is not present in a probe set, ideally some constant expression difference is expected
between two genotypes for all probes in the probe set. The magnitude and direction of the
difference depends on gene expression differences between two genotypes. The top right panel
in Figure 4.1 illustrates a gene that has higher expression in genotype A than in genotype B.
In both top panels in Figure 1, there is a constant signal intensity difference between the two
genotypes for every probe in the probe set. The fluctuations of intensities over probes can be
explained by differences in probe sequence that result in different hybridization characteristics.
When an SFP is present in a probe set, the expression difference between two genotypes
is not constant for every probe in the probe set. The bottom panels in the Figure 4.1 are
examples of an SFP in Probe 5. The low intensity signal for genotype B at this probe is due to
poor hybridization, which can be explained by the difference between the probe sequence and
the RNA molecule produced by genotype B. The right bottom panel in Figure 4.1 shows an
example of a gene that is differentially expressed between genotypes. In particular, genotype A
produces more RNA for this gene than genotype B. Because the difference between genotypes
is substantially larger for Probe 5 than for the other probes, there is evidence for an SFP.
4.3 Materials and Methods
In this section, we describe several data sets that will be used to examine the performance
of SFP detection methods. We then present some details about five published methods for
detecting SFPs and introduce two new methods.
4.3.1 Data Sets
Maize Data:
CEL files containing raw Affymetrix Maize GeneChip array data are available from NCBI
Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo/). The dataset
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GSE8194 consists of 36 Genechip arrays. For seedling aerial, immature ear, and embryo tissues,
three biological replications for each of inbred lines B73, Mo17, B73×Mo17, and Mo17×B73 are
available (Stupar et al., 2006). GSE8308 contains 24 Genechip arrays corresponding to three bi-
ological replications for each of two tissues (endosperm 13 days after pollination and endosperm
19 days after pollination) and four genotypes B73, Mo17, B73×Mo17, and Mo17×B73 (Stupar
et al., 2007). We only focus on the inbred lines B73 and Mo17 here to simplify the presentation
of our main ideas. Therefore, by combining GSE8194 and GSE8308, we have 30 arrays from
three biological replications for each combination of five tissue types and two inbred lines.
Barley Data:
This data set was analyzed in Rostoks et al. (2005). As described there, Affymetrix Bar-
ley1 GeneChip data was produced within an international collaborative project (A.Druka,
G.Muehlbauer, I.Druka, R.Caldo, U.Baumann, N.Rostoks, A.Schreiber, R.Wise, A.Kleinhofs,
T.Close, et al., unpublished work). The complete data set consists of 36 arrays, with three
replicate arrays for each of 12 combinations of genotype (two levels) and tissue type (six lev-
els). The two genotypes studied are Golden Promise (GP) and Morex (MX), and the six tissue
types are abbreviated COL, CRO, GEM, LEA, RAD, and ROO. Rostoks et al. (2005) found
that for the ROO tissue, one replicate that was nominally of GP genotype had a very high
correlation with the three replicates of the MX genotype. This replicated was re-assigned as
genotype MX.
Soybean Data:
Data from 75 Affymetrix Soybean GeneChips are available from an experiment involving five
genotypes, five harvest times, and three replications. The experiment was designed as a ran-
domized complete block design with replications as blocks and genotypes as treatments. Re-
peated measures of each experimental unit (pot containing multiple soybean plants) yielded
expression measures at five times for each combination of genotype and replication. Two of
the five genotypes are parental lines that differ in seed protein content and will be denoted
here by H and L for high and low protein. The other three lines resulted from a cross between
the parental lines, repeated selfing, and then repeated backcrosses to the low-protein parental
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line L. The three backcross lines (denoted BC1, BC2, and BC3) were selected from many such
lines for their high-protein seed content. Thus, the backcross lines have a genome with DNA
content that is very similar to the parent line L (due to repeated backcrossings) but protein
producing characteristics that are very similar to the parent line H. The hypothesis is that the
backcross lines possess unknown segments of DNA from the parental line H that are important
for protein production. By identifying SFPs that distinguish parental line L from the backcross
lines and parental line H, we can gain clues about regions of the genome that may be important
for protein production.
4.3.2 Candidate Analysis Methods
In this section, we describe seven methods for SFP identification from oligonucleotide mi-
croarray data. We have included what we believe to be the five most popular methods from
the literature, along with two new methods that we have developed.
1. Borevitz: This is the method proposed in Borevitz et al. (2003). Initially, the method
performs a spatial correction to the data. After the correction step, the log-scale perfect
match (PM) intensities are used in the analysis. For each probe, the samples from both
genotypes are compared by using a modified t-statistic. The test statistic is very similar
to that used in Significance Analysis of Microarrays (SAM) (Tusher et al., 2001). The
difference between the probe sample mean for one genotype and the probe sample mean
for the other genotype is divided by the square root of the sum of the probe-specific
sample variance pooled across both genotypes and the median of all such probe-specific
sample variances in the probe set. The permutation testing was applied according to SAM
to get some nominal control of false discovery rate. R functions for this method were
downloaded from http://naturalvariation.org/sfp and adjusted slightly for appropriate
application to our data sets.
2. Cui: This is the method proposed in Cui et al. (2005). The idea of the method is
based on the expectation that, for each gene, two genotypes will have parallel expression
values for all probes in a given probe set, except for probes that cover SFPs. The
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first step in the method involves removing all probe sets that are not called present by
Affymetrix software on all chips. The log-scale PM values without background correction
and normalization were considered for the further steps of the analysis. As described in
the paper, the log-scaled observed PM value of a probe is modeled as the sum of a probe
set expression index, a probe affinity effect, and a random error. After estimating an
expression index for the probe set and probe affinity effects for each probe in the probe
set by using the replicate samples of each genotype, the difference between the median
estimated affinity effects of the two genotypes are calculated for each probe. An extreme
difference for any probe in the probe set suggests the presence of an SFP in that probe.
To identify the extreme differences, they used the projection pursuit method, which is a
robust measure of the outlyingness of an observation in a sample. The authors calculate
an overall score that measures the extent to which a particular probe set is judged to
be outlying, as well as probe-specific scores that quantify the contribution of individual
probes to the overall outlyingness of their probe sets. The probe sets with the highest
overall outlying scores are then identified as containing putative SFP probe(s). Then an
SFP will be located at the probe with the highest individual outlying score. Dr. Cui
kindly provided the R scripts that we adjusted appropriately for application to our data
sets.
3. Greenhall: This is the method proposed in Greenhall et al. (2007). The proposed al-
gorithm, called GeSNP, identifies probes which show hybridization differences between
two genotypes after normalizing for expression level differences. GeSNP has five major
steps. First, the individual hybridization intensity values are extracted from the CEL
files. Second, the difference between PM and MM intensities is calculated for each probe
pair in each probe set. Some of probe sets are filtered, i.e., a probe set from a sample
is excluded if <65% of the PM-MM values for the probe set are positive. Third, the
PM-MM values in each probe set of a sample are scaled. The scaling factor is calculated
by dividing an arbitrary target value of 200 with the standard deviation of the PM-MM
values for a probe set excluding the largest and smallest PM-MM values. Fourth, for
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each genotype, sample average and sample standard deviation of the scaled PM-MM
values are calculated. Fifth, the hybridization pattern differences are identified for each
probe by using two-sample t-test that is computed using separate variance estimates for
each genotype. Probes are ordered with respect to their t values. The performance of
the GeSNP algorithm was compared with the algorithm of Ronald et al. (2005), which
uses a different approach for background subtraction, normalization, and calculating the
summary t-statistic for each probe. It was shown on a test data set that the GeSNP algo-
rithm performed better in ordering the probes than Ronald’s algorithm. We downloaded
the source C++ GeSNP code from http://porifera.ucsd.edu/ cabney/cgi-bin/geSNP.cgi
and applied to our test data.
4. Rostoks: This is the method proposed in Rostoks et al. (2005). The hybridization in-
tensities for each of the perfect match (PM) probes are extracted from the CEL files.
Background correction and quantile normalization are performed by using the RMA
method in the Bioconductor affy package. For a given probe set, a linear model that
includes genotype effects, probe effects, and other effects specific to the data at hand
is fit to the background corrected and normalized PM data. Although the model in-
cludes genotype effects and probe effects, interactions between genotypes and probes
are intentionally excluded. The residuals from this model fit are captured and used for
subsequent analysis. In particular, the residuals for each probe serve as a data set that
is used to test for a significant probe-specific genotype effect. If the residuals for one
genotype tend to be larger than residuals for another genotype for a given probe, this
provides evidence of genotype-dependent hybridization differences for that probe. These
probe specific tests for genotype effects are carried out using SAM approach (Tusher et
al., 2001) available in the Bioconductor package siggenes. Significant probes from this
analysis are called SFPs. To implement this method, we used the R script available at
http://naturalvariation.org/barley and adjusted it slightly for application to our data
sets.
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5. West: This is the method proposed in West et al. (2006). As described in the paper,
the CEL files are subjected to background correction by using the RMA method in the
affy package. The background-corrected hybridization values for each of the PM oligonu-
cleotide probes in each probe set are then used for subsequent analysis. A summary
measure is used to describe each probe in relation to the other probes within the probe
set on a given chip. The summary measure, called SFPdev, is calculated for the ith
probe on the jth chip as follows:
SFPdevij =
∣∣∣sij − s¯(i)j∣∣∣
sij
,
where sij denotes the signal of the ith probe on the jth chip and s¯(i)j denotes the average
of the other signals in the probe set containing probe i on the jth chip. A “parental min-
max” algorithm is then used to calculate a “gap” value. The minimum SFPdev value
among the replicate samples of the given genotype is divided by the maximum SFPdev
value among the replicate samples of other genotype and vice versa. An SFP is declared
for a particular probe if its gap value is greater than 2. We implemented this method in
R for application to our data sets.
6. Contrast: This is a new method that we propose as follows. To illustrate Contrast
method, we will consider a simple microarray experiment, where there are K biological
replications for each of two genotypes. The following linear mixed model can be used as
a base model for each probe set. Let
Yijk = µ+ ρi + γj + θij + cj(k) + eijk (4.1)
i = 1, 2, . . . , p; j = 1, 2; k = 1, . . . ,K;
where Yijk is the background corrected, quantile normalized, log-scaled observed PM
value of the ith probe from the kth GeneChip of the jth genotype; µ is an intercept
parameter; ρ1, . . . , ρp are fixed probe effects, γ1 and γ2 are fixed genotype effects; the θij
values are probe-by-genotype interaction effects; the cj(k) values are normally distributed
random chip effects with mean 0 and variance σ2c ; and the eijk terms are normally
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distributed random errors with variance σ2e . The GeneChip random effects are included
in the model to account for correlation between probes from the same chip, and as is
standard, all random effects are assumed to be independent. For each probe i in a probe
set, we define a difference value between the average signal intensities of two genotypes
as
di = Y i1. − Y i2., i = 1, 2, . . . , p.
From model (4.1), it follows that
d ≡ (d1, . . . , dp)
′ ∼ N(δ,Σ),
where δ ≡ (δ1, . . . , δp)
′; δi ≡ γ1−γ2+θi1−θi2 for i = 1, . . . , p; and Σ =
2σ2
e
K
Ip×p+
2σ2
c
K
Jp×p.
When an SFP is not present in a given probe set, ideally the mean of di should be the
same for each probe. That is,
δ1 = . . . = δi = . . . = δp. (4.2)
However, if there is an SFP in a probe, the equality in (4.2) will not hold due to interaction
between probe and genotype. A test for interaction between probe and genotype based
on model (4.1) could be used to identify probe sets that contain one or more SFPs,
but we require more specific information about which individual probes contain SFPs.
Therefore, we focus on finding probes with genotype differences (di) that are significantly
different from the average of the genotype differences of the other probes in the same
probe set ({d1, . . . , dp} \ {di}).
Suppose that only the ith probe in a given probe set contains an SFP. Let δ−i denote
the assumed constant value of δj for all j 6= i. Consider the test of
H∗0i : δi = δ−i vs. H
∗
Ai : δi 6= δ−i.
This null hypothesis will be false when only the ith probe contains an SFP. A natural test
statistic for measuring evidence against H∗0i – and therefore ranking probes for evidence
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of an SFP – is
ti =
di −
1
p−1
∑
j 6=i dj√
2
K
σˆ2e(1 +
1
p−1)
, (4.3)
where σˆ2e is the REML estimate of σ
2
e obtained from the fit of linear model (4.1). More
generally, this test is actually a special contrast which tests
H0i : δi =
1
p− 1
∑
j 6=i
δj vs. HAi : δi 6=
1
p− 1
∑
j 6=i
δj . (4.4)
7. RContrast: This is a robust version of the contrast test. Note that the null H0i in (4.4)
will actually be false for all i = 1, . . . , p whenever a probe set contains one or more SFPs.
Also, the presence of multiple probes with SFPs can reduce power for SFP detection
when the effects of the SFPs are in the same direction. For these reasons, we consider a
robust test statistic defined as
tRi =
di − Tbi√
2
K
σˆ2e
{
1 +
∑
j 6=iw
2
j/
(∑
j 6=iwj
)2} , (4.5)
where Tbi is the Tukey biweight estimator of the mean for the sample of differences
S−i ≡ {d1, . . . , . . . , dp} \ {di} and the wj values are weights discussed below.
The Tukey biweight estimator is introduced on page 382 of Hoaglin et al. (1983) and is
defined in our case as follows. Let M−i denote the median of S−i, and let MAD−i denote
the median absolute deviation of S−i. For all j 6= i, define
uj =
dj −M−i
9MAD−i
, (4.6)
and let
wj =

(1− u2j )
2 if |uj | ≤ 1
0 otherwise
(4.7)
Then
Tbi =
∑
j 6=i djwj∑
j 6=iwj
. (4.8)
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Due to the weighting scheme, outlying dj values are downweighted or removed in the
Tukey biweight estimator. Thus, the presence of multiple SFPs will be less problematic
for the RContrast approach. Also, for a probe set that does contain an SFP, the tRi
value for any probe that does not contain the SFP will tend to be closer to 0 than the
ti value due to the downweighting of the dj value corresponding to the SFP-containing
probe. Thus, the tRi values may be better able to distinguish SFP-containing probes
from non-SFP-containing probes than the ti values.
4.4 Application
In this section, we use two publicly available data sets to examine the performance of the
methods described in Section 3. The validation rates of predicted SFPs will be established via
comparisons to a known set of SNPs for both data sets. Additionally, we will apply selected
methods to the soybean data set to identify potential probes with SFPs.
4.4.1 Identification of Single Feature Polymorphisms in Maize
Our maize data sets each contain of 17,734 probe sets. We will consider in our analysis the
17,579 probe sets that each contain 15 probe pairs. Wu et al. (2009, unpublished manuscript)
state that 273 probes were found to target 213 of 1,016 validated SNPs and 6,270 probes had
perfect matches to 2,100 non-SNP-containing gene regions. Of these 6,270 probes with no SFP,
6,216 probes were contained in the probe sets with 15 probes that we analyzed. Therefore,
273 SNP probes and 6,216 no-SNP probes were treated as “gold standard” probes for SFP
detection.
Each of the five maize tissue samples was analyzed by each of the seven methods. The
prediction results of each algorithm in each tissue were ranked in descending order according
to the algorithm-specific SFP selection statistic. The top 2000, 4000,. . ., 10000 probes were
picked and compared with the 273 Gold standard SNP probes and the 6,216 gold standard
no-SNP probes. At each level, we calculated true positives (TP) (the number of correctly-
predicted SNP probes), false positives (FP) (the number of no-SNP probes that were incorrectly
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predicted as SFP probes), false negatives (FN) (the number of SNP probes missed in the SFP
prediction, here FN=273-TP), and true negatives (TN) (the number of no-SNP probes that
were not predicted to be SFPs, here TN=6216-FP). Then sensitivity (SN) was calculated as
TP/(TP + FN), and specificity (SP) was calculated as TN/(TN + FP).
Table 4.1 summarizes the TP values for each of the seven methods when the top 2000,
4000,. . ., 10000 probes were called SFPs in each of the five maize tissues. At every cut-off
level, the RContrast method identified the highest number of SFPs correctly for the immature
ear tissue. In addition, for endosperm 13 DAP and endosperm 19 DAP tissues, RContrast had
the highest TP value when the top 4000 or more probes were considered. For all five maize
tissues, RContrast found the highest number of SFPs correctly for cut-off levels of 5000 probes
or higher. For lower cut-off levels, the method of Cui et. al. (2005) performed better than
other procedures for 19 DAP embryo tissue and seedling tissue.
We also examine receiver operator characteristic (ROC) curves to compare the effectiveness
of the methods for separating probes with a SFP from probes with no SFP. The SFP selection
statistic produced by each method provides a rank order of probes from most evidence for an
SFP to least evidence. The quality of the ranking varies from method to method and can
be judged by comparing ROC curves. The greater the area under an ROC curve the better
the corresponding method is at distinguishing probes with SFPs from probes with no SFPs.
Because the patterns of the curves and differences among the curves were quite similar for
each maize tissue data, here we only examine the plots for the endosperm 19 DAP tissue
(Figure 4.2).
Figure 4.2 has four panels. Both panels on the top were produced by using the all the
probes in the endosperm 19 DAP tissue data set. Top left panel shows the number of correctly
identified SFPs when top 10, 20,. . . , 10000 probes were declared to contain SFPs. The curve
corresponding to the RContrast method were slightly higher than curves corresponding to
other methods. This plot provides information similar to that in Table 4.1 and shows that the
RContrast method identified more SFP probes correctly than the other methods when the top
3000 or more probes were declared to contain SFPs. The top right panel of Figure 4.2 shows
114
ROC curves for the seven methods. This plot illustrates that an analysis with the RContrast
method is slightly more effective at distinguishing probes with SFPs from probes without SFPs
than the other methods.
In the bottom panels of Figure 4.2, we only used the 6,489 gold standard probes. The
bottom left panel shows the number of correctly identified SFPs when the top 1, 5,. . ., 6489
probes were declared to be SFPs. Similar to the panel above, the curve corresponding to the
RContrast method is slightly higher than curves corresponding to other methods. Rostock’s
approach lags behind the RContrast method. Because Cui’s method filters probe sets with
present and absent calls, it could not identify all of the 273 gold standard SFP probes. The
bottom right panel of this figure illustrates ROC curves corresponding to the seven methods
when using only the gold standard probes after present and absent call filtering. The plot
shows that an analysis with the RContrast method is slightly more effective at distinguishing
probes with SFP from probes without SFPs than the other methods. Similar to the TP panel,
Rostoks approach lags behind the RContrast approach. All these panels in this figure suggest
that the RContrast method is the most effective method for identifying probes that contain
SFPs. Figures for other maize tissues are presented in the Supplementary Materials that
accompany this manuscript and provide similar results in favor of the RContrast approach.
4.4.2 Identification of Single Feature Polymorphisms in Barley
Each of six tissues in the barley data set contains of 22,840 probe sets. We focus our analysis
on the subset of 22,801 probe sets that each contain 11 probe pairs. Rostoks et al. (2005) pro-
vided sequence polymorphism information for 2667 probes at http://naturalvariation.org/barley.
They found 66 probes that matched neither genotype in the data set and thus excluded those
probes from further analysis. We use the remaining 2601 probes as a gold standard set in
which 401 probes contained SFPs and 2200 probes did not.
Each of the six tissue samples was analyzed by each of the seven methods. For 250,811
(22,801 × 11) probes, the prediction results of each algorithm in each tissue/development stage
were ranked according to the method-specific SFP selection statistic. The top 1000, 2000,. . .,
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10000 probes were picked and compared with the 401 gold-standard SNP probes and the 2,200
gold-standard no-SNP probes. From these comparisons, the number of true positives, the
number of false positives, the number of false negative, the number of true negatives, the
sensitivity value, and the specificity value were calculated as defined previously.
Table 4.2 summarizes the TP values for each of the seven methods when the top 2000,
4000,. . ., 10000 probes were declared to contain SFPs in each of the six barley tissues. At
each cut-off level, the Contrast or RContrast method identified the highest number of SFPs
correctly for the ROO tissue. Also, the RContrast method identified the highest number of
SFPs correctly for every tissue when the top 5000 or more probes were declared to contain
SFPs. When the cut-off level was equal to 2000 probes, Cui’s method performed better than
the other procedures for all the tissues except the ROO tissue. If the top 4000 probes were
considered, the TP value for the Cui method was the highest for only one tissue, the TP value
for the RContrast method was the highest for 4 tissues, and the Contrast method TP value
was the highest for one tissue. In summary, there are totally 36 cut-off levels in the table (6 cut
off levels × 6 tissues). For 25 combinations of tissue and cut-off level, the RContrast method
identified the highest number of SFPs correctly. For 7 combinations of tissue and cut-off, Cui’s
method provide the highest TP count. For the other 4 combinations, the Contrast method had
the highest TP value. These observations suggest that the RContrast method was the most
effective for identification of SFPs in the barley data.
We also used ROC panels to compare the effectiveness of the methods for separating probes
with SFPs and probes with no SFPs in the barley data. Because the patterns of the curves and
differences among the curves were quite similar for each barley tissue, here we only examine
Figure 4.7 for the RAD tissue. The figure has four panels. Both panels on the top were
produced by using the all the probes in the RAD tissue data set. The top left panel shows
the number of correctly identified SFPs when top 10, 20,. . . , 10000 probes were declared to
contain SFPs. The curve corresponding to the RContrast method is slightly higher than curves
corresponding to other methods. This plot provides similar information to that contained in
Table 4.2 and shows that the RContrast method identified more SFP probes correctly than
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the other methods when the top 4000 or more probes were declared to contain SFPs. The
top right panel of Figure 4.7 shows ROC curves for the seven methods. The plot illustrates
that an analysis with the RContrast method is slightly more effective at distinguishing probes
with SFPs from probes without SFPs than the other methods. Cui’s method seems to work
well when a smaller number of probes are declared to contain SFPs, but it loses power as
the number of probes declared to contain SFPs increases. The Greenhall method was least
effective among all seven methods.
The bottom panels of Figure 4.7 were produced by using only 2601 gold standard probes.
The left panel shows the number of correctly identified SFPs when the top 1, 5,. . ., 2601 probes
were declared to contain SFPs. It shows that the curve corresponding to the RContrast method
is slightly higher than curves corresponding to other methods. The Contrast and Rostoks
approaches lag behind the RContrast method. Because Cui’s method excludes probe sets with
absent calls, it could not identify all of the 401 gold standard SNP probes. Lastly, we examine
the bottom right panel of this figure, which illustrates ROC curves corresponding to the seven
methods when using only the gold standard probes after present and absent call filtering. It
shows that an analysis with the RContrast method is slightly more effective at distinguishing
probes with SFPs from probes without SFPs than the other methods. The Borevitz method
seems to be powerful when few probes are declared to contain SFPs, but it lags behind the
Rostoks and Contrast approaches when greater numbers of probes are declared to contain
SFPs. All these panels in this figure indicate that the RContrast method is the most effective
method for identifying probes with SFPs. Figures for other barley tissues are presented in
Supplementary Materials accompanying this paper. These plots also support the conclusion
discussed here.
4.4.3 Identification of Single Feature Polymorphisms in the Soybean Data
Each of the 75 Affymetrix soybean GeneChip contains 37,593 soybean probe sets. We
present results for the analysis of the 37,376 probe sets that each contain 11 probe pairs. To
identify SFPs that distinguish parental line L from the backcross lines and parental line H,
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we considered four analyses comparing BC1 versus L, BC2 versus L, BC3 versus L, and H
versus L by using the RContrast method. We conducted a separate analysis for each of the
five harvest time points, which leads to 20 analyses (4 pairwise comparisons of genotypes at 5
time points).
The prediction results within each time point and each comparison were ranked according
to their |tRi| values. The top 300 probes were identified from each comparison of parental line
L versus the three backcross lines, and the top 1500 probes were identified from the comparison
of parental lines L and H at each time point. These collections of top probes were compared
to identify probes common to all collections. Such probes may correspond to genomic regions
where DNA from the H line is important for high protein production. (Recall that the backcross
lines produce seeds with high protein content similar to the H line despite having very little
DNA from the H line.) Counts of common probes are summarized in the bottom row and in
the last column of Table 4.3. At each of the five time points, respectively, the bottom row
shows that the method identified a total of 73, 66, 53, 61, and 46 common probes among
the four genotype comparisons. For each of the four genotype comparisons, respectively, the
method identified a total of 51, 54, 100, and 608 common probes across the five times points.
We identified 32 probes showing SFPs at all five time points for all four genotype comparisons.
To illustrate SFPs discovery in soybean data, we will use three probesets as an example.
These probe sets include probe(s) that was(were) among the 32 probes which were identified
as containing SFPs in all sets. Figure 4.14 illustrates the di values of the 11 probes in probe
set Gma.11144.2.S1 at. Probes 10 and 11 in this probe set were among the 32 probes that
were identified as containing SFPs in all sets. The figure has four panels corresponding to the
comparisons of BC1 versus L (top left), BC2 versus L (top right), BC3 versus L (bottom left),
and H versus L (bottom right). In each of the four panels of the figure, the di values of these
two probes were significantly higher than the di values of the other 9 probes at each of the 5
time points. Similarly, Probe 9 is identified to carry SFP in probe set Gma.734.1.A1 at (Fig-
ure 4.13) and probes 7, 8, and 9 are identified to have SFPs in probe set GmaAffx.39499.1.S1 at
(Figure 4.15). Figures 4.16, 4.17, and 4.18 illustrate SFPs in these probe sets in an alternative
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way.
4.5 Concluding Remarks
We have introduced two new statistical algorithms to identify single feature polymorphisms
from oligonucleotide array data. The idea of our methodology is to find – after accounting for
the overall gene expression level differences in the probe set – extreme hybridization differences
between two genotypes that are often caused by sequence polymorphism. For each probe in
a probe set, we define a difference value that is contrasted with the average of the difference
values for the rest of the probes in that probe set. We have modified our contrast statistic
by using the Tukey biweight estimator of the average differences in our test statistic to avoid
potential problems caused by the presence of multiple SFPs within a single probe set.
We have compared the performance of our algorithms with five previously published meth-
ods by using two publicly available microarray data sets. The validation rates of predicted
SFPs were established via comparisons to a known set of SFPs for both data sets. It was
shown that our algorithms provided performance superior to the other methods in ordering
probes for evidence of SFPs. The SFP selection statistic of the Borevitz method was not
formulated to separate the binding differences due to sequence differences from overall gene
expression differences. The Rostoks method identifies SFPs by using the residuals from a probe
level model which accounts for the overall gene expression level in the probe set. However,
their probe level model does not include individual chip effects. Furthermore, residuals from
their model fit were used as data points in subsequent SAM analysis to find probes contain-
ing SFPs. By construction, residuals contain dependencies that are not accounted for in the
SAM analysis. Although the West method calculates an SFP selection statistic with the idea
of comparing the intensity level of each probe to the intensity level of the rest of the probes
in a probe set, it fails to correct for overall differential gene expression properly. The same
problem was also seen in the Greenhall approach. Although Cui’s method and our method
share the similar idea of identifying the outlying probe in the probe set, we have observed that
their prefiltering with presence calls cause to miss the several probes with SFPs in the gold
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standard data. Finally, we believe that all these observations could explain why our method
works better than existing methods for most of the data sets that we examined.
Although the RContrast method provided a better ordering of the probes for evidence of
SFPs than other methods for most of the data sets we presented, it is difficult to use this
or other methods to assess the false discovery rate in a set of probes declared to be SFPs.
Assuming that model (4.1) is correct, the Contrast approach can be used to obtain a valid test
of H0i vs. HAi for each probe. However, as discussed previously, it is possible for H0i to be
false even when there is no DNA variation between the genotypes for the ith probe in a probe
set. More generally, the assumption of no genotype-by-probe interaction for probes with no
SFPs may not hold. For example, due to variation in the sequences of probes within any probe
set, the hybridization characteristics of probes vary. Some probes may be more effective at
detecting differential expression than others. Thus, for genes that are differentially expressed
between genotypes, interactions between genotype and probes may exist even when no SFPs
are present in the probe set. For these reasons, we do not believe it is feasible at this time to
provide formal assessments of error rates in SFP calls without gold standard data sets. We
believe that the existing and our newly proposed SFP detection approaches can be used to
identify good SFP candidates that must be further verified using other means.
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Table 4.1 SFP Identification by the Seven Method for the Five Tissues in
the Maize Data Set. The table values provide the number of
probes correctly identified as containing an SFP when the top
2000, 4000,. . ., 10000 probes were declared to contain SFPs using
each method.
Tissue Cut-off Borevitz Cui Greenhall Rostoks West Contrast RContrast
2000 53 76 49 45 43 68 68
4000 77 107 82 85 72 105 107
13 5000 92 119 95 89 88 118 124
DAP 6000 102 125 111 106 92 127 130
Endo 7000 112 131 120 111 104 134 139
8000 118 134 126 116 109 139 147
10000 139 143 136 130 119 152 165
2000 43 70 50 53 47 66 65
4000 75 97 76 82 76 101 105
19 5000 81 102 88 93 86 108 112
DAP 6000 88 108 97 99 93 116 123
Endo 7000 100 115 104 108 97 124 129
8000 111 120 111 116 101 130 138
10000 120 130 120 123 117 139 146
2000 66 85 69 66 58 85 86
4000 102 121 108 107 90 125 136
Immature 5000 118 131 123 119 101 140 148
6000 133 144 131 130 108 149 164
Ear 7000 147 150 143 137 118 159 171
8000 156 156 151 147 122 168 181
10000 176 166 168 159 136 175 190
2000 36 78 42 46 42 72 67
4000 67 114 79 76 72 109 109
19 5000 80 131 94 90 88 128 131
DAP 6000 88 137 112 99 98 136 142
Embryo 7000 102 142 125 110 107 147 151
8000 109 145 133 118 112 152 163
10000 137 156 144 133 126 163 177
2000 39 72 54 52 38 71 71
4000 73 113 83 86 69 105 106
5000 94 123 97 99 83 115 125
Seedling 6000 109 131 112 110 92 124 133
7000 126 138 122 122 99 135 141
8000 134 141 134 132 104 140 145
10000 152 148 144 141 122 149 160
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Table 4.2 SFP Identification by the Seven Method for the Six Tissues in
the Barley Data Set. The table values provide the number of
probes correctly identified as containing an SFP when the top
2000, 4000,. . ., 10000 probes were declared to contain SFPs using
each method.
Tissue Cut-off Borevitz Cui Greenhall Rostoks West Contrast RContrast
2000 66 131 86 102 86 120 122
4000 133 163 127 160 143 177 181
COL 5000 160 170 141 182 163 198 204
6000 177 175 154 189 174 207 216
8000 208 179 173 212 197 226 225
10000 220 184 186 222 214 234 242
2000 49 157 74 92 95 124 126
4000 81 185 130 155 148 183 186
CRO 5000 94 192 152 177 169 205 211
6000 118 197 167 190 179 217 227
8000 157 206 189 222 204 241 247
10000 186 213 213 240 225 259 265
2000 61 159 82 94 93 118 115
4000 131 195 142 175 159 199 194
GEM 5000 160 204 160 201 187 215 219
6000 183 207 177 218 207 236 242
8000 223 215 198 245 237 259 278
10000 243 224 215 266 254 277 291
2000 46 146 71 92 74 99 98
4000 82 172 119 134 124 159 167
LEA 5000 112 181 134 155 135 174 182
6000 132 184 143 178 152 189 199
8000 166 187 166 201 170 212 220
10000 183 188 179 215 195 231 231
2000 74 154 89 101 107 128 120
4000 135 188 138 162 163 189 199
RAD 5000 161 192 159 190 186 221 226
6000 185 194 175 214 206 236 242
8000 222 204 199 248 230 258 271
10000 249 210 213 261 241 275 282
2000 67 6 88 90 82 116 112
4000 143 58 127 158 147 172 179
ROO 5000 170 60 144 180 165 199 209
6000 190 60 154 196 187 216 225
8000 217 92 173 234 218 242 250
10000 237 111 186 255 231 261 266
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Table 4.3 Identifying SFPs in the Soybean Data Set. Table entries are the
number of probes declared to contain an SFP for each combi-
nation of time and genotype comparison. The margins of the
table give the number of probes common to all the collections of
probes represented in each column or row of the table.
Time=20 Time=25 Time=30 Time=35 Time=45 Common
BC1 vs L 300 300 300 300 300 51
BC2 vs L 300 300 300 300 300 54
BC3 vs L 300 300 300 300 300 100
H vs L 1500 1500 1500 1500 1500 608
Common 73 66 53 61 46 32
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Figure 4.1 Single Feature Polymorphisms Description. Top left panel: For
all probes, genotype A and genotype B have same expression
level. Top right panel: A gene has higher expression in geno-
type A than in genotype B. Bottom left panel: For all probes,
genotype A and genotype B have same expression level except
probe 5 which reveals an SFP. Bottom right panel: A gene is
differentially expressed between genotypes and there is evidence
for an SFP in probe 5.
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Figure 4.2 Maize Data: Endosperm 19 DAP Tissue. Performance of the
methods for SFP discovery in the maize Endosperm 19 DAP tis-
sue. Top Left: The number of correctly identified SFPs when
the top 10, 20,. . ., 10000 probes among all probes were declared
to contain SFPs. Top Right: ROC curves corresponding to the
seven methods when using all the probes in the data set. Bot-
tom Left: The number of correctly identified SFPs when the
top 1, 5,. . ., 6489 probes among all gold-standard probes were
declared to contain SFPs. Bottom Right: ROC curves corre-
sponding to the seven methods when using only gold-standard
probes.
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Figure 4.3 Maize Data: Endosperm 13 DAP Tissue. Performance of the
methods for SFP discovery in the maize Endosperm 13 DAP tis-
sue. Top Left: The number of correctly identified SFPs when
the top 10, 20,. . ., 10000 probes among all probes were declared
to contain SFPs. Top Right: ROC curves corresponding to the
seven methods when using all the probes in the data set. Bot-
tom Left: The number of correctly identified SFPs when the
top 1, 5,. . ., 6489 probes among all gold-standard probes were
declared to contain SFPs. Bottom Right: ROC curves corre-
sponding to the seven methods when using only gold-standard
probes.
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Figure 4.4 Maize Data: Immature Ear Tissue. Performance of the meth-
ods for SFP discovery in the maize Ear tissue. Top Left: The
number of correctly identified SFPs when the top 10, 20,. . .,
10000 probes among all probes were declared to contain SFPs.
Top Right: ROC curves corresponding to the seven methods
when using all the probes in the data set. Bottom Left: The
number of correctly identified SFPs when the top 1, 5,. . ., 6489
probes among all gold-standard probes were declared to contain
SFPs. Bottom Right: ROC curves corresponding to the seven
methods when using only gold-standard probes.
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Figure 4.5 Maize Data: 19 DAP Embryo Tissue. Performance of the meth-
ods for SFP discovery in the maize Embryo tissue. Top Left:
The number of correctly identified SFPs when the top 10, 20,. . .,
10000 probes among all probes were declared to contain SFPs.
Top Right: ROC curves corresponding to the seven methods
when using all the probes in the data set. Bottom Left: The
number of correctly identified SFPs when the top 1, 5,. . ., 6489
probes among all gold-standard probes were declared to contain
SFPs. Bottom Right: ROC curves corresponding to the seven
methods when using only gold-standard probes.
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Figure 4.6 Maize Data: Seedling Tissue. Performance of the methods for
SFP discovery in the maize Seedling tissue. Top Left: The
number of correctly identified SFPs when the top 10, 20,. . .,
10000 probes among all probes were declared to contain SFPs.
Top Right: ROC curves corresponding to the seven methods
when using all the probes in the data set. Bottom Left: The
number of correctly identified SFPs when the top 1, 5,. . ., 6489
probes among all gold-standard probes were declared to contain
SFPs. Bottom Right: ROC curves corresponding to the seven
methods when using only gold-standard probes.
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Figure 4.7 Barley Data: RAD Tissue. Performance of the methods for SFP
discovery in the Barley RAD tissue. Top Left: The number of
correctly identified SFPs when the top 10, 20,. . ., 10000 probes
among all probes were declared to contain SFPs. Top Right:
ROC curves corresponding to the seven methods when using
all the probes in the data set. Bottom Left: The number of
correctly identified SFPs when the top 1, 5,. . ., 2601 probes
among all gold-standard probes were declared to contain SFPs.
Bottom Right: ROC curves corresponding to the seven methods
when using only gold-standard probes.
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Figure 4.8 Barley Data: COL Tissue. Performance of the methods for SFP
discovery in the Barley COL tissue. Top Left: The number of
correctly identified SFPs when the top 10, 20,. . ., 10000 probes
among all probes were declared to contain SFPs. Top Right:
ROC curves corresponding to the seven methods when using
all the probes in the data set. Bottom Left: The number of
correctly identified SFPs when the top 1, 5,. . ., 2601 probes
among all gold-standard probes were declared to contain SFPs.
Bottom Right: ROC curves corresponding to the seven methods
when using only gold-standard probes.
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Figure 4.9 Barley Data: CRO Tissue. Performance of the methods for SFP
discovery in the Barley CRO tissue. Top Left: The number of
correctly identified SFPs when the top 10, 20,. . ., 10000 probes
among all probes were declared to contain SFPs. Top Right:
ROC curves corresponding to the seven methods when using
all the probes in the data set. Bottom Left: The number of
correctly identified SFPs when the top 1, 5,. . ., 2601 probes
among all gold-standard probes were declared to contain SFPs.
Bottom Right: ROC curves corresponding to the seven methods
when using only gold-standard probes.
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Figure 4.10 Barley Data: GEM Tissue. Performance of the methods for
SFP discovery in the Barley GEM tissue. Top Left: The num-
ber of correctly identified SFPs when the top 10, 20,. . ., 10000
probes among all probes were declared to contain SFPs. Top
Right: ROC curves corresponding to the seven methods when
using all the probes in the data set. Bottom Left: The num-
ber of correctly identified SFPs when the top 1, 5,. . ., 2601
probes among all gold-standard probes were declared to con-
tain SFPs. Bottom Right: ROC curves corresponding to the
seven methods when using only gold-standard probes.
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Figure 4.11 Barley Data: LEA Tissue. Performance of the methods for
SFP discovery in the Barley LEA tissue. Top Left: The num-
ber of correctly identified SFPs when the top 10, 20,. . ., 10000
probes among all probes were declared to contain SFPs. Top
Right: ROC curves corresponding to the seven methods when
using all the probes in the data set. Bottom Left: The num-
ber of correctly identified SFPs when the top 1, 5,. . ., 2601
probes among all gold-standard probes were declared to con-
tain SFPs. Bottom Right: ROC curves corresponding to the
seven methods when using only gold-standard probes.
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Figure 4.12 Barley Data: ROO Tissue. Performance of the methods for
SFP discovery in the Barley ROO tissue. Top Left: The num-
ber of correctly identified SFPs when the top 10, 20,. . ., 10000
probes among all probes were declared to contain SFPs. Top
Right: ROC curves corresponding to the seven methods when
using all the probes in the data set. Bottom Left: The num-
ber of correctly identified SFPs when the top 1, 5,. . ., 2601
probes among all gold-standard probes were declared to con-
tain SFPs. Bottom Right: ROC curves corresponding to the
seven methods when using only gold-standard probes.
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Figure 4.13 Soybean Data: SFPs in Probe set Gma.734.1.A1 at. For the
five time points, each panel shows di values of 11 probes in the
probe set Gma.734.1.A1 at which is identified to have SFP in
Probe 9. Top Left: BC1 versus L, Top Right: BC2 versus L,
Bottom Left: BC3 versus L, and Bottom Right: H versus L.
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Figure 4.14 Soybean Data: SFPs in Probe set Gma.11144.2.S1 at. For
five time points, each panel shows di values of 11 probes in the
probe set Gma.11144.2.S1 at which is identified to have SFPs
in Probes 10 and 11. Top Left: BC1 versus L, Top Right: BC2
versus L, Bottom Left: BC3 versus L, and Bottom Right: H
versus L.
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Figure 4.15 Soybean Data: SFPs in Probe set GmaAffx.39499.1.S1 at. For
five time points, each panel shows di values of 11 probes in the
probe set GmaAffx.39499.1.S1 at which is identified to have
SFPs in Probes 7, 8, and 9. Top Left: BC1 versus L, Top
Right: BC2 versus L, Bottom Left: BC3 versus L, and Bottom
Right: H versus L.
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Figure 4.16 Soybean Data: SFPs in Probe set Gma.734.1.A1 at. At five
time points, each panel shows di values of 11 probes in the
probe set Gma.734.1.A1 at which is identified to have SFP in
Probe 9. Top Left: BC1 versus L, Top Right: BC2 versus L,
Bottom Left: BC3 versus L, and Bottom Right: H versus L.
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Figure 4.17 Soybean Data: SFPs in Probe set Gma.11144.2.S1 at. At five
time points, each panel shows di values of 11 probes in the
probe set Gma.11144.2.S1 at which is identified to have SFPs
in Probes 10 and 11. Top Left: BC1 versus L, Top Right: BC2
versus L, Bottom Left: BC3 versus L, and Bottom Right: H
versus L.
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Figure 4.18 Soybean Data: SFPs in Probe set GmaAffx.39499.1.S1 at. At
five time points, each panel shows di values of 11 probes in the
probe set GmaAffx.39499.1.S1 at which is identified to have
SFPs in Probes 7, 8, and 9. Top Left: BC1 versus L, Top
Right: BC2 versus L, Bottom Left: BC3 versus L, and Bottom
Right: H versus L.
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CHAPTER 5. General Conclusion
In the first research chapter of this thesis, we proposed a method that combines results
from the fit of full and selected linear mixed models to identify differentially expressed genes
and provide FDR control at target levels when the true underlying random effects structure
varies across genes. Our simulation illustrated that the performance of our hybrid method
is not effected by the proportion of non-null genes in the data set. We also showed that our
method is robust with respect to the presence of outlying observations and the method can
tolerate some level of missing data. It is also observed that our hybrid procedure provide
conservative FDR levels maybe far below nominal. This situation results because the operator
characteristics of testing following model selection are far superior to those of the ANOVA
method alone. We are of the traditional opinion that an error rate below nominal is preferred
to an error rate above nominal. Nonetheless, there is room to improve the power of our
proposed procedures, and we hope to address this issue in future research.
In the second research chapter, we have introduced a hierarchical Bayesian analysis method
for discovering differentially expressed genes when a microarray experiment involves multiple
sources of variation through the inclusion of multiple random factors. When microarray ex-
periment have complex experimental design and the sample size for each gene is small, the
analysis with the classical gene-by-gene mixed linear model suffers from low degrees of freedom
to estimate all the model parameter considered in the model. Our hierarchical Bayesian model
borrows strength across genes by for estimating the gene specific model parameters. Instead of
inverse gamma or uniform priors, this model make use of the half-Cauchy priors for the standard
deviation parameters of the random factors with few effects. Simulation study showed that
our hierarchical Bayesian approach is much powerful than a traditional gene-by-gene mixed
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linear model analysis at distinguishing differentially expressed genes from non-differentially
expressed genes. Although our proposed methodology provides better ordering of the genes,
further work needs to be done in developing the next level of hierarchical models, in which we
should be able to estimate the false discovery rate to find a reasonable cutoff point on the list.
Therefore, in a classical gene-by-gene mixed linear model analysis, there will be very few
degrees of freedom to estimate the variance components In the final research chapter, we dis-
cuss about the identification of Single Feature Polymorphisms (SFPs) from oligonucleotide
arrays. This is important for producing more accurate expression measurements when com-
paring samples of different genotypes. To identify SFPs from oligonucleotide array data, we
have developed two new statistical algorithms where a difference value is defined for each probe
after accounting for the overall gene expression level differences in the probe set. First method
contrast the difference value of each probe with the average of the difference values for the rest
of the probes in that probe set. Second method is a robust version of the first method. We also
summarized several SFPs discovery methods in the literature. The performance of all these
methods were compared with the performance of our proposed methods by using two publicly
available data sets. Our methods provided a better ordering of the probes for evidence of SFPs
than other methods for most of the data sets we presented.
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